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Introduction
Colorectal resection is a commonly performed procedure in surgery. The main indication is 
colorectal cancer, but inflammatory bowel disease also contributes. Restoring continuity of the bowel is essential, yet, unfortunate for both patients and surgeons, this includes the risk of anastomotic leakage (AL). AL is characterized by anastomotic dehiscence leading to leak-age of intestinal content into the abdominal or pelvic cavity(1). AL can result in peritonitis, abscess formation and sepsis often requiring reoperation with a temporary or permanent 
stoma. This severe postoperative complication contributes to one-third of the postoperative mortality after colorectal surgery(2).
The incidence of AL varies from 4-33% with a higher incidence in the lower gastrointestinal 
tract, rectal anastomoses manifesting the highest rates(3). The incidence of AL has not been reduced over the last decades despite the introduction of minimally invasive techniques in colorectal surgery(4, 5). With 10.000 colorectal resections for colorectal cancer performed 
in The Netherlands yearly, a substantial number of patients is at risk for AL. In addition, AL substantially prolongs hospital stay and increases medical costs by as much as $24.000, 
thereby approximately tripling the expenditure relative to that of normal recovery after col-orectal surgery(6, 7).
Although the exact pathophysiology is unknown, several risk factors for AL after colorectal 
surgery have been identified. Preoperative risk factors are male sex, American Society of 
Anesthesiologists fitness grade above II, renal disease, co-morbidity and history of radio-
therapy. Tumor characteristics associated with AL are distal location, size, advanced stage and metastatic disease. Smoking, obesity, poor nutrition, alcohol abuse and immunosup-pressants are considered adjustable risk factors(8).
DiagnosisAL is usually diagnosed within 6 to 15 days after surgery(9, 10). However, it was recently 
demonstrated that 20% of leakages after low anterior resection were diagnosed even be-yond 30 days(11). Clinical symptoms, laboratory results and radiological studies are part of the diagnostic strategy. Clinical manifestations of this postoperative complication include fever, abnormal vital signs and abdominal pain, however these symptoms are common after 
colorectal surgery and therefore not specific for AL(12). From laboratory tests, serum C-re-active protein (CRP) is the most used negative predictive marker(13). CRP is synthesized by 
the liver in response to inflammation(14). CRP levels also rise in response to trauma, isch-
emia, and other inflammatory complications, so CRP monitoring is also lacking specificity 
for AL(15). Radiological studies aim to show communication between intra- and extra-lumi-
9Introduction
nal compartments. In clinical practice, abdominal computed tomography (CT) scanning is 
most frequently used to diagnose AL(16, 17). The sensitivity is reported to be around 65% 
(18, 19). However, in comparison to the widespread use of CT scanning for AL, evidence on the diagnostic accuracy is scarce. Besides, the relatively poor diagnostic accuracy, radia-
tion exposure and costs impede implementation of routine CT-scanning in clinical practice. In addition, this relatively low sensitivity is mostly due to high rates of false-negatives and 
must be taken into account in order to prevent delay in diagnosis(20). Delayed reinterven-
tion after false-negative CT scanning is associated with high mortality(21). Actually, delay 
in diagnosis of 2.5 days is associated with an increase in mortality from 24% to 39%(22). Hence, early detection of AL after colorectal surgery is crucial in order to minimize morbid-ity and mortality.
Reliable biomarkers might contribute to early detection of AL. Recent studies have focused 
on different biomarkers for AL in both serum and drain fluid. Several biomarkers represent-
ing different stages of ischemia, inflammation and necrosis have been identified and yielded promising results. Peritoneal cytokines, lactate and pH seem to have the potential to detect AL early after colorectal surgery(23, 24). In addition, measuring Enterococcus faecalis in 
drain fluid may be an affordable and fast screening method(25). A systematic review con-cluded that combining biomarkers yields improved predictive accuracy compared to sepa-rate analysis of biomarkers(26).
Intervention
The choice of intervention for suspected AL is quite complex with very limited evidence 
available. Treatment strategies consist of non-surgical and surgical treatment options. An-tibiotics and radiological drainage are nonsurgical treatment options. Surgical drainage, removal or repair of the anastomosis and creation of a deviating ileostomy or permanent 
colostomy are surgical treatment options(27). The type of intervention strongly depends on the severity of AL and the general condition of the patient(28).
Preservation of the anastomosis, most often with diversion of the fecal stream by ostomy seems safe when both sepsis and fecal contamination are absent(29, 30). A questionnaire 
amongst members of the Dutch Society for Gastrointestinal Surgery showed that Dutch col-orectal surgeons, in case of a left sided colonic or rectal anastomosis, prefer preserving the anastomosis in non-septic young patients whereas in older patients or in patients with ab-
dominal sepsis, they prefer sacrificing the anastomosis with the construction of an end co-lostomy(28). Nevertheless, half of all patients who undergo stoma formation due to leakage are left with a permanent stoma(31).
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Finally, also minimal invasive strategies for the management of AL after colorectal surgery 
are under scrutiny. Traditional management mandates laparotomy, however nowadays AL can safely be managed laparoscopically(32). Moreover, endoluminal vacuum therapy seems 
effective in treating extraperitoneal AL(33, 34).
PreventionPrevention of AL and its clinical consequences after colorectal surgery is ideal, although 
most innovative prevention strategies are still in an experimental phase. The unknown pathophysiology of AL after colorectal resection impedes development of well-founded pre-vention strategies and emphasizes the need for an integrated approach.
Preoperative risk assessment and optimization of adjustable risk factors such as smoking and obesity might prevent AL(35). Moreover, pre-operative risk assessment also facilitates intra-operative decision-making whether to protect the anastomosis from passage of intra-luminal content by constructing an ostomy. However, diversion seems not to reduce the in-cidence of AL, instead it only minimizes its consequences(8, 36).
The GRECCAR 5 trial has shown that pelvic drainage after rectal excision for rectal cancer does not prevent AL in an early postoperative phase, but it was not found to be detrimental 
either(37). Hence, the opportunity to detect AL with innovative drain fluid analysis might justify pelvic drainage after rectal resection.
Surgeons have attempted to detect leakage with intraoperative tests assessing anastomot-
ic integrity and thereby leaving the possibility for immediate repair. These methods have 
emerged over the last decades. The air leak test (ALT) is one of these techniques and used most frequently, although convincing evidence is scarce(38). Endoscopic visualization of colorectal anastomoses is another intraoperative test and might be a useful tool visualiz-
ing the intraluminal anastomotic line(39). The next advancement involves measurement of 
microperfusion at the anastomotic site and holds great potential(40). In this field, indocy-
anine green (Icg)-enhanced fluorescence is one of the latest techniques yielding promising 
results(41). Future studies require proper study design and sufficient sample size in order to determine their effectiveness in preventing AL.
It was previously demonstrated that mechanical bowel preparation does not reduce the leakage rate and should therefore not be prescribed routinely(42). However, recent evidence showed that there may be a role for the combination of oral antibiotics and mechanical bow-el preparation in the prevention of anastomotic leakage after colorectal resection(43, 44)
11
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In addition, techniques that mechanically protect the anastomosis from leaking have been 
proposed. Tissue adhesives such as sealants used to reinforce the anastomosis showed promising results although translation to clinical research is lacking(45, 46). Intraluminal devices which mechanically shield intraluminal content from the anastomosis are under scrutiny, however results of recent studies were disappointing(47, 48).
Outline of this thesisEven in 2019, colorectal AL remains the most serious complication after colorectal resec-tion. Although the outcomes of colorectal surgery have been improved over the last decades, 
the incidence of AL has not been reduced. This emphasizes the need for an integrated ap-proach of clinical perspectives for this postoperative complication. Improved risk assess-ment, surgical techniques and early detection offer opportunities to reduce the incidence as 
well as to minimize the consequences of this postoperative complication. Therefore, the aim 
of this thesis is to explore new clinical perspectives of colorectal AL in order to minimize the incidence and the consequences of this severe postoperative complication.
In Part I of this thesis, risk assessment of anastomotic leakage after colorectal resection is described.
In Chapter 2 risk factors are identified for early and late AL separately. The hypothesis that 
early AL is related to technical failure and late AL to healing deficiencies is evaluated.
In Chapter 3 it is investigated whether the interval between preoperative short-course ra-
diotherapy and surgery for rectal cancer influences the incidence of AL.
In Chapter 4 the association between age and AL after colorectal resection is explored.
In Chapter 5 postoperative complications are compared after chemoradiation and surgery for locally advanced rectal cancer and short-course radiotherapy followed by surgery after a prolonged interval.
In Part II of this thesis, surgical techniques are evaluated.
In Chapter 6 postoperative morbidity between laparoscopic (LaTME) and transanal total 
mesorectal excision (TaTME) for rectal cancer is compared.
In Chapter 7 it is assessed whether postoperative morbidity is influenced by the number of surgeons involved in the surgical procedure in a low-volume hospital.
1
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In Part III of this thesis, prevention of AL after colorectal resection is addressed.
In Chapter 8 a systematic review and meta-analysis are described exploring whether the 
intraoperative ALT prevents colorectal clinically manifest AL.
In Part IV of this thesis, innovative techniques for early detection of AL are evaluated.
In Chapter 9 available literature on systemic and peritoneal inflammatory cytokines mea-surement for early detection of colorectal AL is evaluated in a systematic review and me-ta-analysis.
In Chapter 10 an international multicenter prospective cohort study aims to assess a combi-nation of biomarkers as a clinically useful tool for early detection of AL after rectal resection.
In Chapter 11 the findings of this thesis will be discussed.
13
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Abstract
BackgroundAnastomotic leakage remains a major complication after surgery for colorectal carcinoma, 
but its origin is still unknown. Our hypothesis was that early anastomotic leakage is mostly related to technical failure of the anastomosis, and that late anastomotic leakage to healing 
deficiencies.
Objective
The aim of this study was to assess differences in risk factors for early and late anastomotic leakage.
Design
This was a retrospective cohort study.
Settings
The Dutch ColoRectal Audit is a nationwide project that collects information on all Dutch patients undergoing surgery for colorectal cancer.
PatientsAll patients undergoing surgical resection for colorectal cancer in the Netherlands between 2011-2015 were included.
Main Outcome Measures
Late anastomotic leakage was defined as anastomotic leakage leading to reintervention later than 6 days postoperatively.
Results
In total, 36 929 patients were included; early anastomotic leakage occurred in 863 (2.3%) 
patients, and late anastomotic leakage occurred in 674 (1.8%) patients. From a multivar-iable multinomial logistic regression model, independent predictors of early anastomot-ic leakage relative to no anastomotic leakage and late anastomotic leakage relative to no 
anastomotic leakage included male sex (OR 1.8 p < 0.001 and OR 1.2 p = 0.013) and rectal 
cancer (OR 2.1 p < 0.001 and OR 1.6 p = 0.046). Additional independent predictors of early 
anastomotic leakage relative to no anastomotic leakage included BMI (OR 1.1 p = 0.001), 
laparoscopy (OR 1.2 p = 0.019), emergency surgery (OR 1.8 p < 0.001) and no diverting ile-
ostomy (OR 0.3 p < 0.001). Independent predictors of late anastomotic leakage relative to no 
anastomotic leakage were Charlson Comorbidity Index of ≥ II (OR 1.3 p = 0.003), ASA score 
21
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III to V (OR 1.2 p = 0.030), preoperative tumor complications (OR 1.1 p = 0.048), extensive 
additional resection because of tumor growth (OR 1.7 p = 0.003), and preoperative radiation 
(OR 2.0 p=0.010).
Limitations
This was an observational cohort study.
ConclusionsMost risk factors for early anastomotic leakage were surgery-related factors, representing 
surgical difficulty, which might lead to technical failure of the anastomosis. Most risk factors for late anastomotic leakage were patient related factors, representing the frailty of patients 
and tissues, which might imply healing deficiencies.
2
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Introduction
Surgical resection is the standard for curative treatment of colorectal cancer. Unfortunately, anastomotic leakage (AL) remains a major complication after resection, but its origin is still 
mainly unknown. The incidence of AL in the literature varies from 3% to 28% and one-third 
of all postoperative mortality is related to AL(1). Delay in diagnosing AL results in increased postoperative mortality(2).
In general, AL is diagnosed within the first 2 weeks after surgery(3-5). In previous studies, 
late AL was defined as AL diagnosed 21 or 30 days after surgery or as AL diagnosed after 
hospital discharge(6-11). However, a recent study advocated that redefinition of early and 
late AL with a proper cutoff point of a specific day is necessary for precise discrimination 
and they determined the cutoff at postoperative day 6(12). This demonstrates that there is 
no consensus in the literature regarding the definition of late AL.
Most previous studies suggested that early and late AL are different entities, although these 
studies were based on relatively small sample sizes(6-11). These previous studies showed that the postoperative course differs for patients with early AL and late AL. Patients with early AL are more likely to undergo re-laparotomy as intervention(10, 12). However, the long-term stoma retention rate in patients with late AL is higher than in patients with early 
AL(11). These differences in postoperative course emphasize that, in clinical practice, more attention should be paid to the distinction between early AL and late AL. In addition, better insight in the nature of AL could also contribute to early detection of AL, especially of late AL, because one-third of AL is diagnosed after 30 days after surgery(13).
A technically not well-constructed anastomosis might result in immediate anastomotic de-hiscence with subsequent clinical symptoms, whereas a well-constructed anastomosis will 
develop anastomotic dehiscence more slowly in case wound healing is impaired. The aim of this study was to assess differences in risk factors for early and late AL to demonstrate whether early AL is related to technical failure of the anastomosis and late AL to healing 
deficiencies.
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Methods
Data were derived from the Dutch ColoRectal Audit (DCRA), a nationwide quality improve-
ment project, that collects information on all Dutch patients undergoing surgical resection 
for primary colorectal cancer. Data registered were patients’, tumor and treatment charac-teristics as well as patient outcomes. For this study no ethical approval or informed consent 
was required under Dutch law. Further details of this dataset regarding collection and meth-odology have been published previously(14).
Inclusion and exclusion criteriaAll patients undergoing surgical resection for primary colorectal cancer in the Netherlands 
between January 2011 and December 2015 and registered in the DCRA before March 31th 2016 were included in this study. Patients without a primary anastomosis, and patients for 
whom the day of diagnosis of AL was unknown were excluded from analysis. Patients in 
whom AL occurred later than 90 days after surgery were excluded. Data are usually regis-
tered at 30 days after surgery unless the initial hospital stay takes longer. Therefore, we con-
sidered data registered about AL later than 90 days after surgery as unreliable. We excluded patients with multiple synchronous tumors due to differences in prognosis(15).
Early versus late AL
AL was defined as clinically relevant AL that requires radiological or surgical re-interven-
tion(16). We defined early AL as AL leading to reintervention until day 6 postoperatively and late AL as AL leading to reintervention after day 6 postoperatively. In previous literature, 
there is no consensus on the definition of late AL. To test our hypothesis, it was not sufficient 
to base our definition on the day of discharge, which is highly sensitive to institutes and oth-
er postoperative complications. Although it might be a fluent transition for early to late AL, 
for precise discrimination we think it is important to use a definition based on a specific day. 
Besides, the transition in origin of AL from technical failure to healing deficiencies should be 
captured during the first postoperative days.
OutcomesEarly and late ALs were primary outcome measures. Potential risk factors for early and late 
AL were retrieved from the DCRA database including patients characteristics (sex, age, BMI, 
Charlson Comorbidity Index(17, 18), ASA score(19), and previous abdominal surgery), tu-mor characteristics (tumor location, tumor stage, metastasis, and preoperative tumor com-plication), and treatment characteristics (surgical technique, urgency of surgery, diverting ileostomy, additional resection of adjacent organs because of tumor growth or because of 
metastasis and preoperative radiotherapy). In the DCRA database, preoperative tumor char-
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acteristics were specified as anemia, ileus, abscess, and perforation.
Statistical analysisMultiple imputation was performed to deal with missing values assuming data were missing 
at random(20). Five imputed datasets have been created based on AL, hospital, sex, Charlson 
Comorbidity Index, diverting ileostomy, metastasis and preoperative tumor complication. Multivariate multinominal logistic regression analyses were performed to test independent associations between patient, tumor and treatment characteristics and the occurrence of no, early and late AL. A multinominal logistic regression model is applicable when an outcome variable has more than 2 categories, but no ordering in these categories can be assumed. All clinically relevant variables were added to the model as independent variables (full model). Covariate selection was driven by available knowledge and biological plausibility of poten-
tial confounders. Tests for interactions between covariates were not implemented. More details concerning the relevant predictors of AL were described elsewhere(21, 22). Results 
were reported as ORs with 95% CI. Significance was considered as a p-value of <0.05. All statistical analyses were performed in SPSS version 22.
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Results
A total of 49 941 patients underwent surgery for primary colorectal cancer in the Nether-
lands between 2011 and 2015. After exclusion of patients without a primary anastomosis 
(n = 11 246), 38 695 patients were eligible for inclusion. Patients in whom AL occurred later than 90 days after surgery, and patients for whom the day of diagnosis of AL was unknown 
(n = 558) were excluded from analysis. Because of differences in prognosis we excluded pa-
tients with multiple synchronous tumors (n = 1208). In total, 36 929 patients were included.
Of these 36 929 patients, 80.9% underwent surgery for a colon tumor and 63.1% underwent 
laparoscopic surgery (Table 1).
AL leading to re-intervention occurred in 1537 (4.2%) patients. Early AL occurred in 863 
(2.3%) patients and late AL occurred in 674 (1.8%) patients. The median interval between 
colorectal resection and intervention for AL was 6 days. The median interval between colorectal resection and intervention for early AL was 4 days, and for late AL, the median 
interval between colorectal resection and intervention was 10 days. In 18%, AL was diag-
nosed after hospital discharge. In patients with early AL, 3.1% were diagnosed after hospital 
discharge, and in patients with late AL, 37.4% was diagnosed after hospital discharge. The 
incidence of early AL in patients with a colon tumor was 2.3% and, in patients with a rectum 
tumor, the incidence was 2.4%, whereas the incidence of late AL was 1.6% in patients with 
a colon tumor and 3.0% in patients with a rectum tumor.
Table 1. Patient, tumor and treatment characteristics. Values in parentheses are percentages unless 
identified otherwise No anastomotic leakage
n = 35392
Early anastomotic leakage
n = 863
Late anastomotic leakage
n = 674
Patient characteristics
Sex Female 16373 (46.3%) 276 (32.0%) 273 (40.5%)Male 19008 (53.7%) 587 (68.0%) 401 (59.5%)Missing 11 (0.0%) 0 0
Age, mean ± SD, yr 69.3 (±10.67) 68.6 (±10.55) 69.0 (±9.83)Missing 16 0 0
BMI, mean ± SD, kg/m3 26.3 (±4.71) 27.0 (±6.54) 26.4 (±4.81)Missing 1332 21 13Charlson Comorbidity 
Index
0 18401 (52.0%) 428 (49.6%) 311 (46.1%)I 8025 (22.7%) 197 (22.8%) 159 (23.6%)
≥ II 8966 (25.3%) 238 (27.6%) 204 (30.3%)ASA score I-II 27872 (78.8%) 650 (75.3%) 503 (74.6%)III-V 7471 (21.1%) 213 (24.7%) 171 (25.4%)missing 49 (0.1%) 0 (0.0%) 0 (0.0%)
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Table 1. (Continued) No anastomotic leakage
n = 35392
Early anastomotic leakage
n = 863
Late anastomotic leakage
n = 674Previous abdominal surgery No 23332 (65.9%) 603 (69.9%) 435 (64.5%)Yes 12006 (33.9%) 257 (29.8%) 238 (35.3%)missing 54 (0.2%) 3 (0.3%) 1 (0.1%)
Tumor characteristics
Tumor location Colon 28723 (81.2%) 697 (80.8%) 463 (68.7%)Rectum 6669 (18.8%) 166 (19.2%) 211 (31.3%)
Tumor stage T1 3867 (11.0%) 84 (9.7%) 76 (11.3%)
T2 7026 (20.0%) 140 (16.3%) 117 (17.4%)
T3 19604 (55.4%) 524 (60.7%) 385 (57.1%)
T4 4503 (12.8%) 112 (13.0%) 95 (14.1%)Missing 392 (0.8%) 3 (0.3%) 1 (0.1%)Metastasis No 32023 (90.5%) 770 (89.2%) 600 (89.0%)Yes 3369 (9.5%) 93 (10.8%) 74 (11.0%)Preoperative tumor complication No/missing 23378 (66.1%) 551 (63.8%) 423 (62.8%)Yes 12014 (33.9%) 312 (36.2%) 251 (37.2%)Perforation 253 (0.7%) 3 (0.3%) 5 (0.7%)Abscess 253 (0.7%) 3 (0.3%) 8 (1.2%)Anemia 6774 (19.1%) 147 (17.0%) 138 (20.5%)Ileus 3257 (9.2%) 116 (13.4%) 61 (9.1%)
Treatment characteristicsSurgical technique Open 12864 (36.3%) 292 (33.8%) 261 (38.7%)Laparoscopic 22343 (63.1%) 566 (65.7%) 410 (60.8%)
Other/missing 185 (0.6%) 5 (0.5%) 3 (0.5%)
Urgency of surgery Elective 31860 (90.0%) 738 (85.5%) 610 (90.5%)
Urgent/Emergency 3519 (9.9%) 125 (14.5%) 64 (9.5%)Missing 13 (0.0%) 0 (0.0%) 0 (0.0%)
Diverting ileostomy No 29962 (84.7%) 796 (92.2%) 519 (77.0%)Yes 5430 (15.3%) 67 (7.8%) 155 (23.0%)Additional resection because of tumor growth No 31519 (89.1%) 797 (92.4%) 598 (88.7%)Limited 1727 (4.9%) 31 (3.6%) 38 (5.6%)
Extensive 1121 (3.2%) 35 (4.1%) 38 (5.6%)Missing 1025(2.9%) 0 (0.0%) 0 (0.0%)Additional resection because of metastasis No 34140 (96.5%) 836 (96.9%) 642 (95.3%)Yes 1179 (3.3%) 26 (3.0%) 31 (4.6%)Missing 73 (0.2%) 1 (0.1%) 1 (0.1%)Preoperative radiotherapy No 28768 (81.3%) 694 (80.4%) 463 (68.7%)Radiation 2716 (7.7%) 52 (6.0%) 104 (15.4%)Chemo radiation 1994 (5.6%) 37 (4.3%) 56 (8.3%)Missing 1914 (5.4%) 37 (4.3%) 51 (7.6%)
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From a multivariable multinomial logistic regression model, independent predictors of early 
AL relative to no AL and late AL relative to no AL included male sex (OR 1.8 95% CI 1.6 – 2.1 
p < 0.001 and OR 1.2 95% CI 1.0 - 1.4 p = 0.013) and rectal cancer (OR 2.1 95% CI 1.6 -2.8 p < 
0.001 and OR 1.6 95% CI 1.0 – 2.4 p = 0.046). Additional independent predictors of early AL 
relative to no AL included BMI (OR 1.1 95% CI 1.0 – 1.2 p = 0.001), laparoscopic surgery (OR 
1.2 95% CI 1.0 - 1.4 p = 0.019), emergency surgery (OR 1.8 95%CI 1.4 - 2.2 p < 0.001) and no 
diverting ileostomy (OR 0.3 95% CI 0.2 – 0.4 p < 0.001). Independent predictors of late AL 
relative to no AL were Charlson Comorbidity Index of ≥II (OR 1.3 95% CI 1.1 – 1.6 p = 0.003), 
ASA score III to V (OR 1.2 95% CI 1.0 – 1.5 p = 0.030), preoperative tumor complications (OR 
1.1 95% CI 1.0 – 1.4 p = 0.048), extensive additional resection because of tumor growth (OR 
1.7 95%CI 1.2 – 2.5 p = 0.003), and preoperative radiation (OR 2.0 95%CI 1.2 - 3.4 p = 0.010) 
(Table 2).
Independent predictors for early AL relative to late AL were male sex (OR 1.5 95% CI 1.2 – 
1.9 p < 0.001), laparoscopic surgery (OR 1.3 95% CI 1.0 – 1.6 p = 0.048), emergency surgery 
(OR 1.9 95% CI 1.3 – 2.7 p = < 0.001), no diverting ileostomy (OR 0.4 95% CI 0.2 – 0.6 p < 
0.001), and no preoperative radiotherapy (OR 0.4 95% CI 0.2 – 0.8 p = 0.005). These varia-
bles had a different effect on the occurrence of early AL compared to late AL (Table 2).
In addition, stratification for colon and rectum showed that diverting ileostomy and pre-operative radiotherapy were independent risk factors for late AL in rectum tumors but not 
for colon tumors. Furthermore, in the stratified analysis open surgery was an independent risk factor for early AL in colon tumors while laparoscopic surgery was an independent risk factor for early AL in rectum tumors.
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Table 2. Multivariate multinomial logistic regression model representing independent risk factors for early and late anastomotic leakage.Early vs no anastomotic leakage Late vs no anastomotic leakage Early vs late anastomotic leakage
OR
(95% CI)
P value  OR
 (95% CI)
P value OR
 (95% CI)
P value
Patient characteristics
Sex Female 1.0 1.0 1.0Male 1.8
(1.6 - 2.1)
<0.001 1.2
(1.0 - 1.4)
0.013 1.5
(1.2 - 1.9)
<0.001
Age, per 10-year increase 0.9(0.9 - 1.0) 0.015 1.0(0.9 - 1.1) 0.413 1.0(0.9 - 1.0) 0.322BMI, per 5 kg/m2 increase 1.1(1.0 - 1.2) <0.001 1.0(0.9 - 1.1) 0.881 1.0(1.0 - 1.2) 0.079Charlson Comorbidity 
Index
0 1.0 1.0 1.0
I 1.0(0.9 - 1.2) 0.707 1.2(1.0 - 1.5) 0.078 0.9(0.7 - 1.1) 0.279
≥ II 1.1(0.9 - 1.3) 0.206 1.3(1.1 - 1.6) 0.003 0.8(0.6 - 1.1) 0.169ASA score I-II 1.0 1.0 1.0III-V 1.2(1.0 - 1.4) 0.091 1.2(1.0 - 1.5) 0.030 0.9(0.7 - 1.2) 0.618Previous abdominal surgery No 1.0 1.0 1.0Yes 1.0(0.8 - 1.1) 0.566 1.1(0.9 - 1.3) 0.262 0.9(0.7 - 1.0) 0.220
Tumor characteristics
Tumor location Colon 1.0 1.0 1.0Rectum 2.1
(1.6 - 2.8)
<0.001 1.6
(1.0 - 2.4)
0.046 1.4(0.8 - 2.3) 0.240
Tumor stage T1 1.0 1.0 1.0
T2 1.0(0.7 - 1.3) 0.721 0.8(0.6 - 1.1) 0.119 1.2(0.8 -1.8) 0.365
T3 1.3(1.0 - 1.6) 0.067 1.0(0.8 - 1.3) 0.832 1.2(0.9 - 1.7) 0.267
T4 1.2(0.9 - 1.6) 0.312 1.1(0.8 - 1.5) 0.652 1.1(0.7 - 1.7) 0.722Metastasis No 1.0 1.0 1.0Yes 1.1(0.8 - 1.4) 0.593 1.1(0.8 - 1.4) 0.478 1.0(0.7 - 1.4) 0.980Preoperative tumor complication No 1.0 1.0 1.0Yes 1.0(0.8 - 1.1) 0.816 1.1(1.0 - 1.4) 0.048 0.8(0.7 - 1.0) 0.220
Treatment characteristics
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Table 2. (Continued) Early vs no anastomotic leakage Late vs no anastomotic leakage Early vs late anastomotic leakage
OR
(95% CI)
P value  OR
 (95% CI)
P value OR
 (95% CI)
P value
Surgical technique Open 1.0 1.0 1.0Laparoscopic 1.2
(1.0- 1.4)
0.019 1.0(0.8 - 1.1) 0.619 1.3(1.0 - 1.5) 0.048
Urgency of surgery Elective 1.0 1.0 1.0Emergency 1.8
(1.4 - 2.2)
<0.001 0.9(0.7 - 1.3) 0.711 1.9(1.3 - 2.7) <0.001
Diverting ileostomy No 1.0 1.0 1.0Yes 0.3
(0.2 - 0.4)
<0.001 0.8(0.6 - 1.1) 0.207 0.4(0.2 - 0.6) <0.001Additional resection because of tumor growth No 1.0 1.0 1.0Limited 0.8(0.6 - 1.2) 0.364 1.2(0.9 - 1.7) 0.259 0.7(0.4 - 1.1) 0.146
Extensive 1.3(0.9 – 2.0) 0.136 1.7(1.2 - 2.5) 0.003 0.8(0.5 - 1.3) 0.330Additional resection because of metastasis No 1.0 1.0 1.0Yes 0.9(0.6 - 1.3) 0.544 1.2(0.8 - 1.8) 0.478 0.8(0.4 - 1.4) 0.347Preoperative radiotherapy No 1.0 1.0 1.0Radiation 0.8(0.6 - 1.2) 0.265 2.0(1.2 - 3.4) 0.010 0.4(0.2 - 0.8) 0.005Chemo radiation 0.9(0.6 - 1.5) 0.684 1.4(0.8 - 2.8) 0.256 0.6(0.2 - 1.6) 0.310
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Discussion
This study showed that male sex and rectal cancer were independent risk factors for both early and late AL. Younger age, increased BMI, laparoscopic surgery, emergency surgery, and no a diverting ileostomy were independent risk factors for early AL. In addition, high 
Charlson Comorbidity Index, high ASA score, preoperative complications, additional resec-tion because of tumor growth, and preoperative radiotherapy were independent risk factors 
for late AL. Male sex, laparoscopic surgery, emergency surgery, construction of diverting ileostomy and preoperative radiotherapy had a different effect on the occurrence of early, 
compared with late AL. Our results demonstrated that most risk factors for early AL were 
surgery-related factors, representing surgical difficulty, which might lead to technical failure of the anastomosis. Most risk factors for late AL were patient-related factors, representing 
the frailty of patients and tissues that influences the healing capacity of bowel tissue.
The results of this study are in accordance to previous literature. A previous study has shown that prolonged duration of surgery and blood loss during surgery, both representing 
surgical difficulty, were related to early AL(6). Another study indicated that preoperative radiotherapy or chemoradiation was a risk factor for late AL(7, 10, 11). Although, it has been demonstrated that advanced tumor stage (American Joint Committee on Cancer stage 
III-IV) and a histological finding of poorly differentiated or mucinous adenocarcinoma were 
independent risk factors for early AL, this study did not find this(11). One study found a low 
incidence of late AL (0.04%) and the authors attributed this to the extended period of pelvic 
drainage, which may shortened the interval of diagnosis(8). On the contrary, another study 
reported an incidence of AL after 30 days postoperatively of 31.6%(23). It should be taken 
into account that these previous studies applied different definitions for late AL. Besides, these previous studies were based on relatively small sample sizes.
Male sex was an independent risk factor for both early AL and late AL, and thus for AL in 
general. However, male sex seemed to be a greater risk factor for early AL when compared to 
late AL. This could be attributable to the smaller pelvis and stronger muscular wall in males, which impedes surgery. Furthermore, rectal cancer was an independent risk factor for both 
early and late AL which can be explained by the fact the risk of AL in general is increased for anastomoses situated closer to the anal verge(24).
Younger age and increased BMI were independent risk factors for early AL, possibly be-
cause younger patients are less prone to healing deficiencies. Also, increased BMI is associ-
ated with AL in colorectal surgery(25). The increased mesocolon thickness and abdominal pressure in obese patients may complicate the construction of the anastomosis. However, 
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increased BMI is related to impaired microcirculation, which is considered to decrease the healing capacity at the anastomotic site, which may also play a role for late AL, although this study did not demonstrate this.
Furthermore, we found that laparoscopic surgery was an independent risk factor only for 
early AL. The COLOR study indicated that the incidence of AL does not differ between laparo-scopic and open surgery(26, 27). Nevertheless, it has been shown recently that risk factors for AL are different between laparoscopic and open surgery. Risk factors for AL after laparo-
scopic surgery were related to surgical difficulty(28). This is in accordance to our findings and hypothesis. Furthermore, in the early years of laparoscopic surgery some comorbidities 
were considered as contraindications for laparoscopic surgery. Therefore, in this observa-tional study, we should take into consideration that selection bias might have affected our results even though we have adjusted for comorbidities in the multivariate analysis.
Emergency surgery was also identified as an independent risk factor for early AL. Emergen-cy surgery is often performed during evening and night shifts because of acute indications. Surgery at these hours is associated with worse postoperative outcomes(29, 30). Colorec-tal surgery performed during evening and night shift is related to AL(31). Surgery at these 
times might be performed by less specialized surgeons implying surgical difficulty due to 
less experience highly suggestive for technical failure of the anastomosis.
Preoperative tumor complications were heterogeneous in influencing our hypothesis, be-
cause these not only represent surgical difficulty but also frailty of patients’ tissue at the anastomotic site. Nevertheless, our results proposed that preoperative tumor complications 
were an independent risk factor for late AL. Table 1 showed that almost 20% of the preop-erative tumor complications was anemia which may lead to reduced healing capacity at the anastomotic site. Furthermore, ileus could also strongly affect the quality of bowel tissue, 
but this also represents surgical difficulties constructing the anastomosis.
No diverting ileostomy was an independent risk factor for early AL. From DCRA it was pre-viously shown that stoma construction in rectal surgery does not affect the incidence of AL or mortality rates(32). In addition, it was recently shown that, when AL occurred in patients with a diverting ileostomy that fewer reinterventions were required, which could be sug-gestive for less severe clinical presentation of AL(33). It might be possible that a diverting ileostomy delays the diagnosis of AL because of less severe presentation of AL.
Also, additional resection because of tumor growth was an independent risk factor for late 
AL. These major surgical procedures are demanding for patients, among others because of 
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blood loss and hypotension during surgery. Hypotension compromises local tissue perfu-
sion and leads to reduced tissue oxygenation, causing healing deficiencies. Surgery with additional resections because of tumor growth is also technically demanding but might not 
specifically complicate the construction of the anastomosis.
Preoperative radiotherapy is indicated in most cases of rectal cancer(34). Preoperative ra-diotherapy reduces the incidence of local recurrence but is also related to higher postopera-tive morbidity(35). Our results showed that preoperative radiotherapy was an independent risk factor for late AL. Preoperative radiotherapy not only affects tumor tissue but also the 
surrounding healthy tissue including the adjacent bowel wall and its vascularization. This could imply decreased healing capacity at the anastomotic site and therefore be related to late AL.
In addition, stratification for colon and rectum showed comparable results. As expected, diverting ileostomy and preoperative radiotherapy were not a risk factor for late AL in co-lon resections possibly due to the small numbers because these strategies are usually not 
applied in the treatment of colon tumors. Furthermore, in the stratified analysis open sur-gery was an independent risk factor for early AL in colon tumors while laparoscopic surgery was an independent risk factor for early AL in rectum tumors. However, laparoscopic ap-
proach reflects a technical challenging procedure, it is possible that, in colon surgery, open 
approach was used more often for difficult cases, resulting in selection bias.
In this study, the cutoff between early and late AL was set on 6 days based on the median. 
However, the transition from early AL, hypothesized to be related to surgical difficulty, to late AL, hypothesized to be related to frailty of tissue and patients, might not be captured 
at this exact day, and the transition might very well be a more fluent process. Therefore, we 
could not state that there are two separate populations of AL, but our findings indicate that, within the group of AL, there might be different entities.
This distinction in origin between early and late AL also has implications for fair comparison 
of quality of hospitals. In early AL, the technical skills of the surgeon have more of influence, and, hence the surgeon could be more accountable, whereas, for late AL, patient character-
istics might be of more influence.
There were some limitations in our study. First, the definition of late AL was arbitrary. This study only evaluated clinically relevant AL that required re-intervention, and, therefore the 
definition of late AL was based on the day of reintervention. For this retrospective study, reg-istration of day of intervention was more reliable than day of clinical symptoms. In previous 
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studies, late AL was defined as AL diagnosed after hospital discharge, after 6, 21 or 30 days postoperatively. Most previous studies aimed to determine whether there are two entities of 
colorectal AL. However, we hypothesized that the time of occurrence of AL reflects the origin 
of leakage. Therefore, we defined late AL as AL leading to re-intervention after day 6 post-operatively, which was the median (postoperative day 6). Since data were available, we have 
also performed the analysis with the cutoff point of late AL at first quartile of discharge (day 
5) and third quartile of discharge (day 10). These analyses did not fundamentally change the results presented in our study and the conclusion was similar.
Second, the DCRA data are usually registered until 30 days after surgery unless the initial 
hospital stay is longer. Therefore, extreme late AL is not included. Besides, the underregis-tration of AL in general might be a problem in nation-wide databases. Last, the analysis of observational data could be affected by confounding and this might lead to bias. Although we performed a multivariate analysis to adjust for patient, tumor and treatment charac-teristics, still unknown confounding factors could be present that were not registered in 
the DCRA, such as medication use, smoking, criteria for diverting ileostomy, mobilization of 
splenic flexure, blood loss, and operative time.
However, the strength of this study was that results were based on a nationwide cohort representing a large sample size that induces statistical power to detect differences between risk factors for early and late AL. Furthermore, previous studies only concerned AL of the sigmoid and rectum; we have now shown that our hypothesis may be applicable to AL of all colorectal cancers.
Conclusion
This study demonstrated that early and late AL have different risk factors. Our findings sug-
gest that risk factors for early AL are related to surgical difficulty that may lead to technical failure of the anastomosis, resulting in immediate anastomotic dehiscence, whereas risk factors for late AL are related to frailty of patients and tissues, which may imply healing 
deficiencies at the anastomotic site leading to delayed anastomotic dehiscence in a possibly technically well-constructed anastomosis. In our opinion, especially in patients with high risk for late AL, it is important for surgeons to inform patients about possible occurrence of 
AL in the late postoperative period especially since 18% of AL occurred after hospital dis-
charge. Furthermore, in early AL, quality of the surgery seems more of influence than in late AL, so hospital comparison should consider the different entities separately, with different 
case-mix adjustments.
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Abstract
BackgroundShort-course preoperative radiotherapy is indicated in patients with resectable rectal can-cer to control local recurrence. Although no clear evidence is available, short-course radio-
therapy with operation within one week is common practice. The aim of this study was to investigate the impact of timing of operation for rectal cancer after short-course radiother-apy on anastomotic leakage.
Study Design
Data from the Dutch ColoRectal Audit (DCRA) were used. All patients who received short-course preoperative radiotherapy and underwent elective operation within 14 days for 
rectal cancer between January 1st, 2011 and December 31th, 2016 were included. Interval 
between radiotherapy and operation was calculated by extracting date of start of radiother-
apy from the date of operation. Patients were divided into short interval (<4 days) and long 
interval (>4 or more days). The interval and other patient or perioperative parameters were included in univariable and multivariable logistic regression analyses to identify independ-ent associations with anastomotic leakage.
Results
In total, 2131 patients were eligible for analysis: 1055 (49.5%) patients had operations <4 
days after radiotherapy and 1076 (50.5%) patients had operation after 4 or more days. One 
hundred and eighty-five (8.7%) patients experienced anastomotic leakage. The incidence of 
anastomotic leakage was significantly higher in patients who underwent operation within 
<4 days (10.1% vs 7.2% p = 0.018). In the multivariable analysis, an interval of <4 days 
was significantly associated with anastomotic leakage (OR 1.438, 95% CI 1.054 - 1.962 
p = 0.022).
Conclusion
Elective surgery for rectal cancer <4 days after preoperative short-course radiotherapy re-sulted in an increase of anastomotic leakage.
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Introduction
Short-course preoperative radiotherapy (RT) is indicated in patients with resectable rectal 
cancer to control local recurrence and to improve long-term cancer specific survival(1-3). 
Although acknowledged for its evident benefit for oncological outcomes, RT has also been 
challenged for its influence on postoperative morbidity and mortality. Mortality has been proven not to be increased with optimal strategies of radiation(4), and, with regard to post-
operative morbidity, short-course preoperative RT seems to lead to slightly more complica-tions after operation. Among these, anastomotic leakage (AL) is the most feared, and leads to increased postoperative morbidity and mortality(5).
In most countries, operations are scheduled within 1 week after the end of short-course RT. 
However, no clear evidence regarding the optimal timing of operation after short-course RT 
is currently available. Performing operation at the time of maximum radiation effect might 
complicate the construction of an anastomosis because of inflammation and irritation of the 
bowel tissue. This might also compromise anastomotic healing and could even result in AL. 
To this end, we aim to investigate the influence of the interval between short-course preop-
erative RT and operation for rectal cancer with regard to the incidence of AL.
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Methods
Dutch ColoRectal Audit
Data were derived from the Dutch ColoRectal Audit (DCRA), which registers all colorectal 
cancer resections in The Netherlands. The DCRA is a nationwide web-based registry. Com-
pleteness and accuracy of the DCRA is validated by comparison to the Netherlands Cancer 
Registry. No ethical approval nor informed consent was required for this study under Dutch 
law. Detailed information regarding data collection and methodology of the DCRA was pub-lished previously(6).
Patient selection
All patients who received short-course preoperative RT and underwent operation for rectal 
cancer between January 1, 2011 and December 31, 2016 were selected. Patients without a 
primary anastomosis and patients with preoperative chemotherapy were excluded. In ad-
dition, patients with an unknown interval between RT and operation or with an interval <0 
days or >14 days were excluded. Patients with an interval <0 days were operated before the 
end of RT because of an acute indication or incorrectly registered. Patient with an interval of >14 days did not comply to common clinical practice or were patients who were too frail 
to undergo chemoradiation including long-course radiation (25x5 Gy) or long-course radi-
ation without chemotherapy and received short-course RT with delayed operation after 8 
weeks, as this is indicated in the Dutch Guidelines. In this respect, patients with an interval 
>14 days were excluded to ensure homogeneity. In addition, patients undergoing urgent 
operations were excluded.
Interval
A conventional short-course preoperative RT scheme for rectal cancer consists of 5x5 Gy, 
which is delivered at consecutive days (www.oncoline.nl). Interval in days between RT and 
operation was calculated with the start date of RT and the date of operation. It was possible 
to calculate the interval between the end of RT and operation because RT was administered 
during weekdays only. Therefore, the interval between the end of RT and operation could 
be estimated by subtracting 4 days from the interval when the RT started on Monday or by 
subtracting 6 days from the interval when the RT started on another day of the week, taking into account the weekend. Based on the median of the interval (4 days), patients were divid-
ed into short interval (<4 days) and long interval (≥4 days).
Outcomes
Anastomotic leakage was the primary outcome measure. In the DCRA, AL was defined as clinically relevant AL that requires radiological or surgical re-intervention (i.e. Grade B/C)
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(7). The circumferential resection margin (CRM) and mortality within 30 days after oper-
ation were also registered in the DCRA database. Potential confounding factors were re-
trieved from the DCRA database including patient, tumor and treatment characteristics (sex, 
age, BMI, Charlson Comorbidity Index, ASA score, pathological TNM stage, resection margin, surgical technique, urgency of operation, construction of a diverting ileostomy, additional resection because of tumor growth).
Statistical analysisContinuous variables were represented as medians with interquartile range and the Mann 
Whitney U test was used to compare medians. The Chi-square test or Fisher’s exact test 
was used to compare dichotomous variables. One-way ANOVA test was used to compare categorical variables. Multivariate logistic analysis was performed to identify the effect of time interval on AL, while adjusting for confounding. All clinically relevant variables were 
included in the multivariable model. We calculated the area under the receiver’s operating characteristics curve and performed the Hosmer-Lemeshow test for the full multivariable 
model. Statistical significance was defined as 2-sided P value < 0.050. SPSS® software 21.0 
was used for statistical analysis (IBM, Armonk, New York, USA)
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Results
In total, 5888 patients with preoperative short-course RT for rectal cancer were registered 
in the DCRA database between January 1th, 2011 and December 31th, 2016. Of these pa-
tients, 2747 patients without a primary anastomosis were excluded and 387 patients with 
preoperative chemotherapy were excluded. In addition, 134 patients with an unknown in-
terval between RT and operation were excluded and 484 patients with an interval <0 days 
or >14 days were excluded. In addition, 5 patients underwent urgent operation and were 
excluded. In total, 2131 patients were eligible for analysis (Figure 1).
Figure 1. Flowchart of patient selection. DCRA, Dutch ColoRectal Audit.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DCRA 2011-2016 Patients with preoperative short-course radiotherapy for rectal cancer  
n = 5888     (n =   ) 
 Patients with preoperative chemotherapy 
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 Patients with interval <0 and >14 days  
n = 484     
 Eligible patients  
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 Patients undergoing urgent surgery 
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Table 1 shows patient, tumor and treatment characteristics associated with anastomotic 
leakage. Most patients were male (63.2%) and the median age was 67.0 years. Most patients 
had a pathological tumor stage of pT3 and a pathological nodal stage of pN0. In total, 79.2% 
of all procedures were performed laparoscopically and 68.1% of all patients received a di-verting ileostomy during operation.
In total, 185 (8.7%) patients suffered from AL. Patients with AL were more often male 
(p = 0.025) and were significantly younger (p = 0.005). In patients with AL a diverting ile-
ostomy was less frequently constructed during operation (p < 0.000). No statistically signif-
icant difference was found for BMI, Charlson Comorbidity index, ASA score, TNM stadium, surgical technique, urgency of operation, additional resection because of tumor growth, 
CRM and mortality (Table 1).
Table 1. Patient, tumor, and treatment characteristics associated with anastomotic leakage
Characteristic Number of 
patients
(n = 2131)
Anastomotic 
leakage
(n = 185)
No Anastomotic 
leakage
(n = 1946)
Missing P value
Patient
Sex, n (%)Male 1347 (63.2) 131 (70.8) 1216 (62.5) 1 (0.0) 0.025*Female 783 (36.7) 54 (29.2) 729 (37.5)
Age, y, median (IQR) 67.0 (60.0 – 73.0) 65.0 (59.0 – 71.0) 67.0 (60.0 – 73.0) 0 (0.0) 0.005*BMI, kg/m3, median (IQR) 26.0 (23.8 – 28.4) 26.0 (23.6 – 28.3) 26.0 (23.8 – 28.4) 22 (1.0) 0.976Charlson Comorbidity 
Index, n (%)0 1388 (65.1) 120 (64.9) 1268 (65.2) 0 (0.0) 0.107I 401 (18.8) 27 (14.6) 374 (19.2)
≥ II 342 (16.0) 38 (20.5) 304 (15.6)
ASA score, n (%)I-II 1900 (89.2) 162 (87.6) 1738 (89.3) 1 (0.0) 0.454III-IV 230 (10.8) 23 (12.4) 207 (10.6)
Tumor
Distance to anal verge, 
cm, median (IQR)
10.0 (7.0 – 12.0) 9.0 (7.0 – 10.5) 10.0 (8.0 – 12.0) 46 (2.6) 0.001*
Pathological T stage, n 
(%)
pT0 12 (0.6) 0 (0.0) 12 (0.6) 10 (0.5) 0.145†
pT1 171 (8.0) 21 (11.4) 150 (7.7)
pT2 767 (36.0) 54 (29.2) 713 (36.6)
pT3 1126 (52.8) 105 (56.8) 1021 (52.5)
pT4 45 (2.1) 4 (2.2) 41 (2.1)
Pathological N stage, n (%)pN0 1290 (60.5) 108 (58.4) 1182 (60.7) 17 (0.8) 0.697pN1 563 (26.4) 50 (27.0) 513 (26.4)pN2 261 (12.2) 26 (14.1) 235 (12.1)
Pathological M stage, n (%)
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Table 1. (Continued)
Characteristic Number of 
patients
(n = 2131)
Anastomotic 
leakage
(n = 185)
No Anastomotic 
leakage
(n = 1946)
Missing P value
pM0 1983 (93.1) 171 (92.4) 1812 (93.1) 104 (4.9) 0.272†pM1 44 (2.1) 6 (3.2) 38 (2.0)
Treatment
Surgical technique, n (%)
Open 443 (20.8) 41 (22.2) 402 (20.7) 1 (0.0) 0.632Laparoscopic 1687 (79.2) 144 (77.8) 1543 (79.3)
Diverting ileostomy, n 
(%)Yes 1451 (68.1) 96 (51.9) 1355 (69.6) 0 (0.0) 0.000*No 680 (31.9) 89 (48.1) 591 (30.4)Additional resection because of tumor growth, 
n (%)Yes 24 (1.1) 3 (1.6) 21 (1.1) 14 (0.7) 0.457†No 2093 (98.2) 180 (97.3) 1913 (98.3)
Interval, n (%)
<4 days 1055 (49.5) 107 (57.8) 948 (48.7) 0 (0.0) 0.018*
≥4 days 1076 (50.5) 78 (42.2) 998 (51.3)Postoperative outcome
CRM, n (%)R0 2067 (97.0) 183 (98.9) 1884 (96.8) 25 (1.2) 0.250†R1-2 39 (1.8) 1 (0.5) 38 (2.0)
Mortality, n (%)Yes 22 (1.0) 2 (1.1) 20 (1.0) 11 (0.5) 1.000†No 2098 (98.5) 183 (98.9) 1915 (98.4)
*Statistically significant†Fisher’s Exact TestAL, anastomotic leakage
IQR, interquartile rangeCRM, circumferential resection margin 
Median interval between RT and operation was 4 days (Figure 2). Most patients had the op-
eration on the third day after RT. In total, 1055 (49.5%) patients had operations in <4 days 
after RT while 1076 (50.5%) patients had operation after ≥4 days after RT (Table 2). The 
incidence of anastomotic leakage for patients who underwent operation in <4 days was sig-
nificantly higher than for patients who underwent operation after ≥4 days (10.1% vs 7.2% 
p = 0.018). In addition, CRM involvement was more frequently observed in patients who un-
derwent operation in <4 days after RT (2.6% vs 1.1% p = 0.013). Hospital stay and mortality 
were not significantly different for patients who underwent operation <4 days after RT. All 
other variables were not related to the interval between RT and operation.
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Figure 2. Anastomotic leakage and the interval between short-course preoperative radiotherapy and operation. Percentages above the bars represent the incidence of anastomotic leakage.
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Table 2. Patient, tumor, and treatment characteristics associated with interval between radiotherapy and operation
Characteristic Number of 
patients
(n = 2,131)
Interval <4 days
(n = 1,055)
Interval ≥4 days
(n = 1,076)
Missing P value
Patient
Sex, n (%)Male 1347 (63.2) 678 (64.3) 669 (62.2) 1 (0.0) 0.331Female 783 (36.7) 377 (35.7) 406 (37.7)
Age, y, median (IQR) 67.0 (60.0 – 73.0) 67.0 (60.0 – 73.0) 67.0 (60.0 – 73.0) 0 (0.0) 0.914BMI, kg/m3, median (IQR) 25.9 (23.8 – 28.4) 26.1 (23.9 – 28.9) 25.7 (23.7 – 28.1) 22 (1.0) 0.073Charlson Comorbidity 
Index, n (%)0 1388 (65.1) 677 (64.2) 711 (66.1) 0 (0.0) 0.497I 401 (18.8) 199 (18.9) 202 (18.8)
≥ II 342 (16.0) 179 (17.0) 163 (15.1)
ASA score, n (%)I-II 1900 (89.2) 932 (88.3) 968 (90.0) 1 (0.0) 0.205III-IV 230 (10.8) 123 (11.7) 107 (9.9)
Tumor
Distance to anal verge, 
cm, median (IQR)
10.0 (7.0 – 12.0) 10.0 (8.0 – 12.0) 10.0 (7.0 – 12.0) 46 (2.6) 0.193
Tumor stage, n (%)
pT0 12 (0.6) 3 (0.3) 9 (0.8) 10 (0.5) 0.407
pT1 171 (8.0) 84 (8.0) 87 (8.1)
pT2 767 (36.0) 385 (36.5) 382 (35.5)
pT3 1126 (52.8) 558 (52.9) 568 (52.8)
pT4 45 (2.1) 19 (1.8) 26 (2.4)
Pathological N stage, n (%)pN0 1290 (60.5) 642 (60.9) 648 (60.2) 17 (0.8) 0.506pN1 563 (26.4) 268 (25.4) 295 (27.4)pN2 261 (12.2) 135 (12.8) 126 (11.7)
Pathological M stage, n (%)pM0 1983 (93.1) 980 (92.9) 1000 (93.9) 104 (4.9) 0.824pM1 44 (2.1) 21 (2.0) 23 (2.1)
Treatment
Surgical technique, n (%)
Open 443 (20.8) 220 (20.9) 223 (20.7) 1 (0.0) 0.933Laparoscopic 1687 (79.2) 834 (79.1) 853 (79.3)
Diverting ileostomy, n (%)Yes 1451 (68.1) 711 (67.4) 740 (68.8) 0 (0.0) 0.494No 680 (31.9) 344 (32.6) 336 (31.2)Additional resection because of tumor 
growth, n (%)Yes 24 (1.1) 13 (1.2) 11 (1.0) 14 (0.7) 0.649No 2093 (98.2) 1036 (98.2) 1057 (98.2)Postoperative outcome
CRM, n (%)R0 2067 (97.0) 1017 (96.4) 1051 (97.7) 25 (1.2) 0.013*
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Table 2. (Continued)
Characteristic Number of 
patients
(n = 2,131)
Interval <4 days
(n = 1,055)
Interval ≥4 days
(n = 1,076)
Missing P value
R1-2 39 (1.8) 27 (2.6) 12 (1.1)Anastomotic leakage, 
n (%)Yes 185 (8.7) 107 (10.1) 78 (7.2) 0 (0.0) 0.018*No 1946 (91.3) 948 (89.9) 998 (92.8)
Mortality, n (%)Yes 22 (1.0) 8 (0.8) 14 (1.3) 11 (0.5) 0.208No 2098 (98.5) 1046 (99.1) 1052 (97.8)
*Statistically significantCRM, circumferential resection margin
IQR, interquartile range 
Univariable and multivariable logistic regression models were performed to estimate the 
effect of interval between RT and operation on AL (Table 3). In the univariable analysis, an 
interval of <4 days was associated with AL (OR 1.444 95% CI 1.064 – 1.959 p = 0.018). When 
sex, age, BMI, diverting ileostomy and distance to the anal verge were added to the mod-
el, this significant association was still observed present (OR 1.438 95% CI 1.054 – 1.962 
p = 0.028). The area under the receiver operating characteristics curve was 0.667 and the 
Hosmer-Lemeshow test obtained a Chi-square of 12.168 (p = 0.144).
Table 3. Multivariable logistic regression analysis of factors predicting anastomotic leakage
Characteristic Univariable OR
(95% CI)
P Value Multivariable OR 
(95% CI)
P Value
Sex 0.688 (0.494 – 0.956) 0.026* 0.647 (0.462 – 0.906) 0.011*Age per 10 years 0.843 (0.723 – 0.984) 0.030* 0.849 (0.725 – 0.995) 0.043*BMI per 10 kg/m2 1.071 (0.965 – 1.189) 0.199 1.136 (0.994 – 1.298) 0.062
Diverting ileostomy 0.470 (0.347 – 0.638) 0.000* 0.379 (0.275 – 0.524) 0.000*
Distance to anal verge per 2 cm 0.869 (0.792 – 0.953) 0.003* 0.808 (0.733 – 0.889) 0.000*
Interval <4 days 1.444 (1.064 – 1.959) 0.018* 1.438 (1.054 – 1.962) 0.022*
*Statistically significant
OR, odds ratio; CI confidence interval
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Discussion
Preoperative RT can be considered a double-edged sword. Choosing a proper interval be-
tween short-course preoperative RT and operation can guarantee both its therapeutic effect 
and control its possible damage. Our study has shown that operation for rectal cancer within 
<4 days after short-course preoperative RT, which is the most commonly applied interval in 
the Netherlands, results in significantly more AL. The interval between short-course pre-
operative RT and operation is usually not determined by a medical-based decision. So, this 
study warns surgeons that an inappropriate interval between RT and operation may com-promise surgical safety.
Initially, RT was developed in squamous cell carcinomas from head and neck regions to decrease local recurrence, to downstage the tumor to allow an operation and to preserve organ functions, which are the same motives for the use in rectal cancer. In contrast to squa-
mous cell carcinomas, adenocarcinomas regress quite slowly as a result of RT(8). In most 
Western countries, short-course preoperative RT is administrated in patients with a resect-able tumor to control local recurrence rather than to achieve downstaging of the tumor. For 
this reason, the interval between short-course preoperative RT and operation is relatively 
short. Based upon subgroup analyses of the Stockholm I,II and III and TME trial, operation 
after short-course RT should be performed within 5 days after RT(9). However, delaying 
operation for several weeks after short-course RT is recommended to achieve tumor down staging in elderly patients with a nonresectable rectal tumor who are too frail to tolerate 
conventional chemoradiation(10-12). Today the question is whether this strategy is also applicable to younger patients with regard to oncological outcomes and especially the re-duction of postoperative mortality and morbidity. Recently the Stockholm III trial concluded 
that delayed operation (4-8 weeks) after short-course RT gave similar oncological outcomes 
compared to short-course RT with immediate operation (<1 week) and that postoperative complications were reduced substantially with delayed operation(13).
The interim analysis of the Stockholm III trial showed that more postoperative complica-
tions were seen in patients in the 5x5 group with immediate operation with an interval of 
11-17 days between the start of RT and operation(4). In addition, a subgroup analysis of 
the TME trial showed that elderly patients operated 4–7 days after the last fraction of radi-otherapy had higher mortality(14). In contrast, our study showed increased AL in patients 
operated <4 days after the end of short-course RT. These conflicting data might indicate that is even better to wait longer than the time period which was captured in our study (14 days), 
which is current clinical practice in The Netherlands, as the results of the Stockholm III trial suggested(13).
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Most previous studies did not evaluate the incidence of AL with regard to an optimal timing of operation after neoadjuvant therapy because of the relatively low incidence of AL requir-
ing large sample sizes to provide high level of evidence. Only one study reported that shorter intervals by one week between preoperative chemoradiation and operation for rectal cancer were associated with AL(15). In addition, a meta-analysis found no effect of neoadjuvant 
therapy for rectal cancer on the incidence of AL(16). This meta-analysis analyzed the effect of chemoradiation and radiation alone separately, however within the group of radiation 
alone no difference was made for long-term and short-course RT. The relatively long inter-
val between long-term RT and operation might have affected this analysis because possibly enabling the bowel to heal from the damage caused by radiation.
We believe the interval between preoperative short-course RT and operation is of great im-portance because the interval is an easily adjustable factor in contrast to many well-known 
AL risk factors(17-19). Therefore, optimal strategies regarding the interval are highly desir-able in clinical practice.
This study demonstrated that younger age is associated with AL, which is in line with pre-
vious population-based studies. Both the Danish Colorectal Group and the American Col-
lege of Surgeons National Surgical Quality Improvement Program (NSQIP) concluded that increasing age is related to a lower risk of AL(18, 20, 21). Furthermore, a study from the 
Michigan Surgical Quality Collaborative cohort found a younger mean age in patients with AL(22). In addition, this study shows that the incidence of AL is lower in diverted patients 
(6.6% vs 13.1%) although the effect of a diverting ileostomy was not of this extent in pre-vious literature(23). Nevertheless, this study included a homogenous study population in 
which all patients received short-course preoperative RT and a primary anastomosis.
This study also reported more CRM involvement in patients who underwent operation for 
rectal cancer within <4 days after RT (Table 2). Nevertheless, this finding was based on rel-
atively small numbers since only 39 patients had a positive CRM. Unfortunately, it was not possible to establish the association with long-term oncological outcomes such as local re-
currence and survival because the DCRA only registers until 30 days postoperatively. How-ever, already in 1994 it was shown that CRM involvement is related to local recurrence(24). 
A few years later it was demonstrated that CRM involvement also influences distant metas-tasis and survival and therefore CRM involvement is considered an important prognostic marker for selecting patients for adjuvant therapy(25, 26).
With regard to the pathophysiology, we assume that RT not only affects tumor cells but also 
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healthy surrounding tissue possibly compromising anastomotic healing. In animal exper-
iments, anastomotic strength was decreased by long-term preoperative RT but for short-
course preoperative RT no difference was observed(27). Another study indicated that 
long-term preoperative RT resulted in decreased blood flow at the anastomotic site(28). 
Nevertheless, clinical studies failed to demonstrate an association between preoperative RT and anastomotic leakage(16, 29).
There were some limitations in this study. First, this was an observational study suscep-tible to bias and confounding. Multivariable analysis was performed to reduce the effect 
of known confounding factors. Second, the DCRA database does not contain information 
on the smoking status and preoperative medication use. Therefore, we could not adjust for these factors, which are known to be related to AL. In addition, dichotomization of the in-
terval might be associated with loss of power and residual confounding(30). The strength of this study is that results are based on a nation-wide cohort. In addition, the current study provides the best evidence so far about the effect of the interval on anastomotic leakage. However, a double-blind randomized controlled trial would provide the highest level of ev-
idence, considering the relatively low event rate of AL, this design would require extremely large sample sizes. Nevertheless, other population-based studies could be used to address the same problem.
Conclusions
Today, accumulating evidence is available that delaying operation after short-course preop-
erative RT for rectal cancer is beneficial, resulting in less postoperative complications and 
oncological outcomes are similar. This study underlines that especially the incidence of AL, which is the most feared complication after rectal resection, is increased when operation for 
rectal cancer is performed <4 days after the end of RT. Prospective evaluation is required to assess evidence-based guidelines recommending optimal intervals between short-course 
preoperative RT and operation for rectal cancer.
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Abstract
Background
The aim of this study was to investigate the effect of age on CAL and its associated mortality.
Methods
Data were derived from the Dutch ColoRectal Audit. All patients undergoing resection for 
colorectal cancer in the Netherlands between January 2011 and December 2016 were in-
cluded. Univariable and multivariable logistic regressions were performed to test the effect of age on CAL and its associated mortality.
Results
In total, 45 488 patients were included. The incidence of CAL was 6.4% in patients <60 years 
old, 5.5% in patients 60-69 years old, 5.4% in patients 70-80 years old, and 4.9% in patients 
≥80 years old (p < 0.001). Multivariate analysis showed that age was protective for CAL 
(OR 0.965 per 5 years 95% CI 0.941 – 0.985 p < 0.001). Mortality after CAL was 1.3% in 
patients <60 years old, 4.8% in patients 60-69 years old, 12.3% in patients 70-80 years old 
and 27.0% in patients >80 years old (p < 0.001). Older age was associated with mortality 
following CAL (OR 1.497 per 5 years 95% CI 1.364 – 1.647 p < 0.001).
Conclusions
This population-based study suggests a protective effect of increased age on CAL after colorectal cancer resection. However, older age is strongly associated with mortality after CAL.
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Introduction
Colorectal cancer is the third most common cancer worldwide(1). The Netherlands Can-cer Registry (NCR) reported that the incidence of colorectal cancer is rapidly increasing, from 9106 cases in 2000 to 15 427 in 2016(2). Several factors contribute to this increase, including early detection programs and the ageing population(3). In the Netherlands, the incidence of colorectal cancer increases with age, with patients aged 60 years and older 
accounting for the majority of newly diagnosed cases. Furthermore, about 17% of newly diagnosed patients with colorectal cancer are over 80 years old(4). So, in a progressively aging population the burden of colorectal cancer is rising.
Surgical resection remains the cornerstone of curative treatment for colorectal cancer. Nev-ertheless, postoperative morbidity and mortality are often increased in elderly patients 
possibly due to coexisting comorbidities(5). Therefore, it remains challenging for surgeons to decide whether to treat colorectal cancer in elderly patients conservatively or with sur-gical resection. Previous literature has shown that colorectal surgery in elderly patients is 
safe and that 1-year mortality is similar to overall life expectancy(6, 7). Increasing age is no longer considered a contraindication for colorectal surgery. Nevertheless, these previous 
studies did not specifically address colorectal anastomotic leakage (CAL), which is one of the most severe complications after colorectal surgery due to its associated morbidity and mortality(8, 9).
The effect of age on CAL after colorectal cancer resection remains unclear. Most studies 
identified age as a risk factor, but the results were contradictive. Some studies showed a decreased risk of CAL in older patients (10-14), while others suggest advancing age is a risk factor for CAL(9, 11). In addition, it was previously demonstrated that mortality following CAL is increased in elderly patients (15).
The aim of this study was to investigate the effect of age on CAL and its associated mortality in a population-based study.
4
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Methods
Study design
Data were derived from the Dutch ColoRectal Audit (DCRA), a web-based national registry for primary colorectal cancer resections. All patients undergoing primary colorectal cancer resection with construction of a primary anastomosis between 1st of January 2011 and 31st 
of December 2016 were included. Patients with other procedures than ileocecal resection, 
right/left hemicolectomy, sigmoid, low anterior resection or subtotal colectomy were ex-
cluded. Patients with a transanal procedure or an end ostomy were excluded. Patients with 
missing information on age or CAL were also excluded.
The DCRA is a quality improvement project, in which all Dutch hospitals participate(16). Annual comparison with the National Cancer Registration is performed on completeness 
and data are verified by independent data managers visiting all hospitals. Under Dutch law 
no ethical approval or informed consent was required for this study, as only de-identified 
patient information was provided. Details regarding data collection and methodology have been previously published elsewhere(16).
Outcome measures and other variables
Patients were divided into four age groups. Group I were patients aged <60 years, Group II 60-69 years, Group III 70-80 years, and Group IV >80 years old.
The primary outcome was CAL within 30 days after surgery. CAL was defined as a clinically relevant colorectal anastomotic leak leading to radiological or surgical re-intervention. Sec-ondary outcome of interest was mortality following CAL within 30 days after surgery.
Patient, tumor, and treatment characteristics were extracted from the DCRA [gender, age, 
Body Mass Index (BMI), Charlson Comorbidity Index, American Society of Anesthesiologists 
(ASA) score, preoperative radiotherapy, preoperative chemotherapy, tumor location, TNM stage, preoperative tumor complications, type of procedure, surgical technique, conversion, urgency of surgery, stoma, perioperative complications, additional resection because of tu-mor growth, additional resection because of metastasis]. Information on management of 
CAL was also extracted from the DCRA [type of re-intervention and time to intervention].
Statistical Analysis
Differences in patient, tumor, and treatment characteristics between age groups were exam-
ined using one-way analysis of variance (ANOVA) for continuous variables and Chi-square tests for categorical variables. Continuous variables were described as mean with standard 
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deviation, while categorical variables as frequencies with percentages. Multiple imputation was performed to deal with missing values assuming data were missing at random(17). Five 
imputed datasets were created based on gender, age, BMI, Charlson Comorbidity Index, ASA score, preoperative radiotherapy, preoperative chemotherapy, tumor location, tumor inva-sion, preoperative tumor complication, type of procedure, surgical technique, urgency of surgery, protective stoma, additional resection because of tumor growth, additional resec-
tion because of metastasis, and CAL. Univariable and multivariable regression models were 
performed. Age was evaluated as a continuous variable and as categorical variable. Tests for non-linearity were performed. Multivariate analysis was performed taking in consideration all clinically relevant variables for the outcome of interest. No variable selection was per-formed on the data. Additionally, to test whether the effect of age was different for tumor 
location (colon/rectum) the univariable and multivariable analyses stratified for tumor lo-cation. Intervention rates between age groups were tested with Chi-square tests. A p value 
<0.05 was considered statistically significant. All statistical analyses were performed using the Statistical Package for the Social Sciences version 21.0 for Windows (SPSS IBM, Chicago, 
IL, USA).
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Results
Study populationAll patients (46 542) undergoing primary colorectal cancer resection with the construction of a primary anastomosis between 1st of January 2011 and 31st of December 2016 were 
evaluated. After exclusion of 179 patients with procedures other than ileocecal resection, right/left hemicolectomy, sigmoidectomy, low anterior resection or subtotal colectomy, 174 patients with a trans anal procedure, 455 patients with an end ostomy, 25 patients with missing information on age and 221 patients with missing information on CAL, 45 488 pa-tients were eligible for analysis. Patient, tumor, and surgical characteristics per age group 
are presented in Table 1.
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CAL
Overall incidence of CAL was 5.5%. The mean age was lower in patients with CAL compared 
to patients without CAL (68.6 vs 69.4 years p < 0.001). CAL was observed in 6.4% in Group 
I, 5.5% in Group II, 5.4% in Group III and 4.8% in Group IV (p < 0.001) (Table 2). For man-
agement of CAL, open surgical re-intervention was used more often. Time to re-intervention 
was not significantly different between age groups with an overall mean of 9.7 ± 23.8 days 
(Table 2).
Univariable analysis showed that older age per 5 years was protective for CAL (OR 0.961 
per 5 years 95% CI 0.946 – 0.980 p < 0.001) and this association remained the same after 
adjustment for potential confounders in the multivariable analysis (OR 0.965 per 5 years 
95% CI 0.941 – 0.985 p < 0.001). Both univariable and multivariable showed decreased risk 
of CAL in Group II, III and IV compared to Group I (Table 3).
Stratification for tumor location showed similar results for colon tumors. For rectal tumors 
only multivariate analysis with age as a continuous variable reached statistical significance 
(Supplementary table 1). Tests for non-linearity confirmed a linear association between age and CAL.
Mortality following CAL
In total, mortality following CAL was 9.7%. In Group I mortality following leakage was 1.3%, 
in Group II 4.8%, in Group III 12.3% and in Group IV 27.2% (p < 0.001) (Table 2). Univar-iable analysis showed that older age per 5 years was associated with increased mortality 
following CAL (OR 1.677 per 5 years 95% CI 1.539 – 1.818 p < 0.001) and this association remained the same after adjustment for potential confounders in the multivariable analysis 
(OR 1.497 per 5 years 95% CI 1.364 – 1.647 p < 0.001) (Table 3). Both univariable and multi-variable analysis showed increased mortality following CAL in Group II, III and IV compared 
to Group I (Table 3). Tests for non-linearity confirmed a linear association between age and mortality following CAL.
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Table 2. Details on CAL with intervention strategies and following mortality
Total Group I Group II Group III Group IV P-value Missing CAL 2500
(5.5%)
457
(6.4%)
833
(5.5%)
891
(5.4%)
319
4.8%)
<0.001
0 
(0.0%)
Re-intervention
Radiological 118 
(4.7%)
27 
(5.9%)
34 
(4.1%)
38 
(4.3%)
19 
(6.0%)
<0.001
6 
(0.2%)
Surgical 2251 
(90.3%)
399 
(87.5%)
737 
(88.5%)
820 
(92.0%)
295 
(92.5%)
Other
124 
(5.0%)
30 
(6.6%)
57 
(6.9%)
32 
(3.6%)
5 
(1.6%)Surgical re-intervention Laparoscopic 387 (17.2%) 86 (21.6%) 156 (18.8%) 109 (12.2%) 36 (11.3%)
<0.001
0 
(0.0%)
Open
1864 
(82.8%)
313 
(78.4%)
581 
(70.2%)
711 
(79.9%)
259 
(81.2%)Stoma as treatment 1920 (77.3%) 337 (74.4%) 639 (77.1%) 710 (80.0%) 234 (74.1%) 0.048 15 (0.6%)
Time to intervention, 
mean ± SD, days 9.7 (±23.8) 9.1 (±21.8) 10.0 (±22.9) 9.9 (±25.0) 9.7 (±23.8) 0.926 552 (22.1%)Mortality 241 
(9.7%)
6 
(1.3%)
40 
(4.8%)
109 
(12.3%)
86 
(27.2%)
<0.001
17 
(0.7%)
Group I indicates patients aged <60 years, Group II 60-69 years, Group III 70-80 years and Group IV >80 years. CAL indicates colorectal anastomotic leakage.
Table 3. Results of univariable and multivariable logistic regression analysis of age (continuous and categories) for CAL and mortality following CAL
CAL Mortality following CAL
Univariable 
analysis
OR (95% CI, p-value)
Multivariable 
analysis*
OR (95% CI, p-value)
Univariable
analysis
OR (95% CI, p-value)
Multivariable 
analysis†
OR (95% CI, p-value)
Age – continuousAge (per 5 years) 0.961 (0.946 – 
0.980, <0.001)
0.965 (0.941 – 0.985, 0.001) 1.677 (1.539 – 1.818, <0.001) 1.497 (1.364 – 1.647, <0.001)
Age - categoriesGroup I 1 1 1 1Group II 0.863 (0.767 – 0.971, 0.014) 0.865 (0.767 – 0.976, 0.019) 3.778 (1.589 –8.981, 0.003) 2.854 (1.185 – 6.873, 0.020)Group III 0.832 (0.741 – 0.935, 0.002) 0.829 (0.733 – 0.938, 0.003) 10.401 (4.535 – 23.855, <0.001) 6.074 (2.590 – 14.243, <0.001)Group IV 0.746 (0.644 – 
0.865, <0.001)
0.762 (0.649 – 0.895, 0.001) 27.794 (11.966 – 64.559, <0.001) 13.635 (5.666 – 32.809, <0.001)
Group I indicates patients aged <60 years, Group II 60-69 years, Group III 70-80 years and Group IV >80 years. CAL indicates colorectal anastomotic leakage.
* Adjusted for gender, BMI, Charlson Comorbidity Index, ASA Score, preoperative radiotherapy, preoperative chemotherapy, tumor invasion, preoperative tumor complications, type of procedure, surgical technique, urgency of surgery, protective stoma.
† Adjusted for Charlson Comorbidity Index, ASA Score, preoperative radiotherapy, tumor location, tumor invasion, preoperative tumor complications, type of procedure, surgical technique, urgency of surgery, perioperative complications, additional resection because of tumor growth, additional resection because of metastasis.
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Discussion
The aim of this study was to investigate the effect of age on CAL and its associated mortality 
after colorectal cancer resection. This population-based study of 45 488 patients showed a 
protective effect of age on CAL. The incidence of CAL was lowest in patients of >80 years old. However, older age is strongly associated with mortality after CAL. For patients of >80 years 
old, the mortality following CAL was found to be as high as 27.0%.
Several previous studies identified age as risk factor for CAL. The Danish Colorectal Can-cer Group showed that older age is associated with a lower incidence of CAL(12). In addi-
tion, studies from the American College of Surgeons National Surgical Quality Improvement 
Program (NSQIP) also concluded that an increasing age is correlated with a lower risk of CAL(13, 18). Another large prospective multicenter study from Germany which included 17 
867 patients found similar results(10). Recently, a study from the Michigan Surgical Quality 
Collaborative cohort found a younger mean age in patients with CAL(14). These findings 
were not explicitly evaluated in these studies but were one of the risk factors that were 
identified. In contrast, another study reported higher risk of CAL with increasing age, but this study was based on a relatively small sample size compared to the previously men-
tioned national databases(11). In addition, a few other studies demonstrated no significant 
association between age and risk of CAL(15, 19, 20). Different factors could contribute to these contradictory results, such as small sample sizes(19), investigation of only colon or 
rectal cancer(15), and specific setting in a Chinese population, which could be substantially different from the Western population(20).
Preoperative selection of patients might have resulted in selection of the fittest. Increased 
postoperative morbidity and mortality in elderly patients might have influenced surgeons’ decision to be more precautious with surgical intervention in elderly patients(15, 21). In ad-
dition, the healthy survivor effect might have led to selection of the fittest. This phenomenon 
describes survivor bias, which selects patients that made it to a specific age while patients who died before reaching this age were not selected. However, in the present study, despite this selection, elderly patients had worse general health as represented by higher Charlson 
Comorbidity Index and ASA scores.
Right hemicolectomy is associated with low rates of CAL though high rates of mortality, and 
was the most commonly performed procedure in our elderly cohort (Supplementary Table 
2, 3, and 4)(15). This might have influenced the unadjusted comparison of CAL and its as-sociated mortality between the age groups. However, the multivariable model for CAL and mortality following CAL included type of procedure to adjust for this confounding effect.
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Previously, a study from the DCRA found high rates of cardiopulmonary complications in 
elderly patients(4). These complications could be competing risks leading to death even be-fore CAL was clinically present or diagnosed resulting in a lower incidence of CAL in elderly patients.
A more conservative approach with non-interventional treatment of suspected CAL may be 
adopted more often in elderly patients. This might explain the lower incidence of CAL in 
elderly patients in this study since AL was defined as clinically relevant AL which required radiological or surgical re-intervention.
In the Netherlands, the smoking rate decreases from the age of 60 years. This might partially 
explain our results since several studies have shown that active smoking is an independent 
risk factor for CAL(22, 23). Smoking status was not registered in the DCRA so it was not 
possible to explore this association. However, in a large study of 17 518 patients younger age was found to be an independent risk factor for CAL even after correcting for smoking status(18).
Inflammatory bowel disease (IBD) increases risk of CAL. This might partially explain in-
creased risk of CAL in younger patients since IBD appears on younger age(24). Nevertheless, 
just a small percentage of patients with colorectal cancer have IBD at baseline (1-2%)(25). A 
previous study performed a sensitivity analysis by excluding all patients with IBD showing 
still a significant protective effect of age on CAL(18).
Our study suggest that older patients truly have a decreased risk of CAL(10, 12, 13, 18). An 
experimental study found that aging tissues show more chronic inflammation in absence of 
overt infection(26). It might be possible that this chronic inflammation in aging tissues en-ables anastomotic healing since anastomotic healing requires a balanced immune response 
with pro- and anti-inflammatory characteristics preventing an exceeded inflammatory re-sponse(27). In addition, this might contribute to the less severe clinical presentation of CAL 
in elderly patients from subclinical CAL which is not registered in DCRA
This study shows that, despite the protective effect of age on CAL, the mortality following 
CAL increases with higher age. The mortality rate following CAL is well established in liter-ature, especially in patients aged 80 and over(15, 28). A multicenter study demonstrated a fourfold increase in 30-day mortality following CAL(21). Beside frailty of elderly patients, several other factors might contribute to these high rates of mortality following CAL. More-
over, elderly patients sometimes refuse a second intervention or reintubation or sign a Do 
Not Resuscitate (DNR) policy before surgery.
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Emergency surgery was most often performed in Group IV. This might explain the high mor-
tality rates in group IV because emergency surgery is identified as a risk factor for mortality after colorectal surgery(29).
This study shows multivariable logistic regression models with age as a continuous and cat-egorical variable. Categorization of a continuous variable in a multivariable model has sev-eral disadvantages. It could lead to a considerable loss of power, residual confounding and 
bias due to data-derived cut-off values(30). Therefore, our main conclusion was based on the outcomes of the model with age as a continuous variable which was tested for linearity.
Stratified analyses were performed to explore whether the effect of age was different for 
tumor location (Supplementary Table 1). No major differences were observed since the mul-
tivariable analysis for both colon and rectum showed a statistically significant protective 
effect of age on CAL. Nevertheless, it needs to be mentioned that stratification compromises 
the sample size resulting in loss of power. Therefore, it is not possible to perform multivari-
able analysis for mortality following CAL with stratified data due to small numbers of events (i.e. mortality rate of 22 out of 618 patients with CAL after rectum resection). However, uni-
variable exploration indicated that for both colon and rectum the incidence of mortality after CAL increases with age.
The strength of our study is that it was based on a population-based cohort with a large sam-ple size decreasing the risk of a type II error. However, there were several limitations worth 
mentioning. Although DCRA registers many variables there are several that are not (smok-ing, nutritional status, immunosuppression status, medication use) which could have affect-
ed the outcomes of this study. Lastly, the DCRA database registers data until 30 days after surgery, unless the initial hospital stay is longer so long-term outcomes are not registered.
Conclusions
This population-based study showed a protective effect of age on CAL after colorectal cancer 
resection. On the other hand, this study demonstrated that older age is strongly associated 
with increased mortality following CAL which is reported to be as high as 27.0% in patients >80 years.
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Supplementary materials
Supplementary Table 1. Results of univariable and multivariable logistic regression analysis of age 
(continuous and categories) for CAL stratified for colon and rectum tumorsColon CAL
Univariable analysis
OR (95%CI, p-value)
Multivariable analysis*
OR (95%CI, p-value)
Age – continuousAge(per 5 years) 0.995 (0.991 – 1.000, 0.037) 0.993 (0.988 – 0.998, 0.005)
Age - categoriesGroup I 1 1Group II 0.862 (0.746 – 0.997, 0.045) 0.859 (0.741 – 0.997, 0.045)Group III 0.897 (0.780 – 1.033, 0.131) 0.860 (0.742 – 0.997, 0.045)Group IV 0.822 (0.696 – 0.972, 0.022) 0.773 (0.645 – 0.925, 0.005)
Rectum CAL
Univariable analysis
OR (95%CI, p-value)
Multivariable analysis†
OR (95%CI, p-value)
Age – continuousAge(per 5 years)  0.970 (0.937 – 1.015, 0.179) 0.951 (0.913 – 0.995, 0.029)
Age - categoriesGroup I 1 1Group II 0.955 (0.779 – 1.171, 0.955) 0.884 (0.716 – 1.091, 0.250)Group III 0.820 (0.656 – 1.023, 0.079) 0.742 (0.586 – 0.939, 0.013)Group IV 0.822 (0.543 – 1.245, 0.355) 0.693 (0.448 – 1.070, 0.098)
Group I indicates patients aged <60 years, Group II 60-69 years, Group III 70-80 years and Group IV >80 years. CAL indicated colorectal anastomotic leakage.
* Adjusted for gender, BMI, Charlson Comorbidity Index, ASA Score, tumor invasion, preoperative tumor complications, type of procedure, surgical technique, urgency of surgery
† Adjusted for gender, BMI, Charlson Comorbidity Index, ASA Score, preoperative radiotherapy, preoperative chemotherapy, tumor invasion, preoperative tumor complications, type of procedure, surgical technique, urgency of surgery, protective stoma
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Supplementary Table 2. CAL per type of surgical procedure
Total Group I Group II Group III Group IVCAL 2500 457 833 891 319
Total 45488 7184 15042 16651 6611
CAL% 5.5% 6.4% 5.5% 5.4% 4.8%Ileocecal resection CAL 17 1 3 6 7
Total 398 71 90 130 107
CAL% 4.3% 1.4% 3.3% 4.6% 6.5%Right hemicolectomy CAL 728 79 182 315 152
Total 18214 1920 5023 7304 3967
CAL% 4.0% 4.1% 3.6% 4.3% 3.8%
Transversal resection CAL 56 5 18 15 18
Total 889 90 220 361 218
CAL% 6.3% 5.6% 8.2% 4.2% 8.3%Left hemicolectomy CAL 291 56 87 110 38
Total 4023 635 1350 1503 535
CAL% 7.2% 8.8% 6.4% 7.3% 7.1%Sigmoidectomy CAL 695 127 254 242 72
Total 12933 2213 4827 4609 1284
CAL% 5.4% 5.7% 5.3% 5.3% 5.6%Low anterior resection CAL 614 167 251 168 28
Total 8213 2064 3238 2498 413
CAL% 7.5% 8.1% 7.8% 6.7% 6.8%Subtotal colectomy CAL 90 19 35 33 3
Total 671 162 252 197 60
CAL% 13.4% 11.7% 13.9% 16.8% 5.0%
Group I indicates patients aged <60 years, Group II 60-69 years, Group III 70-80 years and Group IV >80 years. CAL indicates colorectal anastomotic leakage.
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Supplementary Table 3. Overall mortality per type of surgical procedure
Total Group I Group II Group III Group IVMortality 1045 45 160 404 436
Total 45488 7184 15042 16651 6611
Mortality% 2.3% 0.6% 1.1% 2.4% 6.6%Ileocecal resection Mortality 26 0 2 8 16
Total 396 71 90 128 107
Mortality% 6.6% 0.0% 2.2% 6.3% 15.0%Right hemicolectomy Mortality 568 17 69 210 272
Total 18143 1915 5004 7272 3952
Mortality% 3.1% 0.9% 1.4% 2.9% 6.9%
Transversal resection Mortality 33 2 4 8 19
Total 886 89 219 361 217
Mortality% 3.7% 2.2% 1.8% 2.2% 8.8%Left hemicolectomy Mortality 112 8 19 43 42
Total 4011 633 1346 1498 534
Mortality% 2.8% 1.3% 1.4% 2.9% 7.9%Sigmoidectomy Mortality 178 11 34 75 58
Total 12900 2209 4814 4596 1281
Mortality% 1.4% 0.5% 0.7% 1.6% 4.5%Low anterior resection Mortality 94 5 23 47 19
Total 8191 2059 3234 2487 411
Mortality% 1.1% 0.2% 0.7% 1.9% 4.6%Subtotal colectomy Mortality 34 2 9 13 10
Total 667 159 251 197 60
Mortality% 5.1% 1.3% 3.6% 6.6% 16.7%
Group I indicates patients aged <60 years, Group II 60-69 years, Group III 70-80 years and Group IV >80 years. CAL indicates colorectal anastomotic leakage.
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Supplementary Table 4. Mortality following CAL per type of surgical procedure
Total Group I Group II Group III Group IVMortality 240 6 40 109 85
Total CAL 2474 449 824 886 315
Mortality% 9.7% 1.3% 4.9% 12.3% 27.0%Ileocecal resection Mortality 4 0 0 2 2
Total CAL 17 1 3 6 7
Mortality% 23.5% 0.0% 0.0% 33.3% 28.6%Right hemicolectomy Mortality 115 2 15 45 53
Total CAL 724 78 180 315 151
Mortality% 15.9% 2.6% 8.3% 14.3% 35.1%
Transversal resection Mortality 7 0 2 1 4
Total CAL 55 5 18 15 17
Mortality% 12.7% 0.0% 11.1% 6.7% 23.5%Left hemicolectomy Mortality 29 1 3 19 6
Total CAL 288 55 87 108 38
Mortality% 10.1% 1.8% 3.4% 17.6% 15.8%Sigmoidectomy Mortality 55 1 12 25 17
Total CAL 692 127 251 242 72
Mortality% 7.9% 0.8% 4.8% 10.3% 23.6%Low anterior resection Mortality 22 2 5 13 2
Total CAL 611 166 251 167 27
Mortality% 3.6% 1.2% 2.0% 7.8% 7.4%Subtotal colectomy Mortality 8 0 3 4 1
Total CAL 87 17 34 33 3
Mortality% 9.2% 0.0% 8.8% 12.1% 33.3%
Group I indicates patients aged <60 years, Group II 60-69 years, Group III 70-80 years and Group IV >80 years. CAL indicates colorectal anastomotic leakage.
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Abstract
Objective
To investigate differences in postoperative outcomes between short-course radiotherapy 
and delayed surgery (SCRT-delay) and chemoradiation (CRT) in patients with locally ad-vanced rectal cancer (LARC).
Background
In frail patients SCRT-delay is recommended as an alternative to CRT for the treatment of 
LARC. The heterogeneity of this patient group and the lack of data impede the design of evidence-based guidelines. With the increasing aging population, more evidence is needed to justify the choice of neoadjuvant treatment in frail patients. Furthermore, previous trials 
suggest that SCRT-delay is an adequate neoadjuvant treatment for intermediate to high risk rectal cancer.
Methods
This was an observational study with data from the Dutch ColoRectal Audit (DCRA). LARC 
patients who underwent surgery (2014-2017) after an interval of ≥6 weeks were included. Missing values were replaced by multiple imputation. Propensity score matching (PSM) was 
applied to create comparable groups. Differences were analyzed using Chi-square test for categorical variables, independent sample t-test for continuous variables and Mann-Whit-
ney U test for non-parametric data.
Results
2,926 patients were included. After PSM, the SCRT-delay group as well as the CRT group 
comprised 238 patients. Patients in the SCRT-delay group were older and had more comor-
bidities. They more often underwent abdominoperineal resection. SCRT-delay less often 
resulted in a pathological complete response. There were no differences in postoperative (surgical) complications.
Conclusion
Despite their age and comorbidities, postoperative complications were not increased in the 
SCRT-delay group. Considering surgery-related complications, SCRT-delay is a good alter-native neoadjuvant treatment option for frail LARC patients. However, more data on local recurrence and survival is needed.
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Introduction
In compliance with European guidelines, neoadjuvant treatment for locally advanced rectal 
cancer (LARC) in the Netherlands comprises neoadjuvant chemoradiation (CRT), followed 
by surgery according to total mesorectal excision (TME) principles. Short-course radiother-
apy followed by surgery after a prolonged interval (SCRT-delay) is recommended as an alter-native to chemoradiation in older patients with comorbidities or frail patients with a poor performance status, because of their higher risk of (surgical) complications(1).
Postoperative morbidity and mortality are often increased in frail or elderly patients as a re-
sult of concomitant comorbidities(2). Data on surgical management of rectal cancer in these 
patients is scarce and reported postoperative morbidity and mortality figures vary widely in 
the population >65 years old(2-4). This patient group might benefit from altered treatment, especially when they are more susceptible to treatment-related complications(5). Moreover, 
inadequate treatment is associated with poor survival(2). Unfortunately, the heterogeneity of this group and the lack of data impede an evidence-based choice of neoadjuvant treat-ment in this patient group(6). With the aging population, there is need for evidence to justify the choice of the most optimal neoadjuvant treatment in frail patients with LARC.
In addition, previous trials suggest that SCRT-delay could also serve as an adequate neoad-juvant treatment for intermediate to high risk rectal cancer(7-9). Although previous trials 
showed that an interval <10 days between SCRT and surgery is associated with anastomotic leakage and postoperative mortality(10, 11), the rate of postoperative complications in the 
Stockholm III trial was lower when surgery was delayed for 4–12 weeks after SCRT(12), sug-
gesting that it is better to prolong the interval between SCRT and surgery. Before adding this 
regimen to current guidelines, more data is needed on postoperative outcomes of SCRT-de-
lay in comparison to CRT. The aim of this study was to investigate the effect of SCRT-delay 
on postoperative outcomes in comparison with CRT, in both the general and the frail popu-lation.
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Methods
Study design
This was an observational study with data from the Dutch ColoRectal Audit (DCRA), a na-tionwide audit which registers clinical outcomes of all patients undergoing primary colorec-
tal surgery in the Netherlands. The DCRA is based on evidence-based guidelines and is vali-dated on a yearly basis with data from the Netherlands Cancer Registry (NCR)(13). Because data could not be traced back to individual patients, neither informed consent nor ethical approval was required for this study.
Patient selection
All patients with ≥cT2 rectal cancer who underwent surgery between May 2014 (after im-
plementation of a new Dutch colorectal cancer guideline) and December 2017, were se-
lected from the DCRA database. Based on Dutch guidelines, LARC was defined as cT3 with 
mesorectal fascia (MRF) involvement, cT4 or cTanyN2. All patients with LARC were included 
in the study. Patients were excluded in case of metastatic disease, tumors located outside the rectum, emergency or urgent surgery. Also, patients who did not receive neoadjuvant treatment, with a missing start date of neoadjuvant therapy, or patients who underwent 
surgery after an interval of less than 6 weeks after the end of radiotherapy were excluded. Furthermore, patients who underwent surgery after an initial watch and wait strategy were 
excluded from the dataset, since the prolonged interval in this group could be associated 
with higher morbidity and a more difficult surgical resection(14). Finally, patients who re-ceived intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Intraopera-
tive Radiation Therapy (IORT) were excluded.
Neoadjuvant therapy
Neoadjuvant treatment entailed either SCRT (25 Gy in fractions of 5 Gy in 5 days) or CRT (45-50 Gy in fractions of 1.8-2 Gy in 5 weeks and concurrent oral Capecetabine 825-1000 mg/m2 twice daily 5-7 days a week). Interval to surgery was calculated from the end of ne-
oadjuvant treatment. The interval between the end of SCRT and surgery was calculated by subtracting 4 days from the interval when treatment started on Monday or by subtracting 6 days from the interval when treatment started on another day, accounting for discontinua-
tion of therapy in the weekend. The same syntax was used for CRT patients, subtracting 32 or 34 days, respectively.
Data collectionPatient characteristics included gender, age at surgery, BMI (kg/m2), number and type of 
comorbidities, and ASA score. Charlson Comorbidity Index was calculated according to the 
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weighted index of comorbidity(15). Tumor characteristics included clinical TNM-stage, MRF 
involvement and tumor distance from the anus (measured at colonoscopy). Treatment char-
acteristics included type of neoadjuvant treatment (SCRT or CRT), date of surgery, surgical procedure and approach, intraoperative complications, conversion, and ostomy creation. Subtotal colectomy, proctocolectomy and sigmoid resection were combined in the subgroup 
‘other surgical procedures’ because of low prevalence. Intraoperative complications com-prised injury of intra-abdominal structures, complications requiring blood transfusion or 
other non-specified complications.
Outcome measures
Follow-up time was 30 days after surgery. The primary outcome measure was the occur-
rence of postoperative complications. Complications were defined according to standards 
of the DCRA(13). Postoperative complications comprised both surgical and non-surgical 
complications and were defined as hospital stay of ≥ 14 days and/or a complication, re-in-tervention due to a complication, and/or death during hospital stay or within 30 days after surgery. Postoperative surgical complications included anastomotic failure, abscess, bleed-ing, ileus, dehiscent fascia, iatrogenic bowel injury, ureter/urethra injury, or other non-spec-
ified complications. Postoperative non-surgical complications included pulmonary, cardiac, 
thrombotic, infectious, neurologic or other non-specified complications.
Postoperative outcome measures included re-intervention, prolonged hospital stay, in-
tensive care unit (ICU) stay and re-admission. Re-intervention involved any laparotomy-, 
laparoscopic- or radiology-assisted treatment for a complication. Admission to the ICU and 
length of hospital stay were dichotomized based on the median length of admission. ICU stay 
was defined as admission to the ICU for at least 1 day. Prolonged hospital stay was defined as admission to the surgical ward for more than 7 days. Pathological outcomes included 
pathological tumor and nodal stage, pathological complete response rate (ypT0N0) and re-section margin.
Missing data
Of the 2,926 patients who met the in- and exclusion criteria, 1,713 (58.5%) patients had 
missing data in 1 or more variables. Missing values were classified as random and replaced by multiple imputation. All observed data, including the outcome, that were applied to 
the dataset after imputation were used as predictors(16, 17). On average, there was 2.3% 
missing data. The number of imputations depended on the average percentage rate of miss-
ingness(18, 19). The imputed data were checked with convergence plots. Imputation was successful if the streams intermingled and were free of any trend(17). Finally, 5 imputed datasets were produced with 5 iterations.
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Propensity score matching
To reduce the likelihood of confounding by indication, propensity score matching was per-
formed(20). The propensity score (i.e. the probability that a patient was assigned to either 
the SCRT-delay or CRT group) was calculated for each patient using logistic regression with 
the variables age, gender, Charlson Comorbidity Index, cT-stage, cN-stage, MRF involvement 
and distance from the anus. These covariates were chosen based on their clinical relevance. 
Propensity score matching was performed using ‘nearest-neighbor matching’ without re-
placement and a 1:1 ratio. The average within-pair difference in propensity scores was min-imized by setting a caliper of 0.25 multiplied by the standard deviation of the logit of the 
propensity score(21). The balance in the matched dataset was expressed in ‘standardized 
mean difference’ (SMD), with an SMD < 0.10 indicating a well-balanced set(22-24).
Statistical analyses
Differences in baseline characteristics and treatment outcomes were analyzed using Chi-square test for categorical variables and independent sample t-test for continuous variables. 
Mann-Whitney U test was used for non-parametric data. The Bonferroni correction was ap-
plied to account for multiple testing. The level of significance was set at p<0.05.
All analyses were performed in IBM SPSS Statistics (version 23 - © 2015 IBM Corporation) 
and RStudio (Version 1.0.143 – © 2009-2016 RStudio, Inc.,‘mice’, ‘tableone’, ‘MatchIt’ and 
‘optmatch’ packages).
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Results
Patient selection
Between May 2014 and December 2017, 8,318 patients with ≥cT2 rectal cancer were reg-
istered in the DCRA database. Patients without locally advanced tumors (n = 3,541), with 
metastatic disease (n = 986), with tumors located outside the rectum (n = 257), who under-
went urgent or emergency surgery (n = 15), who did not receive neoadjuvant treatment or 
if the start date of neoadjuvant therapy was missing (n = 31), who received chemotherapy 
only or chemotherapy combined with short-course radiotherapy (n = 102), who underwent 
surgery after an interval of less than 6 weeks after the end of radiotherapy (n = 298) or after 
an initial watch and wait strategy (n = 34) and who underwent HIPEC or IORT (n = 128) (see 
Supplementary Figure 1) were excluded. Finally, 2,926 patients were included in the analy-
sis. Non-imputed data are provided in Supplementary Table 1 and 2.
Pre-matching results
Pre-matching data are provided in Table 1. In the pre-matching cohort, 642 of 2,926 (21.9%) 
patients who underwent surgery were aged ≥75 years. Patients in the SCRT-delay group had a higher mean age, had more comorbidities and a higher ASA score. Mean BMI was higher in 
the CRT group. The MRF was less often involved in the SCRT-delay group and clinical N-stage 
was higher. There was no difference in the distance from the anus at colonoscopy. With an 
equal interval between neoadjuvant treatment and surgery, patients in the SCRT-delay group more often underwent abdominoperineal resection and more often received a permanent 
colostomy. In the SCRT-delay group, 63 patients (21.9%) received a primary anastomosis, 
compared to 1,253 patients (47.5%) in the CRT group. Pulmonic, cardiologic, infectious and 
neurologic complications were significantly more prevalent in the SCRT-delay group (Table 
2). When stratified for procedure, there were significant more complications after APR in 
the SCRT-delay group (Supplementary Table 3). However, looking into specific subgroups 
of postoperative complications, stratified for surgical procedure, pulmonic, cardiologic, 
infectious and neurologic complications in the SCRT-delay group occurred independent 
of surgical procedure (Supplementary Table 4). There was no difference in the number of re-interventions. In the primary anastomosis group, the frequency of re-interventions for 
anastomotic leakage was not different (4.8% vs. 7.6% after SCRT-delay and CRT, respective-
ly, data not shown). Patients in the SCRT-delay group were more often admitted to the ICU 
and hospital stay was more often prolonged. Furthermore, SCRT-delay less often resulted in 
a pathological complete response compared to CRT (8.0% vs. 16.1%, Table 1).
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Table 1. Patient, tumor and pathological characteristics in the pre-matching cohort. Data are presented as number (percentage) unless stated otherwise.
SCRT-delay
n = 288
CRT
n = 2,638 p-value
Patient characteristics
Gender 0.021 *
Male 161 (55.9) 1,663 (63.0)
Female 127 (44.1) 975 (37.0)
Age (mean (sd)) 77.89 (8.76) 64.59 (10.25) <0.001 *
BMI (mean (sd)) 25.54 (3.94) 26.27 (4.35) 0.006 *
Comorbidities <0.001 *
No 38 (13.2) 871 (33.0)
Yes 249 (86.5) 1,765 (66.9)
Unknown 1 (0.3) 2 (0.1)
Charlson Comorbidity Index <0.001 *
0 103 (35.8) 1,645 (62.4)
1 85 (29.5) 554 (21.0)
2 48 (16.7) 277 (10.5)
3 31 (10.8) 111 (4.2)
≥4 21 (7.3) 51 (1.9)
ASA score <0.001 *
1 20 (6.9) 575 (21.8)
2 157 (54.5) 1,686 (63.9)
3 103 (35.8) 363 (13.8)
4 8 (2.8) 14 (0.5)
Tumor characteristics
Distance from anus at colonoscopy (mean (sd)) 6.69 (4.69) 6.36 (4.42) 0.224
cT 0.425
2 8 (2.8) 95 (3.6)
3 225 (78.1) 1,971 (74.7)
4 55 (19.1) 572 (21.7)
Distance to MRF
 > 1mm 0.003 *
No 206 (71.5) 1,788 (67.8)
Yes 58 (20.1) 721 (27.3)
Unknown 24 (8.3) 129 (4.9)
cN <0.001 *
0 77 (26.7) 346 (13.1)
1 80 (27.8) 648 (24.6)
2 129 (44.8) 1,637 (62.1)
x 2 (0.7) 7 (0.3)
Treatment characteristics
Interval between end of neoadjuvant treatment 
and surgery (median [IQR]) 11.00 [9.00, 15.00]
11 . 0 0  [10 . 0 0 , 13.00] 0.472
Surgical approach <0.001 *
Transabdominal open 58 (20.1) 561 (21.3)
Transabdominal scopic 204 (70.8) 1,933 (73.3)
TaTME or TAMIS TME 18 (6.2) 134 (5.1)
Minimally invasive 8 (2.8) 10 (0.4)
Surgical procedure <0.001 *
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Table 1. (Continued)
SCRT-delay
n = 288
CRT
n = 2,638 p-value
Local excision 8 (2.8) 6 (0.2)
(Low) Anterior Resection 155 (53.8) 1,607 (60.9)
Abdominoperineal Resection 124 (43.1) 996 (37.8)
Other 1 (0.3) 29 (1.1)
Conversion 0.839
No 249 (86.5) 2,297 (87.1)
Yes 39 (13.5) 341 (12.9)
Reason conversion 0.658
Extensive tumor growth 8 (2.8) 6 (0.2)
Accessibility 28 (9.7) 216 (8.2)
Intraoperative complication 3 (1.0) 47 (1.8)
Intraoperative complication 0.954
No 275 (95.5) 2,506 (95.0)
Bleeding 1 (0.3) 17 (0.6)
Spleen injury 0 (0.0) 1 (0.0)
Bowel injury 3 (1.0) 19 (0.7)
Ureter / urethra injury 4 (1.4) 26 (1.0)
Bladder injury 1 (0.3) 17 (0.6)
Vagina injury 1 (0.3) 12 (0.5)
Other 3 (1.0) 40 (1.5)
Primary anastomosis <0.001 *
No 224 (77.8) 1,381 (52.4)
Yes 64 (22.2) 1,257 (47.6)
Ostomy <0.001 *
No 57 (19.8) 521 (19.7)
Diverting ileostomy 27 (9.4) 773 (29.3)
Permanent ileostomy 1 (0.3) 29 (1.1)
Diverting colostomy 7 (2.4) 125 (4.7)
Permanent colostomy 195 (67.7) 1,186 (45.0)
Stoma, unknown type 1 (0.3) 4 (0.2)
Pathological characteristics
pT 0.001 *
0 27 (9.4) 512 (19.4)
1 15 (5.2) 157 (6.0)
2 75 (26.0) 623 (23.6)
3 152 (52.8) 1,202 (45.6)
4 19 (6.6) 125 (4.7)
x 0 (0.0) 13 (0.5)
Unknown 0 (0.0) 6 (0.2)
pN 0.831
0 185 (64.2) 1,776 (67.3)
1 67 (23.3) 571 (21.6)
2 35 (12.2) 282 (10.7)
x 1 (0.3) 7 (0.3)
Unknown 0 (0.0) 2 (0.1)
Pathological complete response, ypT0N0 <0.001 *
No 265 (92.0) 2,213 (83,9)
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Table 1. (Continued)
SCRT-delay
n = 288
CRT
n = 2,638 p-value
Yes 23 (8.0) 425 (16.1)
Radicality 0.087
R0 267 (92.7) 2,512 (95.2)
R1-2 21 (7.3) 126 (4.8)
Missing - -
Abbreviations: sd = standard deviation, IQR = interquartile range, BMI = Body Mass Index (kg/m2), ASA = American 
Society of Anesthesiologists, TaTME = Transanal Total Mesorectal Excision, TAMIS TME = TransAnal Minimal 
Invasive Surgery - Total Mesorectal Excision, pT = pathological tumor stage, pN = pathological nodal stage
Table 2. Postoperative outcomes in pre-matching cohort. Data are presented as number percentage) unless stated otherwise
SCRT-delay
n = 288
CRT
n = 2,638 p-value
Postoperative complications < 30 
days after surgery 124 (43.1) 987 (37.4) 0.070
Type of complication
Pulmonic 25 (8.7) 102 (3.9) <0.001 *
Cardiologic 18 (6.2) 71 (2.7) 0.002 *
Infectious 32 (11.1) 136 (5.2) <0.001 *
Thrombotic 1 (0.3) 14 (0.5) 1.000
Neurological 12 (4.2) 38 (1.4) 0.002 *
Other 48 (16.7) 360 (13.6) 0.188
Surgical complications < 30 days 
after surgery 66 (22.9) 653 (24.8) 0.538
Re-intervention 31 (10.8) 317 (12.0) 0.598
Type of re-intervention 0.334
Radiologic 2 (0.7) 35 (1.3)
Surgery, laparoscopic 3 (1.0) 69 (2.6)
Surgery, open 19 (6.6) 138 (5.2)
Other 7 (2.4) 76 (2.9)
Reason re-intervention 0.572
Anastomotic failure 6 (2.1) 101 (3.8)
Abscess 9 (3.1) 74 (2.8)
Bleeding 1 (0.3) 11 (0.4)
Ileus 2 (0.7) 40 (1.5)
Fascial dehiscence 2 (0.7) 17 (0.6)
Iatrogenic bowel injury 0 (0.0) 5 (0.2)
Ureter / urethra injury 2 (0.7) 5 (0.2)
Other 9 (3.1) 62 (2.4)
≥1 day on ICU 98 (34.0) 712 (27.0) 0.014 *
Hospital stay ≥ 7 days 145 (50.3) 1,076 (40.8) 0.002 *
Readmission < 30 days after surgery 0.539
No 252 (87.5) 2,251 (85.3)
Yes 36 (12.5) 384 (14.6)
Unknown 0 (0.0) 2 (0.1)
Abbreviations: ICU = intensive care unit
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Post-matching results
Baseline characteristics that entered the propensity score model are presented in Table 3. After matching, both groups comprised 238 patients. Patient and tumor characteristics 
were well-balanced between the groups after matching. Differences in patient, treatment 
and pathological characteristics between SCRT-delay and CRT in the post-matching cohort 
are presented in Table 4. After matching, ASA score remained significantly higher in the 
SCRT-delay group. BMI was higher in the CRT group. Patients in the SCRT-delay group more 
often underwent abdominoperineal resection. 53 patients (22.3%) received a primary 
anastomosis, compared to 80 patients (33.6%) in the CRT group. Permanent colostomies 
were more frequent in the SCRT-delay group, but this difference was not significant in the 
post-matching cohort. There were no differences in pathological outcomes.
Table 3. Baseline characteristics used for propensity score matching. Data are presented as number 
(percentage), unless stated otherwise. An SMD <0.1 indicates a good balance.
Pre-matching Post-matching
SCRT-delay CRT SMD SCRT-delay CRT SMD
n = 288 n = 2,638 n = 238 n = 238
Gender 0.146 0.085
Male 161 (55.9) 1,663 (63.0) 139 (58.4) 129 (54.2)
Female 127 (44.1) 975 (37.0) 99 (41.6) 109 (45.8)
Age (mean (sd)) 77.89 (8.76) 64.59 (10.25) 1.394 76.40 (8.80) 75.52 (9.04) 0.099
Charlson Comorbidity 
Index 0.590 0.060
0 103 (35.8) 1,645 (62.4) 96 (40.3) 92 (38.7)
1 85 (29.5) 554 (21.0) 70 (29.4) 73 (30.7)
2 48 (16.7) 177 (10.5) 38 (16.0) 41 (17.2)
3 31 (10.8) 111 (4.2) 21 (8.8) 21 (8.8)
≥4 21 (7.3) 51 (1.9) 13 (5.5) 11 (4.6)
Distance from anus 
at colonoscopy (mean 
(sd))
6.69 (4.69) 6.36 (4.42) 0.074 6.49 (4.62) 6.21 (4.42) 0.061
cT 0.083 0.032
2 8 (2.8) 95 (3.6) 8 (3.4) 8 (3.4)
3 225 (78.1) 1,971 (74.7) 184 (77.3) 181 (76.1)
4 55 (19.1) 572 (21.7) 46 (19.3) 49 (20.6)
Distance to MRF 
>1mm 0.205 0.094
No 206 (71.5) 1,788 (67.8) 168 (70.6) 162 (68.1)
Yes 58 (20.1) 721 (27.3) 54 (22.7) 54 (22.7)
Unknown 24 (8.3) 129 (4.9) 16 (6.7) 22 (9.2)
cN 0.404 0.055
0 77 (26.7) 346 (13.1) 53 (22.3) 54 (22.7)
1 80 (27.8) 648 (24.6) 64 (26.9) 63 (26.5)
2 129 (44.8) 1,637 (62.1) 120 (50.4) 119 (50.0)
Unknown 2 (0.7) 7 (0.3) 1 (0.4) 2 (0.8)
Abbreviations: sd = standard deviation, cT = clinical tumor stage, MRF = Mesorectal Fascia, cN = clinical nodal stage
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Table 4. Differences in patient, treatment and pathological characteristics between SCRT-delay and 
CRT in the matched cohort. Data are presented as numbers (percentage), unless stated otherwise.
SCRT-delay CRT p-value
n = 238 n = 238
Patient characteristics
BMI (mean (sd)) 25.50 (4.08) 26.28 (4.48) 0.048 *
Comorbidities 0.582
No 35 (14.7) 33 (13.9)
Yes 202 (84.9) 205 (86.1)
Unknown 1 (0.4) 0 (0.0)
ASA score 0.031 *
1 19 (8.0) 23 (9.7)
2 128 (53.8) 152 (63.9)
3 84 (35.3) 61 (25.6)
4 7 (2.9) 2 (0.8)
Treatment characteristics
Interval between end of neoadjuvant 
treatment and surgery (median IQR]) 11.50 [9.00, 15.00]
11.00 [10.00, 13.00] 0.635
Surgical approach 0.178
Transabdominal open 45 (18.9) 51 (21.4)
Transabdominal scopic 172 (72.3) 171 (71.8)
TaTME or TAMIS TME 14 (5.9) 15 (6.3)
Minimally invasive 7 (2.9) 1 (0.4)
Surgical procedure 0.024 *
Local excision 7 (2.9) 1 (0.4)
(Low) Anterior Resection 120 (50.4) 147 (61.8)
Abdominoperineal Resection 110 (46.2) 89 (37.4)
Other 1 (0.4) 1 (0.4)
Conversion 32 (13.4) 33 (13.9) 1.000
Reason conversion 0.356
Extensive tumor growth 4 (1.7) 9 (3.8)
Accessibility 25 (10.5) 19 (8.0)
Intraoperative complication 3 (1.3) 5 (2.1)
Intraoperative complication 0.660
No 229 (96.2) 229 (96.2)
Bleeding 1 (0.4) 0 (0.0)
Spleen injury 0 (0.0) 1 (0.4)
Bowel injury 1 (0.4) 3 (1.3)
Ureter / urethra injury 4 (1.7) 2 (0.8)
Bladder injury 1 (0.4) 1 (0.4)
Vagina injury 1 (0.4) 0 (0.0)
Other 1 (0.4) 2 (0.8)
Primary anastomosis 53 (22.3) 80 (33.6) 0.008 *
Ostomy 0.196
No 45 (18.9) 40 (16.8)
Diverting ileostomy 25 (10.5) 43 (18.1)
Permanent ileostomy 1 (0.4) 1 (0.4)
Diverting colostomy 7 (2.9) 9 (3.8)
Permanent colostomy 160 (67.2) 145 (60.9)
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Table 4. (Continued)
SCRT-delay CRT p-value
n = 238 n = 238
Pathological characteristics
pT 0.647
0 23 (9.7) 31 (13.0)
1 11 (4.6) 15 (6.3)
2 61 (25.6) 61 (25.6)
3 129 (54.2) 120 (50.4)
4 14 (5.9) 11 (4.6)
pN 0.075
0 149 (62.6) 169 (71.0)
1 58 (24.4) 46 (19.3)
2 30 (12.6) 19 (8.0)
x 1 (0.4) 4 (1.7)
Pathological complete response, ypT0N0 20 (8.4) 25 (10.5) 0.531
Radicality 0.494
R0 222 (93.3) 217 (91.2)
R1-2 16 (6.7) 21 (8.8)
Abbreviations: sd = standard deviation, IQR = interquartile range, BMI = Body Mass Index (kg/m2), ASA = American 
Society of Anesthesiologists, TaTME = Transanal Total Mesorectal Excision, TAMIS TME = TransAnal Minimal 
Invasive Surgery - Total Mesorectal Excision, pT = pathological tumor stage, pN = pathological nodal stage 
Postoperative outcomes in the post-matching cohort are presented in Table 5. Overall, there 
were no differences in postoperative (surgical) complications. After stratification for sur-
gical procedure, the differences remained non-significant (Supplementary Table 3). Only 
infectious complications were significantly more prevalent in the SCRT-delay group (p = 
0.024). The higher occurrence of pulmonic, cardiologic, infectious and neurologic compli-
cations in the SCRT-delay group in the pre-matched stratified analysis was not seen after 
matching (Supplementary Table 4). The number of re-interventions for anastomotic leak-
age in the primary anastomosis group was not significantly different (7.5% vs. 5% after 
SCRT-delay vs. CRT, respectively, data not shown). There were no differences in ICU admis-sion and hospital stay.
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Table 5. Differences in postoperative outcomes between SCRT-delay and CRT in the matched cohort. 
Data are presented as numbers (percentage), unless stated otherwise.
SCRT-delay CRT p-value
n = 238 n = 238
Postoperative complications < 30 days after surgery 98 (41.2) 91 (38.2) 0.574
Type of complication
Pulmonic 18 (7.6) 13 (5.5) 0.457
Cardiologic 10 (4.2) 12 (5.0) 0.827
Infectious 25 (10.5) 11 (4.6) 0.024 *
Thrombotic 1 (0.4) 1 (0.4) 1.000
Neurological 7 (2.9) 2 (0.8) 0.178
Other 38 (16.0) 29 (12.2) 0.292
Surgical complications < 30 days after surgery 54 (22.7) 44 (18.5) 0.308
Re-intervention 26 (10.9) 26 (10.9) 1.000
Type of re-intervention 0.288
Radiologic 0 (0.0) 2 (0.8)
Surgery, laparoscopic 3 (1.3) 4 (1.7)
Surgery, open 16 (6.7) 9 (3.8)
Other 7 (2.9) 11 (4.6)
Reason re-intervention 0.675
Anastomotic failure 6 (2.5) 5 (2.1)
Abscess 7 (2.9) 9 (3.8)
Bleeding 1 (0.4) 0 (0.0)
Ileus 2 (0.8) 2 (0.8)
Fascial dehiscence 2 (0.8) 1 (0.4)
Iatrogenic bowel injury 0 (0.0) 2 (0.8)
Ureter / urethra injury 2 (0.8) 0 (0.0)
Other 6 (2.5) 7 (2.9)
≥1 day on ICU 76 (31.9) 75 (31.5) 1.000
Hospital stay > 7 days 118 (49.6) 112 (47.1) 0.647
Readmission < 30 days after surgery 27 (11.3) 33 (13.9) 0.490
Abbreviations: ICU = intensive care unit
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Discussion
In this nationwide, propensity score matched study we found no difference in the occur-
rence of surgical complications between patients who underwent SCRT-delay or CRT as ne-oadjuvant therapy for LARC. However, more pulmonic, cardiologic, infectious and neurologic 
complications in the pre-matching cohort in the SCRT-delay group. These differences dimin-ished when patients were matched on age, gender, comorbidities, tumor characteristics and distance from the anus.
The pre-matching cohort represents daily clinical practice in the Netherlands. With the 
addition of SCRT-delay as regimen for LARC to the Dutch guidelines in 2014, more elderly 
patients are offered neoadjuvant treatment(25). In our dataset, 642 of 2,926 (21.9%) pa-
tients who underwent surgery were aged ≥75 years. The percentage of old and frail patients 
was higher in the SCRT-delay group, but these patients were also represented in the CRT group, which underlines the heterogeneity of the elderly population and the differences in treatment choice due to lack of evidence-based data. Previous studies showed various re-
sults in incidence of postoperative morbidity and mortality in the elderly(2-5, 26-28). Tak-ing into account that mortality increases when postoperative complications occur(5, 27) 
and anastomotic leakage results in significantly more anorectal and urinary symptoms and higher Low Anterior Resection Syndrome (LARS) scores(29, 30), the lower prevalence of 
primary anastomosis in the SCRT-delay group in the unmatched cohort might be a result of a defensive attitude towards primary anastomoses in frail and older patients. More post-
operative complications were seen in this cohort after APR in the SCRT-delay group. Also, the rate of pulmonic, cardiologic, infectious and neurologic complications was higher in this group. However, this was not related to surgical procedure and can therefore most likely 
be explained by the frailty of the SCRT-delay population. The lack of differences in surgical 
complications can partly be explained by improved quality of care and better selection of patients(6, 31). Moreover, frail patients that did not undergo surgical resection were not included in this study.
In the pre-matching cohort, we found a significant lower pCR rate in the SCRT-delay group 
(8.0% vs. 16.1%) after a median interval to surgery of 11 weeks. This is comparable with 
pCR rates of 4.4% to 25% in literature, with intervals to surgery varying from 4 to 19 weeks(9, 32-40). However, there were some differences in tumor characteristics between the groups in our dataset. Furthermore, we cannot relate these outcomes to local recurrence 
rates or survival. Three-years OS of 73-78% vs. 65-82.4% and DFS of 53-59% vs. 52-75.1% 
have been previously described for SCRT-delay and CRT, respectively(9, 32). However, these 
studies included younger, WHO 0-1 patients. Differences in survival are partly determined 
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by differences in patient selection for surgical treatment and choices in management of old-er patients with colorectal cancer might greatly affect population-based survival(41). Also, 
the majority of these patients received adjuvant chemotherapy. This is not a part of routine care in the Netherlands.
The post-matching cohort represents a comparison of SCRT-delay and CRT in two groups 
with equivalent age and comorbidities. Here we did not find a difference in postoperative 
complications nor in pathological outcomes between SCRT-delay and CRT. These results 
are in line with 2 randomized trials comparing SCRT-delay +/- chemotherapy and CRT(9, 32). Also, in the Stockholm III trial the frequency of postoperative complications decreased 
by delaying surgery with 4-8 weeks after SCRT(8, 12). This indicates that, considering sur-
gery-related complications and pathological outcomes, SCRT-delay could be a good alterna-
tive neoadjuvant treatment option for LARC patients who are unable to undergo CRT. How-ever, information on treatment compliance is lacking from this study. In the Stockholm III 
trial, 7% of patients were hospitalized for radiation toxicity. Previous studies suggest that 
compliance and immediate toxicity are in favor of SCRT (compared to CRT)(1), but more data is needed. Furthermore, long-term outcomes on local recurrence and survival is need-ed.
This is the first observational study that compares complications after SCRT-delay and CRT in a large population. Since observational studies cannot determine treatment effects as ac-curately as randomized trials(22), this propensity score matched study may provide a useful 
estimation of the differences between SCRT-delay and CRT. Nonetheless, the results of this study should be interpreted carefully. Confounding bias is frequently seen in observation-
al studies(42, 43). Patient and disease characteristics may have influenced the selection of patients for neoadjuvant and surgical treatment. Most likely, only well-conditioned patients 
are included in this database. The biggest pitfall of this study, however, is confounding by indication, since the selection of neoadjuvant treatment is confounded by patient factors, which are also related to the outcome(44, 45). Adjusting for confounding by indication us-ing propensity score analysis is reliable when data on all factors associated with the inter-vention and the outcome is precise and can be accounted for(23, 44). However, unadjusted 
confounding may still exist if unmeasured factors influenced treatment selection. This may lead to biased results(22, 23, 46).
The aging population, the rising incidence and the improved prognosis of rectal cancer will increase the need for surgery in the elderly population in the future(4, 26). Successful sur-gery of elderly patients depends on whether it is done safely, allowing them to preserve 
good quality of life, and a life-expectancy that is not reduced by the treatment(2). SCRT-delay 
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might be a good alternative neoadjuvant treatment option for frail LARC patients. Howev-er, standardized selection criteria based on geriatric assessment, information on treatment compliance, postoperative quality of life and patient preference is needed. Secondly, before 
the indication for SCRT-delay can be expanded to intermediate risk rectal cancer or high-risk rectal cancer, more data on long-term outcomes, such as local recurrence and survival, is needed.
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Supplementary materials
 
Supplementary Figure 1. Flowchart of patient selection. DCRA = Dutch ColoRectal Audit.
May 2014 – December 2017 
Patients with ≥cT2 rectal cancer in the DCRA 
database  
 
n = 8,318 
 
 
 
 
(n = ) 
M1 = 687 
M missing or unknown = 299   n = 986 
 
 
 
 
Locations outside rectum 
Coecum = 40 
Appendix = 10 
Colon ascendens = 23 
Flexura hepatica = 9 
Colon transversum = 22  n = 257 
Flexura splenica = 11 
Colon descendens = 12 
Sigmoid = 112 
Rectosigmoid =18  
 
 
 
 
 
 
 
Non-LARC 
cT2N0 = 403 
cT2N1 = 542 
cT2Nx = 18 
cT2N-missing = 1 
cT3N0 MRF - = 440   n =3,541 
cT3N0 MRF unknown = 81 
cT3N0 MRF missing = 245 
cT3Nx = 76     
cT3 N-missing = 6 
cT3N1 MRF- = 1322 
cT3N1 MRF unknown = 167 
cT3N1 MRF missing = 240 
 
 
 
 
 
 
No neoadjuvant treatment 
Only chemotherapy 
SCRT and chemotherapy 
n = 17 
n = 7 
n = 95  
 
 
Eligible patients 
n = 2,926 
 
Emergency Surgery    n = 6 
Urgent surgery    n = 9 
 
Date neoadjuvant treatment 
missing 
n = 14 
 
Interval to surgery < 6 weeks n = 298 
 
n = 4,777 
n = 3,791 
n = 3,534 
n = 3,415 
n = 3,400 
n = 3,386 
n = 3,088 
Surgery after watchful waiting n = 34 
 
HIPEC 
IORT 
n = 4 
n =124 
 
n = 3,054 
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Supplementary Table 2. Postoperative outcomes in the non-imputed and imputed dataset. Data are presented as number (percentage) unless stated otherwise.
Non-imputed dataset Imputed dataset
SCRT-delay
n = 288
CRT
n = 2,638 p-value
SCRT-
delay
n = 288
CRT
n = 2,638 p-value
Postoperative outcomes
Postoperative 
complications < 30 days 
after surgery
0.001 * 0.070
No 164 (56.9) 1,650 (62.5) 164 (56.9) 1,651 (62.6)
Yes 121 (42.0) 985 (37.3) 124 (43.1) 987 (37.4)
Missing 3 (1.0) 3 (0.1) - -
Surgical complications < 30 
days after surgery 0.003 * 0.538
No 220 (76.4) 1,985 (75.2) 222 (77.1) 1,985 (75.2)
Yes 65 (22.6) 650 (24.6) 66 (22.9) 653 (24.8)
Missing 3 (1.0) 3 (0.1) - -
Re-intervention 0.002 * 0.598
No 257 (89.2) 2,319 (87.9) 257 (89.2) 2,321 (88.0)
Yes 28 (9.7) 316 (12.0) 31 (10.8) 317 (12.0)
Missing 3 (1.0) 3 (0.1) - -
Type of re-intervention 0.012 * 0.334
Radiologic 2 (0.7) 35 (1.3) 2 (0.7) 35 (1.3)
Surgery, laparoscopic 3 (1.0) 68 (2.6) 3 (1.0) 69 (2.6)
Surgery, open 16 (5.6) 137 (5.2) 19 (6.6) 138 (5.2)
Other 7 (2.4) 76 (2.9) 7 (2.4) 76 (2.9)
Missing 3 (1.0) 3 (0.1) - -
Reason re-intervention 0.142 0.572
Anastomotic failure 4 (1.4) 100 (3.8) 6 (2.1) 101 (3.8)
Abscess 9 (3.1) 74 (2.8) 9 (3.1) 74 (2.8)
Bleeding 1 (0.3) 11 (0.4) 1 (0.3) 11 (0.4)
Ileus 2 (0.7) 38 (1.4) 2 (0.7) 40 (1.5)
Fascial dehiscence 2 (0.7) 16 (0.6) 2 (0.7) 17 (0.6)
Iatrogenic bowel injury 0 (0.0) 5 (0.2) 0 (0.0) 5 (0.2)
Ureter / urethra injury 2 (0.7) 5 (0.2) 2 (0.7) 5 (0.2)
Other 8 (2.8) 61 (2.3) 9 (3.1) 62 (2.4)
Missing 3 (1.0) 6 (0.2) - -
≥1 day on ICU 98 (34.0) 712 (27.0) 0.014 * 98 (34.0) 712 (27.0) 0.014 *
Hospital stay ≥ 7 days 145 (50.3) 1,076 (40.8) 0.002 * 145 (50.3) 1,076 (40.8) 0.002 *
Readmission < 30 days after 
surgery 0.698 0.539
No 252 (87.5) 2,250 (85.3) 252 (87.5) 2,251 (85.3)
Yes 36 (12.5) 383 (14.5) 36 (12.5) 384 (14.6)
Unknown 0 (0.0) 2 (0.1) 0 (0.0) 2 (0.1)
Missing 0 (0.0) 3 (0.1) - -
Abbreviations: ICU = intensive care unit
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Abstract
Aim
This subgroup analysis of a prospective multicenter cohort study aims to compare postoper-
ative morbidity between transanal total mesorectal excision (TaTME) and laparoscopic total 
mesorectal excision (LaTME).
Method
This study was designed as a subgroup analysis of a prospective multicenter cohort study. 
Patients undergoing TaTME or LaTME for rectal cancer were selected. All patients were fol-
lowed up until the first visit to the outpatient clinic after hospital discharge. Postoperative 
complications were classified according to Clavien-Dindo classification and Comprehensive 
Complication Index (CCI). Propensity score matching was performed.
ResultsIn total, 220 patients were selected from the overall prospective multicenter cohort study. 
After propensity score matching, 48 patients from each group were compared. The medi-
an tumor height for TaTME was 10.0 cm (6.0 – 10.8) and 9.5 cm (7.0 – 12.0) for LaTME 
(p = 0.459). Duration of surgery and anesthesia were both significantly longer for TaTME 
(221 vs 180 minutes p < 0.001 and 264 vs 217 min p < 0.001). TaTME was not converted 
to laparotomy while surgery in 5 patients undergoing LaTME was converted to laparotomy 
(0.0% vs 10.4% p = 0.056). No statistically significant differences were observed for Cla-
vien-Dindo Classification, CCI, readmissions, reoperations and mortality.
Conclusion
This study showed that TaTME is a safe and feasible approach for rectal cancer resection. 
This new technique obtained similar postoperative morbidity as LaTME.
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Introduction
Total mesorectal resection (TME) is the gold standard for rectal resection. This surgical technique, involving resection of the fatty envelope surrounding the rectum, has substan-tially contributed to local control and survival of rectal cancer(1, 2).
Minimally invasive techniques have been introduced for rectal surgery. Several randomized controlled trials have shown that oncological outcomes are comparable for open and laparo-
scopic surgery for rectal cancer. The COREAN trial has shown short-term benefits for laparo-scopic surgery compared to open surgery and equivalent quality of oncologic resection(3). In the long-term, disease-free survival was similar for the two techniques (4). In addition, 
The COLOR-II trial has confirmed that laparoscopic and open surgery for rectal cancer pro-vide similar long-term outcomes(5).
Recently, it has been shown that age above 65 years, a BMI greater than 25, and tumor lo-cation close to the anal verge are risk factors for the conversion from laparoscopic to open surgery(6). In addition, factors such as a narrow pelvis, or limited views of the distal rectum 
make the laparoscopic approach difficult. These considerations emphasize the need for a new minimally invasive technique that overcomes the limitations of laparoscopy.
Transanal total mesorectal excision (TaTME) may be the solution. Since its introduction in 
2010, TaTME has been shown to be a feasible and safe technique for rectal cancer resections and has subsequently achieved widespread acceptance(7, 8). Nevertheless, to date most ev-idence has been obtained from cohort studies with small sample sizes and retrospective 
design(9-13). Therefore, this study is important because it is the first to provide results of 
a prospective multicenter cohort study. The aim of this study was to compare postoperative 
morbidity between TaTME and LaTME.
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Methods
This study was designed as a subgroup analysis of a prospective multicenter cohort study, 
the APPEAL-II study. Ten hospitals in The Netherlands and Belgium participated in this 
study. This study was approved by the medical ethics committee of the Erasmus University 
Medical Centre in The Netherlands and of the University Hospital Leuven in Belgium. We 
also obtained approval from local ethics committees of the participating hospitals. This pro-
spective cohort was established between August 2015 and October 2017. Patients aged 18 
years and older who underwent partial mesorectal excision (PME) or total mesorectal ex-
cision (TME) with construction of a colorectal or coloanal anastomosis were eligible for in-
clusion. We excluded pregnant women and patients who underwent emergency procedures. All patients received a pelvic drain during surgery that was kept in place for at least the 
first three postoperative days. Drain fluid was obtained for further analysis according to the 
study protocol (https://doi.org/10.1186/ISRCTN84052649). Follow-up, for the purposes 
of this study, was completed at the first visit at the outpatient clinic after hospital discharge. Informed consent was obtained from all patients. For this subgroup analysis, we selected 
patients who underwent TaTME or LaTME for rectal cancer. Patient selection for TaTME or 
LaTME was at discretion of the surgeon.
Baseline characteristics (age, gender, BMI, smoking, alcohol abuse (>14 units per week), ASA score, tumor location, neoadjuvant radiotherapy, neoadjuvant chemotherapy, patholog-
ical TNM stadium) and surgical characteristics (duration of surgery, duration of anesthesia, 
conversion, construction of anastomosis, configuration of anastomosis, diverting ileostomy, 
circumferential resection margin (CRM), distal resection margin (DRM)) were prospectively 
registered. CRM was considered positive when the margin was <1 mm and for the DRM this 
was <1 cm(14).
Outcome measures
The outcome measures of this analysis were postoperative complications, readmissions, re-operations, conversions and mortality. Stoma reversals were not considered as reoperations 
unless it was due to stoma complications. Anastomotic leakage was defined as clinically 
manifest insufficiency of the anastomosis leading to a clinical state requiring re-interven-
tion (i.e. grade B/C)(15). Anastomotic leakage was confirmed by either endoscopy, CT-scan and/or contrast enema or reoperation. Re-intervention for anastomotic leakage consisted of therapeutic antibiotics, (endoscopic) drainage or a surgical re-intervention. Presacral ab-
scesses were classified as anastomotic leakage if extravasation of the colonic contrast was 
visible on radiological imaging. Fistulas attached to the anastomosis on CT-scan were also 
classified as anastomotic leakage. Postoperative complications were classified according to 
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the Clavien-Dindo classification system and grade II or higher was considered to be a severe 
complication(16, 17). In addition, the comprehensive complication index (CCI) for every pa-tient was calculated using www.assessurgery.com(18).
Statistical analysis
Continuous variables were described as median ± IQR and compared by the Mann-Whitney 
U test. Categorical variables were described as percentages and compared by the Chi-square 
test or Fisher’s Exact test when needed. Patients were matched based on the propensity score derived from a logistic regression model with approach as dependent covariate and 
baseline characteristics with p value < 0.1 as independent covariates. In addition, a multi-variate penalized logistic/linear regression model was built to investigate the adjusted as-sociation between the surgical approach and the outcome measures adjusted for aforemen-tioned risk factors in the unmatched dataset (age, gender, BMI, tumor location, pathological tumor stage, neoadjuvant radiotherapy, neoadjuvant chemotherapy, diverting ileostomy, 
approach). All clinically relevant variables were added to the model. Statistical significance 
was defined as p value < 0.050. All analyses were performed using SPSS® software 21.0 
(IBM, Armonk, New York, USA) or R Software.
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Results
This prospective cohort study of patients undergoing partial mesorectal excision (PME) or 
total mesorectal excision (TME) included 301 patients. For this analysis, we excluded 74 patients who underwent PME or who had an open approach and 7 patients were operated 
upon for reasons other than rectal cancer. In total, 220 patients were selected (Figure 1). The 
median follow-up was 27.0 days (IQR 19.0 – 34.0 days).
Figure 1. Flowchart of patient selection.
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Table 1 shows prematching baseline characteristics of the overall study population of 220 
patients. Age, tumor location, pathological T stadium and neoadjuvant chemotherapy were used to calculate the propensity score. After matching for propensity score, 96 patients were eligible for analysis.
Table 1. Demographic characteristics for patients undergoing LaTME and TaTME
TaTME
119 (54.1%)
LaTME
101 (45.9%)
Missing P value
Baseline characteristics
Age, median (IQR†), yr 62.0 (56.0 – 67.0) 66.0 (59.5 – 73.0) 0 (0.0%) 0.003Gender Male 86 (72.3%) 64 (63.4%) 0 (0.0%) 0.158Female 33 (27.7%) 37 (36.6%)BMI‡, median ± (IQR†), kg/m2 26.6 (23.7 – 29.7) 25.2 (23.2 – 28.7) 1 (0.5%) 0.162Smoking Yes 15 (12.7%) 11 (11.5%) 6 (2.7%) 0.780No 103 (87.3%) 85 (88.5%)Alcohol abuse Yes 16 (13.6%) 11 (11.7%) 8 (3.6%) 0.687No 102 (86.4%) 83 (88.3%)Bowel preparation Yes 116 (97.5%) 82 (92.1%) 12 (5.5%) 0.102*No 3 (2.5%) 7 (7.9%)Previous abdominal surgery Yes 37 (31.1%) 35 (35.0%) 1 (0.5%) 0.540No 82 (68.9%) 65 (65.0%)ASA§ score I 11 (9.2%) 16 (16.0%) 1 (0.5%) 0.355*II 77 (64.7%) 64 (64.0%)III 30(25.2%) 19 (19.0%)IV 1 (0.8%) 1 (1.0%)
Tumor distance to anal verge, 
median (IQR†), cm 5.0 (2.1 – 10.0) 12.0 (9.0 – 15.0) 12 (5.5%) <0.001
pT stage pT0 21 (17.8%) 6 (6.0%) 7 (3.1%) 0.027*
pT1 16 (13.6%) 19 (19.0%)
pT2 36 (30.5%) 26 (26.0%)
pT3/4 42 (35.6%) 47 (47.0%)pN stage pN0 83 (69.7%) 68 (67.3%) 7 (3.1%) 0.292pN1 17 (14.3%) 22 (21.8%)pN2 14 (11.8%) 8 (7.9%)pN3 0 (0.0%) 1 (1.0%)Neoadjuvant radiotherapy Yes 67 (56.3%) 60 (60.0%) 1 (0.5%) 0.581Short-course 14 34Long-course 47 25No 52 (43.7%) 40 (40.0%)Neoadjuvant chemotherapy Yes 52 (43.7%) 28 (28.0%) 1 (0.5%) 0.016No 67 (56.3%) 72 (72.0%)
* Fisher Exact Test;† IQR, interquartile range;‡ BMI, body mass index;§ ASA, American Society of Anesthesiologists
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Table 2 shows postmatching baseline characteristics of 48 patients undergoing TaTME and 
48 patients undergoing LaTME. Patients undergoing LaTME received more often neoadju-
vant radiotherapy (43.8% vs 64.6% p = 0.041). The other baseline characteristics were not 
statistically significant different for TaTME and LaTME. Duration of surgery and anesthesia 
were both significantly longer for TaTME (221 vs 180 minutes p < 0.001 and 264 vs 217 min 
p < 0.001). TaTME was not converted to laparotomy while surgery in 5 patients undergoing 
LaTME was converted to laparotomy (0.0% vs 10.4% p = 0.056) (Table 3). Reasons for con-
version were adhesions, obesity, bleeding and insufficient bowel length for stoma creation.
Table 2. Postmatching baseline characteristics
TaTME
48
LaTME
48
Missing P value
Age, median (IQR†), yr  65.0 (56.8 – 71.0) 64.0  (59.3 – 73.0) 0 (0.0%) 0.752Gender Male 33 (68.8%) 32 (66.7%) 0.827BMI‡, median ± (IQR†), kg/m2 27.0 (24.5 – 30.7) 26.1 (24.0 – 29.0) 1 (1.0%) 0.221Smoking 5 (10.4%) 6 (12.5%) 5 (5.2%) 0.661Alcohol abuse 7 (14.6%) 2 (4.2%) 5 (5.2%) *0.164ASA§ score I 4 (8.3%) 6 (12.5%) 0 (0.0%) *0.953II 29 (60.4%) 28 (58.3%)III 14 (29.2%) 13 (27.1%)IV 1 (2.1%) 1 (2.1%)
Tumor location, median (IQR†), cm 10.0 (6.0 – 10.8) 9.5 (7.0 – 12.0) 0 (0.0%) 0.459Neoadjuvant radiotherapy 21 (43.8%) 31 (64.6%) 0 (0.0%) 0.041Short-course 5 (10.4%) 16 (33.3%)Long-course 15 (31.3%) 14 (29.2%)Neoadjuvant chemotherapy 14 (29.2%) 16 (33.3%) 0 (0.0%) 0.660
pT stage pT0 3 (6.3%) 2 (4.2%) 0 (0.0%) *0.973
pT1 7 (14.6%) 7 (14.6%)
pT2 15 (31.3%) 14 (29.2%)
pT3/4 23 (47.9%) 25 (52.1%)pN stage pN0 32 (66.7%) 34 (70.8%) 0 (0.0%) 0.660
pN+ 16 (33.3%) 14 (29.2%)
* Fisher Exact Test;† IQR, interquartile range;‡ BMI, body mass index;§ ASA, American Society of Anesthesiologists
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Table 3. Post matching surgical characteristics
TaTME
48
LaTME
48
Missing P value
Duration of surgery, median 
(IQR†), minutes 221.0 (187.50 – 263.50) 180.0 (141.0 – 205.0) 3 (3.1%) <0.001
Duration of anaesthesia, 
median (IQR†), minutes 264.0 (228.8 – 313.3) 217.0 (176.5 – 244.3) 8 (8.3%) <0.001Conversion 0 (0.0%) 5 (10.4%) 0 (0.0%) *0.056Construction of anastomosis Hand-sewn 7 (14.6%) 0 (0.0%) 0 (0.0%) *0.012Stapler 41 (85.4%) 48 (100.0%)
Configuration of anastomosis Side-to-End 26 (54.2%) 41 (85.4%) 3 (3.1%) *<0.001End-to-End 20 (41.7%) 4 (8.3%)End-to-Side 0 (0.0%) 2 (4.2%)
Diverting ileostomy 40 (83.3%) 23 (47.9%) 0 (0.0%) <0.001CRM involvement 2 (4.2%) 1 (2.1%) 10 (10.4%) *1.000
DRM involvement 5 (10.4%) 8 (16.7%) 8 (8.3%) 0.322
* Fisher Exact Test† IQR, interquartile range
No statistically significant differences were observed for hospital stay, anastomotic leakage, 
ileus, cardiopulmonary complications, wound infections, Clavien-Dindo Classification, CCI, 
readmissions, reoperations and mortality (Table 4). Readmissions were due to anastomotic leakage, high output stoma, ileus, pancreatic pseudocyst and iatrogenic small bowel perfora-
tion. The indications for reoperations were anastomotic leakage and replacement of divert-
ing ileostomy. In the LaTME group, 1 patient died two days after discharge of an unknown reason as autopsy was not performed.
Table 4. Postmatching postoperative course comparison
TaTME
48
LaTME
48
Missing P value
Hospital stay, median (IQR†), days 8.0 (6.0 – 13.5) 7.5 (5.0 – 13.8) 0 (0.0%) 0.596Anastomotic leakage 10 (20.8%) 9 (18.8%) 0 (0.0%) 0.798Ileus 7 (14.6%) 8 (16.7%) 0 (0.0%) 0.779Cardiopulmonary complications 0 (0.0%) 3 (6.3%) 0 (0.0%) *0.242Wound infection 2 (4.2%) 1 (2.1%) 0 (0.0%) *1.000
Clavien Dindo Classification >II 9 (18.8%) 10 (20.8%) 0 (0.0%) 0.798
Comprehensive Complication Index, median 
(IQR†) 14.8 (0.0 – 22.6) 4.4 (0.0 – 22.6) 0 (0.0%) 0.602Readmission 10 (20.8%) 5 (10.4%) 0 (0.0%) 0.160Reoperation 8 (16.7%) 7 (14.6%) 0 (0.0%) 0.779Mortality 0 (0.0%) 1 (2.1%) 0 (0.0%) *1.000
* Fisher Exact Test† IQR, interquartile range
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In the overall study population of 220 patients, multivariate penalized regression analyses 
showed that surgical approach is not associated with Clavien-Dindo Classification >II (OR 
1.02 95% CI 0.41 – 2.51 p = 0.970), CCI (estimate -0.77 95% CI -6.84 – 5.31 P = 0.805), 
readmission (OR 1.13 95% CI 0.43 – 2.99 p = 0.802), and reoperation (OR 1.33 95% CI 0.49 
– 3.64 p = 0.574) (Table 5).
119
Transanal total mesorectal excision
Ta
bl
e 
5.
 M
u
lt
iv
ar
ia
te
 p
en
al
iz
ed
 lo
gi
st
ic
 r
eg
re
ss
io
n 
to
 t
es
t t
he
 a
ss
oc
ia
ti
on
 b
et
w
ee
n 
ap
pr
oa
ch
 a
nd
 C
la
vi
en
-D
in
do
 >
II
, r
ea
d
m
is
si
on
 a
nd
 r
eo
p
er
at
io
n
Cl
av
ie
n-
D
in
do
 >
II
CC
I
R
ea
dm
is
si
on
R
eo
pe
ra
ti
on
O
R
 9
5%
 C
I*
P-valu
e
E
st
im
at
e 
95
%
 C
I*
P-valu
e
O
R
 9
5%
 C
I*
P-valu
e
O
R
 9
5%
 C
I*
P-valu
e
A
ge
, m
ed
ia
n 
(I
Q
R
† ), yr
0.96 0.
92 – 0.
99
0.
01
4
-0.32 -
0.55 - -
0.08
0.
00
8
0.97 0.
94 – 1.
01
0.181
0.96 0.
92 – 1.
00
0.
03
2
Gender
0.77 0.
37 – 1.
59
0.482
-0.76 -5
.66 – 4
.14
0.760
0.88 0.
39 – 2.
02
0.770
1.01 0.
44 – 2.
31
0.980
BMI‡ , m
ed
ia
n 
± 
(I
Q
R
† ), kg/m
2
0.98 0.
90 – 1.
06
0.550
0.06 -0
.45 – 0
.57
0.820
0.98 0.
89 – 1.
07
0.618
1.03 0.
94 – 1.
12
0.588
L
oc
at
io
n 
le
si
on
, m
ed
ia
n 
(I
Q
R
† ), cm
1.00 0.
92 – 1.
08
0.990
0.23 -0
.32 – 0
.78
0.417
1.06 0.
97 – 1.
16
0.171
0.96 0.
87 – 1.
05
0.385
pT
0.88 0.
62 – 1.
24
0.455
-0.76 -3
.03 – 1
.51
0.514
0.94 0.
64 – 1.
39
0.774
1.01 0.
68 – 1.
50
0.952
Neoad
juvant
 radiot
herapy
0.97 0.
41 – 2.
26
0.939
1.63 -4
.21 – 7.
47
0.585
1.05 0.
41 – 2.
70
0.920
0.86 0.
34 – 2.
16
0.748
Neoad
juvant
 chemo
therap
y
0.67 0.
26 – 1.
68
0.391
-7.09 -1
3.30 - -
0.88
0.
02
6
0.80 0.
30 – 2.
16
0.664
0.45 0.
15 – 1.
34
0.153
D
iv
er
ti
n
g 
il
eo
st
om
y
0.56 0.
26 – 1.
23
0.151
1.12 -4
.19 – 6
.43
0.680
2.22 0.
84 – 5.
83
0.107
0.41 0.
17 – 1.
01
0.054
Approa
ch
1.02 0.
41 – 2.
51
0.970
-0.77 -
6.84 – 
5.31
0.805
1.13 0.
43 – 2.
99
0.802
1.33 0.
49 – 3.
64
0.574
* Odd
s 
ra
ti
o 
an
d 
95
%
 c
on
fi
de
n
ce
 in
te
rv
al
†  IQR
, i
n
te
rq
u
ar
ti
le
 r
an
ge
‡ BM
I, 
b
od
y 
m
as
s 
in
de
x
6
120
Chapter 6
Discussion and conclusions
This propensity score matched study of a prospective multicenter cohort study aimed to 
compare postoperative morbidity between TaTME and LaTME. Our results suggest that 
TaTME is a safe and feasible approach for rectal cancer resection and has similar postoper-
ative morbidity to LaTME.
Nowadays, high conversion rates from laparoscopic to open surgery are reported for rec-tal resection especially in elderly patients and obese patients contributing to postoperative morbidity(6). Even in the most recent clinical trials comparing laparoscopic versus robotic 
assisted TME for rectal cancer, conversions were up to 10% in both arms(19). This is one of the main drawbacks of conventional laparoscopic surgery for rectal resection. In the present 
study, TaTME was not converted at all while LaTME was converted to laparotomy in 10.4%. 
A recent single center case-matched study reported similar results(20). This low incidence of conversion seems to be the main advantages of this new technique.
With the introduction of minimal invasive techniques, the short-term outcomes of rectal 
surgery have improved over recent decades. Despite these advances, the incidence of anas-tomotic leakage has not been reduced(21). Anastomotic leakage is one of the major concerns after rectal resection because of associated morbidity and mortality. A recent study demon-strated that large rectal tumors in obese, diabetic male patients who smoke have the highest 
risk for anastomotic leakage after TaTME(22). In line with previous literature, we found no 
difference in leakage rate for TaTME and LaTME (9-11, 13, 23-25). Therefore, the transanal approach does not seem to reduce the incidence of AL after rectal cancer resection.
In contrast to previous studies, our results show that TaTME is associated with more pro-
longed surgery and anesthesia(7, 8). Previously, it was suggested that TaTME can be per-formed by two teams simultaneously, however not all hospitals have the capacity to perform 
TaTME in two teams due to lack of personnel. When TaTME is not performed in two teams simultaneously, this may result in prolonged duration of surgery and anesthesia. Moreover, 
this study included hospitals in which the TaTME technique was recently introduced. There-
fore, a longer duration of surgery might reflect a learning curve. (26). In addition, creation 
of a diverting ileostomy, which was more often performed in the TaTME group, may also 
influence duration of surgery and anesthesia.
After matching for propensity score, patients who underwent LaTME received neoadju-
vant radiotherapy more frequently than TaTME patients. The ESMO clinical practice guide-
lines have recently been updated indicating that specific patients with intermediate risk 
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rectal cancer do not need neoadjuvant treatment in order to minimize local recurrence if 
good-quality TME can be achieved(27). Since the TaTME has recently become more popular, this difference might mirror the update of these guidelines. In addition, this study showed, in the unmatched cohort, that preoperative radiotherapy was not associated with postoper-
ative morbidity (Table 5), and therefore it is unlikely that this difference in baseline charac-
teristics have influenced the results.
In the postmatching TaTME group, more manual and end-to-end anastomoses were ob-served, even though there were no baseline differences in between both groups on tumor height. A systematic review showed similar results(28).
Diverting ileostomies are common after rectal resection but do not reduce anastomotic leak-age or mortality(29). In fact, diverting ileostomies tend to mitigate consequences of anasto-motic leakage resulting in less invasive treatment strategies. In the present study, patients 
who underwent TaTME were more often diverted during primary surgery. A recent single 
center case-matched study found similar results(25). This difference might reflect surgeons’ perception to protect the anastomosis following the new approach while this risk is unsub-stantiated.
In the present study, tumor location was derived from endoscopy. There seems to be a sig-
nificant difference between the tumor location of colorectal cancers reported by endoscopy and the actual location determined during surgery(30). Moreover, the anal verge was the 
reference for determination of the tumor location. Thus, this distance includes the anal canal 
of 3-5 cm(31). This may explain the relatively high tumor location in both the TaTME as the 
LaTME group.
Functional outcomes are of interest for future research. TaTME possibly provides better vis-ualization of the distal rectum which may contribute to preservation of pelvic nerves and 
vascularity resulting in better urinary and sexual function(23, 32).
At this moment, this subgroup analysis provides the highest level of evidence on postoper-
ative short-term after TaTME and LaTME currently available since the results were based on a multicenter prospective cohort study. Nevertheless, we recognize several limitations 
of this study. First, the TME procedures in both groups were not standardized so different types of laparoscopic assisting techniques (i.e. single-port or multi-port) were used. Second, cohort studies are sensitive to bias and confounding. Nevertheless, both propensity score analysis and penalized multivariate regression analyses were performed to adjust for con-founding effects showing similar results.
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This propensity score matched study of a prospective multicenter cohort study aimed to 
compare postoperative morbidity between TaTME and LaTME. The present study showed 
that TaTME is a safe and feasible approach for rectal cancer resection. This new technique 
obtained similar postoperative morbidity. This study is the first to provide evidence based upon prospective data. However, oncological safety in terms of CRM involvement and local recurrence should be obtained in a well-designed randomized controlled trial.
123
Transanal total mesorectal excision
References
1. Kapiteijn E, Putter H, van de Velde CJ, Cooperative investigators of the Dutch ColoRectal 
Cancer G. Impact of the introduction and training of total mesorectal excision on recurrence 
and survival in rectal cancer in The Netherlands. Br J Surg. 2002;89(9):1142-9.2. Wibe A, Moller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, et al. A national strategic change in 
treatment policy for rectal cancer--implementation of total mesorectal excision as routine 
treatment in Norway. A national audit. Dis Colon Rectum. 2002;45(7):857-66.
3. Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, et al. Open versus laparoscopic 
surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN 
trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11(7):637-45.
4. Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB, et al. Open versus laparoscopic surgery 
for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 
survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet On-col. 2014;15(7):767-74.
5. Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, de Lange-de Klerk ES, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015;372(14):1324-32.
6. van der Pas M, Deijen CL, Abis GSA, de Lange-de Klerk ESM, Haglind E, Furst A, et al. Conver-sions in laparoscopic surgery for rectal cancer. Surg Endosc. 2017;31(5):2263-70.
7. Ma B, Gao P, Song Y, Zhang C, Zhang C, Wang L, et al. Transanal total mesorectal excision 
(taTME) for rectal cancer: a systematic review and meta-analysis of oncological and pe-
rioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer. 2016;16:380.8. Xu W, Xu Z, Cheng H, Ying J, Cheng F, Xu W, et al. Comparison of short-term clinical outcomes 
between transanal and laparoscopic total mesorectal excision for the treatment of mid and 
low rectal cancer: A meta-analysis. Eur J Surg Oncol. 2016;42(12):1841-50.
9. Chen CC, Lai YL, Jiang JK, Chu CH, Huang IP, Chen WS, et al. Transanal Total Mesorectal 
Excision Versus Laparoscopic Surgery for Rectal Cancer Receiving Neoadjuvant Chemora-
diation: A Matched Case-Control Study. Ann Surg Oncol. 2016;23(4):1169-76.
10. de’Angelis N, Portigliotti L, Azoulay D, Brunetti F. Transanal total mesorectal excision for 
rectal cancer: a single center experience and systematic review of the literature. Langen-becks Arch Surg. 2015;400(8):945-59.
11. Kanso F, Maggiori L, Debove C, Chau A, Ferron M, Panis Y. Perineal or Abdominal Approach 
First During Intersphincteric Resection for Low Rectal Cancer: Which Is the Best Strategy? 
Dis Colon Rectum. 2015;58(7):637-44.
12. Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, et al. Transanal To-
tal Mesorectal Excision: International Registry Results of the First 720 Cases. Ann Surg. 2017;266(1):111-7.
13. Perdawood SK, Al Khefagie GA. Transanal vs laparoscopic total mesorectal excision for rec-
tal cancer: initial experience from Denmark. Colorectal Dis. 2016;18(1):51-8.
14. Bernstein TE, Endreseth BH, Romundstad P, Wibe A, Norwegian Colorectal Cancer R. What is a safe distal resection margin in rectal cancer patients treated by low anterior resection 
without preoperative radiotherapy? Colorectal Dis. 2012;14(2):e48-55.
6
124
Chapter 6
15. Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A, et al. Definition and grad-ing of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery. 2010;147(3):339-51.
16. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Cla-
vien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187-96.17.
17. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new pro-posal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-13.
18. Slankamenac K, Nederlof N, Pessaux P, de Jonge J, Wijnhoven BP, Breitenstein S, et al. The 
comprehensive complication index: a novel and more sensitive endpoint for assessing out-come and reducing sample size in randomized controlled trials. Ann Surg. 2014;260(5):757-62; discussion 62-3.
19. Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, et al. Effect of Robotic-As-
sisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy 
Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical 
Trial. Jama. 2017;318(16):1569-80.
20. Perdawood SK, Thinggaard BS, Bjoern MX. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries. Surg Endosc. 2018;32(5):2312-21.21. Frouws MA, Snijders HS, Malm SH, Liefers GJ, Van de Velde CJH, Neijenhuis PA, et al. Clini-cal Relevance of a Grading System for Anastomotic Leakage After Low Anterior Resection: 
Analysis From a National Cohort Database. Dis Colon Rectum. 2017;60(7):706-13.22. Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, et al. Incidence and Risk 
Factors for Anastomotic Failure in 1594 Patients Treated by Transanal Total Mesorectal 
Excision: Results From the International TaTME Registry. Ann Surg. 2018.
23. Chouillard E, Regnier A, Vitte RL, Bonnet BV, Greco V, Chahine E, et al. Transanal NOTES to-
tal mesorectal excision (TME) in patients with rectal cancer: Is anatomy better preserved? 
Tech Coloproctol. 2016;20(8):537-44.
24. Fernandez-Hevia M, Delgado S, Castells A, Tasende M, Momblan D, Diaz del Gobbo G, et al. 
Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery. Ann Surg. 2015;261(2):221-7.
25. Persiani R, Biondi A, Pennestri F, Fico V, De Simone V, Tirelli F, et al. Transanal Total Mesorec-
tal Excision vs Laparoscopic Total Mesorectal Excision in the Treatment of Low and Middle 
Rectal Cancer: A Propensity Score Matching Analysis. Dis Colon Rectum. 2018;61(7):809-16.
26. Koedam TWA, Veltcamp Helbach M, van de Ven PM, Kruyt PM, van Heek NT, Bonjer HJ, et al. 
Transanal total mesorectal excision for rectal cancer: evaluation of the learning curve. Tech Coloproctol. 2018;22(4):279-87.
27. Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rodel C, Cervantes A, et al. Rectal cancer: 
ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018.
28. Simillis C, Hompes R, Penna M, Rasheed S, Tekkis PP. A systematic review of transanal 
total mesorectal excision: is this the future of rectal cancer surgery? Colorectal Dis. 2016;18(1):19-36.
29. Snijders HS, van Leersum NJ, Henneman D, de Vries AC, Tollenaar RA, Stiggelbout AM, et al. 
Optimal Treatment Strategy in Rectal Cancer Surgery: Should We Be Cowboys or Chickens? 
125
Transanal total mesorectal excision
Ann Surg Oncol. 2015;22(11):3582-9.30. Blum-Guzman JP, Wanderley de Melo S, Jr. Location of colorectal cancer: colonosco-
py versus surgery. Yield of colonoscopy in predicting actual location. Endosc Int Open. 2017;5(7):E642-E5.
31. Nivatvongs S, Stern HS, Fryd DS. The length of the anal canal. Diseases of the Colon & Rec-tum. 1981;24(8):600-1.
32. Keating JP. Sexual function after rectal excision. ANZ J Surg. 2004;74(4):248-59.
6

C.L. Sparreboom
D.P.V. Lambrichts
A.G. Menon
G.J. Kleinrensink
H.F. Lingsma
J.F. Lange
Surgical Innovation 2019 Aug [Epub ahead of print]
Outcomes after elective colorectal surgery 
by two surgeons versus one in a 
low-volume hospital*
Chapter 7
128
Chapter 7
Abstract
BackgroundImproved patient outcomes after colorectal surgery in high-volume hospitals are leading to centralization of colorectal surgery. However, it is desirable to strive for optimal quality 
of colorectal surgery in low-volume hospitals. This study aimed to assess the effect of the number of surgeons involved in the surgical procedure on patient outcomes in a low-volume hospital.
MethodsAll patients who underwent elective colorectal surgery with construction of a primary anas-tomosis between January 1st 2007 and December 31st 2015 were included in this retrospec-
tive cohort. The propensity score was used to adjust for confounding.
Results
A total of 429 patients were included. 143 patients (33.3%) were operated by one surgeon 
and 286 patients (66.7%) were operated by two surgeons. Patients operated by two sur-geons were younger, more often male, and had a higher BMI. A multivariate analysis with propensity scores revealed that surgery with two surgeons was associated with less reop-
erations (OR 0.4 95%CI 0.2–0.9 p=0.038). Colorectal anastomotic leakage (OR 0.6 95%CI 
0.2–1.3 p=0.204) and mortality (OR 0.8 95%CI 0.2–3.7 p=0.807) were not associated with the number of surgeons involved in the surgical procedure.
Conclusion
The present study shows that elective colorectal surgery in a low-volume hospital performed 
by two surgeons resulted in less reoperations. This might positively influence patient out-comes and might be related to increased surgical quality as compared to procedures per-formed by only one surgeon.
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Introduction
There is a growing interest in quality assessment of colorectal surgery with an increasing need for outcome measures that represent performance of institutes and individual sur-
geons. Variability in patient outcomes following colorectal surgery has been identified to be assigned to both patient-related factors and institution-related factors(1-3). Previous-ly, several studies have reported improved patient outcomes after colorectal surgery in 
high-volume hospitals(4). This has led to centralization of colorectal surgery and centers of 
excellence have been established. However, improvement of patient outcomes after colorec-tal surgery in low-volume hospitals is not addressed within this strategy. As it may not be possible to implement centralization of colorectal surgery on a national level in the near future, it is still of paramount importance to improve quality of care in low-volume centers. Furthermore, patient outcomes from individual surgeons have come under increased scru-tiny. Both volume of surgery and specialization of individual surgeons are associated with improved patient outcomes for colorectal surgery(5-7).
The value of teamwork in the operating room has also earned increasing attention(8). Im-
provement of teamwork in the operating room may have beneficial effects on patient out-comes(9). Some data suggest that there is an association with teamwork culture and re-
duction of surgical site infections(10). Nevertheless, the effect of the number of certified surgeons (i.e. not being a resident) involved in the surgical procedure on patient outcomes after colorectal surgery in a low-volume hospital has not been addressed previously, while this might provide an easy possibility to improve patient outcomes after colorectal surgery in low-volume hospitals.
This study aims to determine the effect of the number of surgeons involved in the surgical 
procedure on quality of colorectal surgery in a low-volume hospital. Our hypothesis was that outcomes of elective colorectal surgery improve when surgical procedures were per-formed by two surgeons compared to one surgeon in a low-volume hospital.
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Materials and methods
Study designWe performed a retrospective, single center, cohort study at the Havenziekenhuis, Rotter-
dam. The Havenziekenhuis is a low-volume, satellite hospital of the Erasmus University 
Medical Center Rotterdam, but it is not a teaching hospital. Therefore, no surgical fellows or residents were involved during the surgical procedures and it was possible to compare outcomes between the different numbers of surgeons involved in the surgical procedure. 
All surgeons involved in the study were formally certified by the Dutch Society of Surgery 
to perform colorectal surgery and had comparable colorectal expertise. Between January 1st 
2007 and December 31st 2015, all patients undergoing elective colorectal surgery with con-struction of a primary anastomosis, with or without a protective ileostomy, were included. 
Patients who received an end colostomy or end ileostomy were not included. The STROBE 
(Strengthening the Reporting of Observational studies in Epidemiology) statement was used for this study(11). Informed consent was waived for participation in this study, because it 
was a retrospective records review. The study was approved the institutional review board 
of the Erasmus University Medical Center Rotterdam.
Data collection
Patients were identified by searching hospital database for DBC Codes (Diagnose Behandel 
Combinatie; Diagnosis Related Groups [DRGs]). Patients’ medical records were reviewed 
and data were collected on patient characteristics: age, sex, Body Mass Index (BMI), Amer-ican Society of Anesthesiologists (ASA) score, diabetes mellitus, smoking, alcohol abuse (>14 drinks per week), medication use. Surgical characteristics were retrieved and included type of surgical procedure, indication, approach (laparoscopic or open), conversion, stoma construction, additional abdominal resection, intraoperative complications, and duration of surgery.
The number of surgeons involved in the surgical procedures were retrieved from surgical reports. In these surgical reports it was marked which surgeons performed the operation 
and who were assisting. Only procedures that started and were completed with two sur-
geons were labeled as ‘two surgeons’. If a surgeon, urologist, or gynecologist briefly joined 
the team to assist with the procedure, it was defined as surgery performed by one surgeon. 
There was no clear rationale within the unit for deciding which patients involved two sur-geons and which patients involved just one. All surgeons performed colorectal resections on their own or together with a colleague.
The postoperative period was restricted to 30 days after the primary procedure and infor-
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mation was obtained regarding postoperative complications. Reoperation, colorectal anas-tomotic leakage (CAL), mortality and length of hospital stay were registered. Reoperation 
did not include closure of ileostomy. CAL was defined as an insufficiency of the anastomosis, demonstrated by either imaging studies or reoperation and leading to a clinical state that required intervention such as antibiotic treatment, radiological drainage or surgical inter-vention.
Statistical analysis
Continuous variables were presented as median with interquartile range (IQR) and univar-
iate testing was performed using Mann-Whitney U test. Dichotomous and categorical var-
iables were presented as numbers with percentages (%) and univariate testing was per-
formed using Pearson’s Chi-squared test or Fisher’s Exact test depending on size of groups. 
To adjust for confounding factors, a propensity score was constructed with a multivariable logistic regression model with variables that might determine whether a patient is operat-ed by one or two surgeons. In this model, we included variables related to the number of 
surgeons involved in surgery that were considered clinically relevant. The propensity score was then added as independent variable to a logistic or linear regression model, depending on the outcome measure, together with the variable that indicated the number of surgeons 
involved. Sensitivity analysis was performed to explore the effect of surgical approach by stratifying the propensity score analysis for laparoscopic or open approach. A two-sided 
p-value of <0.05 was considered statistically significant for all tests. All analyses were per-formed using IBM SPSS Version 21.0.0.1. 7
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Results
We established a retrospective cohort of 441 consecutive patients who were admitted to the Havenziekenhuis Hospital in Rotterdam between January 1st 2007 and December 31th 2015 for elective colorectal resection with construction of a primary anastomosis, with or 
without construction of protective ileostomy. On average 49 elective colorectal resections with construction of a primary anastomosis were performed yearly. Eleven patients were 
excluded due to lack of information on the postoperative course. One patient was excluded due to inconclusive information on the number of operators. In total, 429 patients were eligible for analysis, of which 163 underwent right hemicolectomy, 51 left hemicolectomy, 
143 sigmoid resection and 72 (low) anterior resection. A total of 204 operations (47.6%) 
were performed laparoscopically, of which 38 (18.6%) were converted. The median length 
of hospital stay was 8 days (IQR: 6-13 days) and the incidence of CAL was 8.6% (37 pa-
tients). Forty-two patients underwent reoperation. The median hospital stay for patients that underwent reoperation was 16 days and 7 days for patients that did not underwent 
reoperation (p<0.001).
Ten individual surgeons were involved in this study. In 143 patients (33.3%) surgery was 
performed by one surgeon and in 286 patients (66.7%) by two surgeons. The group of pa-
tients operated by two surgeons was younger (p=0.047), consisted of more males (p=0.034) 
and had a higher BMI (p=0.031) (Table 1). Carcinoma was more often the indication for sur-
gery in patients operated by two surgeons (p=0.001). Laparoscopic surgery was more often 
performed by two surgeons (p<0.001). Moreover, in patients operated by two surgeons, a 
protective ileostomy was constructed more frequently (p<0.001), the duration of surgery 
was significantly longer (p<0.001) and more intraoperative complications were recorded 
(p=0.049).
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Table 1. Univariate analysis of patient and surgical characteristics with number of surgeons involved.
One surgeon
N = 143 (33.3%)
Two surgeons
N = 286 (66.7%)
P value
Patient characteristicsAge (years) 71.8 (65.1-80.2) 68.3 (60.7-76.3) 0.047
SexMaleFemale 66 (46.2%)77 (53.8%) 163 (57.0%)123 (43.0%) 0.034BMI‡ (kg/m2) 24.6 (22.6-27.8) 25.9 (23.4-29.3) 0.031ASA§ I-IIASA§ III-IV 84 (76.4%)26 (23.6%) 203 (80.2%)50 (19.8%) 0.404
Diabetes MellitusYesNo 18 (15.5%)98 (84.5%) 227 (86.6%)35 (13.4%) 0.577SmokingYesNo 20 (18.0%)91 (82.0%) 62 (24.2%)194 (75.8%) 0.190AlcoholYesNo 44 (40.0%)66 (60.0%) 85 (33.2%)171 (66.8%) 0.233CorticosteroidsYesNo 11 (9.0%)111 (91.0%) 24 (9.2%)236 (90.8%) 0.946
NSAIDs||YesNo 6 (5.0%)115 (95.0%) 21 (8.1%)239 (91.9%) 0.269
Surgical characteristics
Type of surgeryRight hemicolectomyLeft hemicolectomySigmoid resection(Low) anterior resection
50 (35.0%)
22 (15.4%)
50 (35.0%)
21 14.7%)
113 (39.5%)
29 (10.1%)
93 (32.5%)
51 (17.8%)
0.326
CarcinomaYesNo 94 (65.7%)49 (34.3%) 230 (80.4%)56 (19.6%) 0.001ApproachLaparoscopic
Open
15 (10.5%)
128 (89.5%)
189 (66.1%)
97 (33.9%)
0.000
ConversionYesNo 1 (6.7%)14 (93.3%) 37 (19.6%)132 (69.8%) 0.313†StomaYesNo 2 (1.4%)141 (98.6%) 40 (14.0%)245 (86.0%) <0.001†Additional abdominal resectionYesNo 11 (7.7%)132 (92.3%) 31 (10.8%)255 (89.2%) 0.306Intraoperative complicationsYesNo 11 (7.7%)132 (92.3%) 38 (13.3%)248 (86.7%) 0.086
Duration of surgery, minutes 101 (75 - 133) 127.5 (101 - 164) <0.001
*Data are patients (%) or median (interquartile range); † Fisher’s Exact test; ‡ BMI, body mass index; § ASA, 
American Society of Anesthesiologists;|| NSAIDs, nonsteroidal anti-inflammatory drug
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For postoperative outcomes, colorectal anastomotic leakage (CAL) was observed in 16 pa-
tients (11.2%) operated by one surgeon and in 21 patients (7.3%) operated by two surgeons 
(p=0.181) (Table 2). Surgery performed by two surgeons was associated with shorter hospi-tal stay (9.0 versus 7.0 days, p=0.001) and less reoperations (14.0% versus 7.7%, p=0.039). 
The indication for reoperation was CAL in 31 patients and abdominal wound dehiscence 
in seven patients. The indication for reoperation in the other four patients was persisting pain and fever, iatrogenic small bowel perforation, ascites and severe postoperative ileus, respectively.
Table 2. Univariate analysis of postoperative outcomes with the number of surgeons involved
Postoperative outcomes One surgeon
N = 143 (33.3%)
Two surgeons
N = 286 (66.7%)
P valueReoperationYesNo 20 (14.0%)123 (86.0%) 22 (7.7%)264 (92.4%) 0.039Colorectal anastomotic leakageYesNo 16 (11.2%)127 (88.8%) 21 (7.3%)265 (92.7%) 0.181MortalityYesNo 5 (3.5%)138 (96.5%) 4 (1.4%)282 (98.6%) 0.153†Hospital stay (days) 9.0 (7.0 - 14.0) 7.0 (5.0 - 11.0) 0.001
*Data are patients (%) or median (interquartile range)
† Fisher’s Exact test.
 For the adjusted analysis, a propensity score was calculated for being operated by one or two 
surgeons with all variables that had a p-value of <0.1 in the univariate analysis or were con-
sidered clinically relevant being age, sex, BMI, carcinoma as indication, surgical approach, protective ileostomy construction, duration of surgery, and intraoperative complications. 
The area under the curve of the calculated propensity score was 0.842.
After adjustment for the propensity score, the number of surgeons involved in the surgi-
cal procedure remained related to post-operative outcomes (Supplementary Table 1). Sur-
gery performed by two surgeons was associated with less reoperations (OR 0.4, 95% CI 
0.2–0.9, p=0.038). Surgery performed by two surgeons was also associated with the lower 
incidence of CAL (OR 0.6, 95% CI 0.2–1.3, p=0.204) and lower mortality (OR 0.8, 95% CI 
0.2–3.7, p=0.807), although not statistically significant. The length of hospital stay was not 
significantly shorter for patients operated by two surgeons (linear regression coefficient 
-0.8, 95% CI -2.9–1.3, p=0.446).
As a sensitivity analysis, the multivariate analysis was repeated with stratification for sur-
gical approach. It was not justified to stratify for surgical approach for mortality because of 
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the small number of events. All estimated ORs were in the same direction as the un-stratified analyses, but P values were higher due to the inherent reduction of sample sizes (Supple-
mentary Table 2).
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Discussion
The purpose of this study was to determine the effect of number of surgeons involved in the surgical procedure on quality of elective colorectal surgery in a low-volume hospital. 
The results of our study suggested that colorectal surgery performed by two surgeons was associated with less reoperations compared to surgery performed by one surgeon in a low volume hospital. In addition, our study showed a trend towards a decrease of CAL, mortality, 
and hospital stay in the group of patients operated by two surgeons, although these findings 
were not statistically significant.
Recently, several studies demonstrated better postoperative outcomes after colorectal surgery in high-volume hospitals(4). Besides, better oncologic outcomes were reported in 
high-volume hospitals(12, 13). Therefore, nowadays, centralization of care in colorectal sur-
gery is becoming more and more important. However, there is a lack of scientific interest to improve quality of colorectal surgery in low-volume hospitals, whereas centralization of 
colorectal surgery might not be implemented on a national level soon. This study showed that performing colorectal surgery with two surgeons in a low-volume hospital might im-prove patient outcomes after colorectal surgery.
The incidence of CAL was 8.6%, which is comparable to previous studies(14, 15). Further-
more, 42 (9.7%) patients underwent reoperation. A recent study evaluating the incidence of reoperation after colorectal surgery as a valid measure for surgical quality reported compa-rable incidence(16). In the multivariate analyses, surgery performed by two surgeons was associated with less reoperations during the postoperative course, but hospital stay was not 
shorter for patients operated by two surgeons. Of all 429 included patients, only 42 (9.8%) patients underwent reoperation. Because of the relatively low incidence of reoperations, the overall hospital stay was not strongly affected by the different incidence of reoperation between the two groups.
The present study might have been subject to selection bias. Patients operated by two sur-geons had higher BMI which might complicate the surgical procedure and lead to worse postoperative patient outcomes(17, 18). Moreover, protective ileostomies were more often constructed during surgery performed by two surgeons which may have possibly result-ed in prolonged duration of surgery. In addition, laparoscopic procedures were more often 
performed by two surgeons. These findings might implicate that surgical procedures per-
formed by two surgeons were associated with increased complexity and difficulty. Never-theless, our study has shown that there were less reoperations in the group of patients that was operated by two surgeons.
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Some differences in the univariate comparison may be related to the difference in surgical approach. However, a multivariate analysis with propensity scores was performed to elim-
inate this case-mix problem. In addition, the results of the sensitivity analysis, stratified by surgical approach, were consistent with our primary analysis.
In our study it was not justified to perform a RCT due to clinical equipoise. Most obser-
vational studies use multivariable analysis or stratification to adjust for confounding, but propensity score analysis offers a powerful alternative to multivariable analysis, especially in situations with a relatively low event rate(19-21). Propensity score analysis accounts for the conditional probability of treatment-selection, thus allowing for reduction of bias when comparing interventions between treatment groups(22).
The Hawthorne effect is a possible explanation for improved outcomes with two surgeons. 
This was recently suggested in a study which found that a multidisciplinary, perioperative 
protocol was associated with reduction in mortality after acute abdominal surgery(23). The Hawthorne effect concerns the awareness of being observed or studied and the resulting possible positive impact on behavior(24). In case of surgery performed by one surgeon, the surgeon was assisted by a surgical assistant while in case of two surgeons there was a con-stant awareness of being observed by someone with comparable skills and qualities, which 
might potentially introduce the Hawthorne effect. Additionally, the combined experience of two surgeons might improve surgical quality through increased technical knowledge and 
awareness. This synergy might be explored in future studies to understand both the techni-cal as well as communication-related mechanisms underlying our observations of improved outcomes with two surgeons.
To our knowledge, this study was the first to investigate the association between the num-ber of surgeons involved in the surgical procedure and the outcomes of colorectal surgery representing quality assessment. We found that surgery performed by two surgeons is as-
sociated with less reoperations and, although not statistically significant, with less CAL and 
mortality, and shorter length of hospital stay. The lack of statistical significance is likely due 
to low statistical power. This study included a large cohort of patients undergoing elective 
colorectal surgery, but only 37 patients (8.6%) suffered from CAL and only nine (2.1%) pa-tients died, which introduces a large risk of a type II error resulting from a relatively low 
event rate. Nevertheless, we can interpret our results with more confidence since the ORs for all outcomes were directing to better outcomes with two surgeons.
There were some limitations in this study that need to be addressed. Although we adjusted for confounding with propensity score analysis, this retrospective observational study was 
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still sensitive to confounding of unknown factors. In the future it might not be possible to 
explore our hypothesis in a RCT due to lack of clinical equipoise, but the results of this retro-
spective study justify conducting a prospective cohort study. Moreover, financial aspects of performing colorectal surgery with two surgeons were not taken into account. Even though this strategy might initially increase procedure-related costs, a decrease in the number of re-operations and postoperative burden might potentially compensate these additional costs.
Conclusion
The present study shows that elective colorectal surgery in a low-volume hospital performed 
by two surgeons resulted in less reoperations. This might positively influence patient out-comes and might be related to increased surgical quality as compared to procedures per-formed by only one surgeon.
139
Two versus one surgeon
References
1. Bos AC, van Erning FN, Elferink MA, Rutten HJ, van Oijen MG, de Wilt JH, et al. No Difference 
in Overall Survival Between Hospital Volumes for Patients With Colorectal Cancer in The 
Netherlands. Dis Colon Rectum. 2016;59(10):943-52.
2. Ghaferi AA, Birkmeyer JD, Dimick JB. Variation in hospital mortality associated with inpa-tient surgery. N Engl J Med. 2009;361(14):1368-75.
3. Wong SL, Revels SL, Yin H, Stewart AK, McVeigh A, Banerjee M, et al. Variation in hospital mortality rates with inpatient cancer surgery. Ann Surg. 2015;261(4):632-6.
4. Yeo HL, Abelson JS, Mao J, O’Mahoney PR, Milsom JW, Sedrakyan A. Surgeon Annual and 
Cumulative Volumes Predict Early Postoperative Outcomes after Rectal Cancer Resection. Ann Surg. 2017;265(1):151-7.
5. Borowski DW, Kelly SB, Bradburn DM, Wilson RG, Gunn A, Ratcliffe AA, et al. Impact of sur-geon volume and specialization on short-term outcomes in colorectal cancer surgery. Br J Surg. 2007;94(7):880-9.
6. Chowdhury MM, Dagash H, Pierro A. A systematic review of the impact of volume of surgery 
and specialization on patient outcome. Br J Surg. 2007;94(2):145-61.7. Sahni NR, Dalton 
M, Cutler DM, Birkmeyer JD, Chandra A. Surgeon specialization and operative mortality in 
United States: retrospective analysis. Bmj. 2016;354:i3571.
8. Frasier LL, Pavuluri Quamme SR, Becker A, Booth S, Gutt A, Wiegmann D, et al. Investigating 
Teamwork in the Operating Room: Engaging Stakeholders and Setting the Agenda. JAMA Surg. 2016.
9. Catchpole K, Mishra A, Handa A, McCulloch P. Teamwork and error in the operating room: analysis of skills and roles. Ann Surg. 2008;247(4):699-706.
10. Fan CJ, Pawlik TM, Daniels T, Vernon N, Banks K, Westby P, et al. Association of Safety Cul-
ture with Surgical Site Infection Outcomes. J Am Coll Surg. 2016;222(2):122-8.
11. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strength-
ening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guide-lines for reporting observational studies. Epidemiology. 2007;18(6):800-4.
12. Gietelink L, Henneman D, van Leersum NJ, de Noo M, Manusama E, Tanis PJ, et al. The Influ-ence of Hospital Volume on Circumferential Resection Margin Involvement: Results of the 
Dutch Surgical Colorectal Audit. Ann Surg. 2016;263(4):745-50.13. Hall GM, Shanmugan S, Bleier JI, Jeganathan AN, Epstein AJ, Paulson EC. Colorectal special-
ization and survival in colorectal cancer. Colorectal Dis. 2016;18(2):O51-60.
14. Gessler B, Bock D, Pommergaard HC, Burcharth J, Rosenberg J, Angenete E. Risk factors for anastomotic dehiscence in colon cancer surgery--a population-based registry study. Int J 
Colorectal Dis. 2016;31(4):895-902.
15. Gessler B, Eriksson O, Angenete E. Diagnosis, treatment, and consequences of anastomotic 
leakage in colorectal surgery. Int J Colorectal Dis. 2017.
16. Lightner AL, Glasgow AE, Habermann EB, Cima RR. Returns to Operating Room After Colon 
and Rectal Surgery in a Tertiary Care Academic Medical Center: a Valid Measure of Surgical 
Quality? J Gastrointest Surg. 2017.
17. He Y, Wang J, Bian H, Deng X, Wang Z. BMI as a Predictor for Perioperative Outcome of Lap-
aroscopic Colorectal Surgery: a Pooled Analysis of Comparative Studies. Dis Colon Rectum. 2017;60(4):433-45.
7
140
Chapter 7
18. Hotouras A, Ribas Y, Zakeri SA, Nunes QM, Murphy J, Bhan C, et al. The influence of obesity 
and body mass index on the outcome of laparoscopic colorectal surgery: a systematic liter-
ature review. Colorectal Dis. 2016;18(10):O337-O66.
19. Adamina M, Guller U, Weber WP, Oertli D. Propensity scores and the surgeon. Br J Surg. 2006;93(4):389-94.
20. D’Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treat-ment to a non-randomized control group. Stat Med. 1998;17(19):2265-81.
21. Pocock SJ, Elbourne DR. Randomized trials or observational tribulations? N Engl J Med. 2000;342(25):1907-9.
22. Hwang ES, Wang X. Value of Propensity Score Matching to Study Surgical Outcomes. Ann Surg. 2017;265(3):457-8.
23. Tengberg LT, Bay-Nielsen M, Bisgaard T, Cihoric M, Lauritsen ML, Foss NB, et al. Multidisci-plinary perioperative protocol in patients undergoing acute high-risk abdominal surgery. Br J Surg. 2017.
24. McCambridge J, Witton J, Elbourne DR. Systematic review of the Hawthorne effect: new con-cepts are needed to study research participation effects. J Clin Epidemiol. 2014;67(3):267-77.
141
Two versus one surgeon
Supplementary materials
Supplementary Table 1. Adjusted analysis with propensity score for postoperative outcomes and the number of surgeons involved
OR (95% CI)* P valueReoperations 0.4 (0.2 – 0.9) 0.038Colorectal anastomotic leakage 0.6 (0.2 – 1.3) 0.204Mortality 0.8 (0.2 – 3.7) 0.807
Linear regression coefficientHospital stay -0.8 (-2.9 – 1.3) 0.446
*Odds ratio and 95% confidence interval
Supplementary Table 2. Sensitivity analysis of adjusted analysis with propensity score stratified for surgical approach.
Open surgery Laparoscopic surgery
OR (95% CI)* P value OR (95% CI)* P valueReoperations 0.5 (0.2 – 1.2) 0.127 0.4 (0.1 – 1.6) 0.178Colorectal anastomotic leakage 0.6 (0.2 – 1.6) 0.315 0.6 (0.1 – 3.4) 0.605Linear regression 
coefficient
Linear regression coefficientHospital stay -1.3 (-3.8 – 1.2) 0.313 0.9 (-3.1 -5.0) 0.445
*Odds ratio and 95% confidence interval
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Abstract
Objective
The intra-operative air leak test (ALT) is a common intraoperative test used to identify me-
chanically insufficient anastomosis. This meta-analysis aims to determine whether ALT aids to the reduction of postoperative colorectal anastomotic leakage (CAL).
Methods
A literature search was performed to select studies in acknowledged databases. Full text 
articles targeting ALT during colorectal surgery were included. Quality assessment, risk of 
bias and the level-of-evidence of the inclusions were evaluated. ALT methodology, ALT(+) (i.e., leak observed during the test) rate, and postoperative CAL rate of the included studies were subsequently analyzed.
Results
Twenty studies were included for analysis, in which we found substantial risks of bias. A 
lower CAL rate was observed in patients underwent ALT than those did not; however, the 
difference was not significant (p=0.15). The intraoperative ALT(+) rate greatly varied among 
the included studies from 1.5% to 24.7%. ALT(+) patients possessed a significantly higher 
CAL rate than the ALT(-) patients (11.4% vs. 4.2% p<0.001).
Conclusions
Based on the available evidence, performing an ALT with the reported methodology has not 
significantly reduced the clinical CAL rate but remains necessary due to a higher risk of CAL 
in ALT(+) cases. Unfortunately, additional repairs under current methods may not effectively 
decrease this risk. Results of this review urge standardization of ALT methodology and effec-
tive methods to repair ALT(+) anastomoses.
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Introduction
Colorectal anastomotic leakage (CAL) is one of the most dangerous short-term compli-
cations after colorectal surgery, attributing to one third of postoperative mortality(1). To 
prevent CAL, substantial efforts have been made. Among them, the air leak test (ALT) is apparently the most frequently performed intraoperative test to identify a mechanically in-
sufficient anastomosis(2). Typically, certain countermeasures such as additional sutures or a temporary protective stoma construction are performed when a leak (e.g. leakage of air bubbles or dye) was observed during the test.
Though being performed by a majority of colorectal surgeons, it remains inconclusive 
whether performing ALT and the immediate repair of the ALT(+) cases (i.e. leak of air/dye 
observed in the test) is beneficial in preventing CAL. This may be due to at least two varia-
bles: first, the etiology of CAL is multi-factorial, comprised of communication between intra- 
and extra-luminal content (e.g., suture dehiscence), anastomotic infection (e.g., peritonitis) 
and healing disturbances (e.g., ischemia). Performing an ALT may provide limited assistance in detecting CAL due to causes other than anastomotic mechanical failure. Second, various 
ALT techniques with different outcomes have been reported, which increases the concern that whether such varying techniques may cause different results in detecting mechanically 
failed anastomosis and eventually lead to different clinical intervention and outcomes. To date, no systematic review or meta-analysis is available providing solid evidence supporting 
routine ALT application. To this end, we performed this review aiming to determine whether implementing the intraoperative air leak test might aid to reduce CAL. 8
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Methods
Literature Search Strategy
The literature search for this systematic review was performed in January 2015 according to the PRISMA (Preferred Items for Reporting of Systematic Reviews and Meta-Analyses) guidelines in databases including Medline, Embase, Cochrane, Web-of-Science and Google Scholar databases. No restrictions regarding publication date or language have been applied during the search. We restricted our search to human studies, clinical trials and controlled 
or randomized controlled trials. The following search strategy was used in Embase and 
modified in other databases accordingly: ((air NEAR/3 (leak* OR pressure* OR insufflat* OR 
burst* OR tight* OR compress* OR inject* OR deflat*) NEAR/3 test*) OR ((((air OR leak* OR 
pressure) NEAR/3 test*):ab,ti) AND (‘anastomosis leakage’/exp OR ‘intestine anastomosis’/
exp OR anastomosis/exp OR (anastomo* OR leak*):ab,ti))) AND (‘intestine surgery’/exp OR in-
testine/exp OR ‘large intestine disease’/exp OR (intestin* OR colorect* OR colon* OR rectum OR 
rectal OR bowel* OR sigmoidectom* OR hemicolectom* OR anorectal OR anal OR anus):ab,ti)
Study Selection
Titles and abstracts of identified articles were independently screened by two authors (R.H. 
and C.S.) for relevance to the subject. Full text articles were included if they targeted in-traoperative air leak test during colorectal surgery and reported the CAL rate accordingly. 
Reviews, letters to editors, congress and meeting abstracts were excluded. Hereafter, the references of the selected articles were screened for any relevant articles.
Quality Assessment and Data Extraction
Quality Assessment and risk of bias were reviewed by two independent authors (R.H. and 
C.S.) according to The Cochrane Collaboration’s tool for assessing risk of bias(3). The tool 
assesses the risk of bias and applicability concerns by means of six key domains including sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and other sources of bias. Afterwards, the Level of Evidence was eval-
uated according to the Levels of Evidence (LOE) 2011 from the Centre for Evidence Based 
Medicine, Oxford(4).
The definition of CAL and the method of performing the air leak test of the included articles 
were recorded. The clinical endpoints, postoperative clinical or radiological colorectal man-
ifestations of CAL were included for analysis. We assessed ALT performance, intraoperative leakage rate, and the corresponding CAL rates. We also evaluated several subgroups includ-
ing the analysis of CAL rate in ALT(+) vs. ALT(-) groups. ALT(+) is defined as leak of air/dye 
observed in the test; ALT(-) is defined as leak of air/dye not observed in the test.
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Statistical Analysis
Our primary objective was to determine whether performing ALT reduces CAL. We made a 
comparison between CAL rates in patients underwent ALT vs. CAL rates in patients that did 
not undergo the test. We also compared the CAL rate in the ALT(+) patients vs. the ALT(-) 
ones to determine whether ALT(+) patients have a higher CAL incidence after surgery. For pooling data and calculating a pooled mean for each outcome, the Mantel-Haenszel method 
was applied using a random-effect model; mean differences with a 95% confidence interval 
were calculated. Statistical heterogeneity was assessed using Q statistic and I2 statistics.
Sensitivity analysis
To assess the individual effect of the studies on the overall outcome, a sensitivity analysis 
was performed. One study was removed at a time to determine whether this would influ-
ence the significance of the pooled outcome.
Analyses were performed using Review Manager software (RevMan version 5.3; The Nordic 
Cochrane Centre, Copenhagen, Denmark).
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Results
Literature search results, level of evidence and risk of bias
In total, there were 500 studies identified during the systematic search, of which, 12 studies appeared to be relevant to the study question and were therefore included for analysis. An ad-ditional 8 articles were selected from the references, boosting the total to 20 included articles (Figure 1). In total, 5283 patients were included for analysis, with 2395 of them undergoing 
ALT. The inclusions contained 2 randomized trials, 7 cohort studies, and 11 case series (Table 
1). The risk of bias of each inclusion was evaluated and listed in Table 2. Substantial risks of bias were observed among different studies, mostly focusing on the lack of randomization and 
clear definition of CAL.
Figure 1. Flow chart of the literature search according to the PRISMA guideline
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Table 2. Risk of Bias of the included studies.
Author Sequence generation Allocation concealment Blinding Incomplete outcome data Selective outcome reporting Other sources of biasLazorthes et al. - - - + + +
Davies et al. - - - + + +Beard et al. + + ? + + +
Griffith et al. - - - + + +Pritchard et al. - - - + + +Yalin et al. - - - + ? +Sakanoue et al. - - - - ? -Vignali et al. - - - + + +Vignali et al. - - - + + +Schmidt et al. - - - + + -Ishihara et al. - - - + ? +Lanthaler et al. - - - + + +Ricciardi et al. - - - + + +Li et al. - - - + + +Shamiyeh et al. - - - + + +Ivanov et al. + ? ? + + +Xiao et al. - - - + + +Lieto et al. - - - + + +
Kamal et al. - - - + + +
Kim et al. - - - + + +
155
Air leak test
Among the inclusions, only 11 studies (5-15) provided detailed diagnostic criteria for CAL. Five studies (8-10, 16, 17) diagnosed CAL based on clinical manifestations, while eight studies (5, 7, 8, 
12-14, 18, 19) provided both clinical and radiological diagnostic criteria of CAL. There were five studies (20-24) that did not provide any references with regard to the diagnosis of CAL.
Various methods of ALT tests were used in the included studies. As listed in Table 1, we found 
that with the exception of one study(24). Despite the fact that all other studies reported their 
methods of ALT evaluation, the methods themselves varied greatly between studies. Not all stud-
ies reported the volume of the inflated gas/dye, while the reported volume varied from 60 ml 
(6) to 400 ml(22). No study mentioned intraluminal pressure measurements during ALT. When 
a leak was observed during ALT, i.e. ALT(+), different repair methods were applied varying from reinforcing sutures up to reconstruction of the anastomosis or performing a diverting stoma(17) 
(Table 1).
As is shown in Figure 2, nine studies reported a comparison of the clinical CAL rate between 
the patients with ALT and those without ALT. Although a lower CAL rate was found in the pa-
tients with ALT, no significant difference was found when compared to the patients without ALT 
(P = 0.15). The heterogeneity among the studies was significant (P = 0.02, I2 = 0.55).
Figure 2. Clinical colorectal anastomotic leakage rate in air leak test (ALT) patients vs. non-ALT patients
Subgroup analysis showed that combining the data of the LOE 1b studies (12, 19) showed a sig-
nificant difference in the CAL rate between patients with ALT and those without ALT (Figure 3), 
while such difference was not significant in the LOE 2b studies (Figure 4). The combined CAL 
rate in the patients with ALT remained stable at 5.8%, 4.7% and 4.9% in the LOE1b, 2b, and 4 
respectively. On the contrary, the CAL rate in the patients without ALT was reported as 16% in 
the LOE 1b studies, which was higher than the rate of 5.3% in the LOE 2b trials.
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Figure 3. Clinical colorectal anastomotic leakage rate in air leak test (ALT) patients vs. non-ALT 
patients: subgroup analysis LOE 1b. LOE = level of evidence
Figure 4. Clinical colorectal anastomotic leakage rate in air leak test (ALT) patients vs. non-ALT 
patients: subgroup analysis LOE 2b. LOE = level of evidence
As is shown in Figure 5, the intraoperative positive rate of ALT varies among different studies 
(1.5% to 24.7%). While the clinical CAL rate in those intraoperative ALT(+) patients was 11.4%, 
compared to 4.2% in ALT(-) patients. The meta-analysis showed a significant difference (P < 
0.001) between these two groups (Figure 6), with no significant heterogeneity between studies 
(P = 0.84, I2 = 0).
Sensitivity analysis
Except from one study, exclusion of the others had no influence on outcome significance. Exclu-sion of one heavily weighted article from Schmidt et al. (9) however, resulted in a major change 
in significance in the clinical CAL rate in ALT patients vs. non-ALT patients evaluation. With this 
article included, an OR of 0.61 [0.32, 1.19] (P = 0.15) was found. After exclusion, an OR of 0.46 
[0.29, 0.74] (P = 0.001) was calculated.
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Figure 5. Intraoperative ALT (+) rate, postoperative CAL rate in ALT (+) cases, and overall post-operative CAL rate. Bars in blue indicate the intraoperative positive rate of the air leak test, i.e. 
ALT(+) rate; bars in red indicate the postoperative CAL rate in the ALT(+) patients; bars in green indicate the overall postoperative CAL rate in all the included patients in each study respectively. 
CAL = colorectal anastomotic leakage, ALT = air leak test, ALT(+) indicates that leak was observed during the test
0
0,05
0,1
0,15
0,2
0,25
Figure 6. Colorectal anastomotic leakage rate in ALT(+) patients vs. in ALT(-) patients. CAL = col-
orectal anastomotic leakage, ALT = air leak test. ALT = air leak test, ALT(+) indicates that leak was 
observed during the test, ALT(-) indicates that no leak was observed during the test
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Discussion
ALT is the most frequent performed intraoperative test to detect mechanically insufficient 
colorectal anastomoses for intraoperative repair. This meta-analysis summarizes the clinical 
evidence regarding the application of ALT. We found that with current evidence, performing 
ALT has not significantly reduced the clinical CAL rate after surgery, but it remains necessary 
due to a significantly higher risk of CAL in patients with a positive leak during the test. The 
standardization of ALT in future studies is urgently needed to further verify the effectiveness 
of ALT and its future applications.
As is shown from our data, no significant reduction of CAL rate is seen in the meta-analysis 
of the CAL rates between patients who underwent ALT and those who did not. Although sub-
group analysis showed a significant difference in the RCT (LOE1b) studies, the limited num-
bers of patients and the extraordinarily high CAL rate in the patients without ALT increases the concern with regards to the reliability of the difference. Particularly since neither of the 
two LOE1b studies blinded the surgeons during postoperative investigation, the observer 
bias may influence the diagnosis of CAL after surgery. For future studies, it is important to 
ensure double blinding when performing a RCT on such topic.
In the sensitivity analysis, the primary comparison in this meta-analysis was heavily influ-
enced by one study with a large number of patients(9). Exclusion of that study resulted in a 
significant outcome in favor of ALT application. This substantially influenced the statistical analysis and the corresponding p value. Moreover, it increased the uncertainty of the actual 
ALT effectiveness. However, we chose to include this study in the final analysis because the 
reporting bias was considered to be limited in the LOE 2b studies since during operation 
surgeons were not aware of the comparison between patients underwent ALT vs. those who 
did not. Of course, one possible bias in LOE 2b studies is the selection bias: surgeons may 
only subject anastomoses that are likely to leak to ALT but not the firm ones, which seems 
also explain the similar CAL rate between patients with and without ALT. This bias does 
exist in many of our LOE 2b inclusions, but not in the studies from Shamiyeh et al. (22) and 
Schmidt et al. (9), which compared historical data (without routine ALT) to recent data (with 
routine ALT). Our further analysis found similar results when we ruled out the selected ALT cases (data not shown).
According to the current data, whether performing ALT significantly reduces the CAL rate 
after surgery is, at best, inconclusive. The abovementioned limitations, together with other 
factors including the heterogeneity in ALT methodology and outcome measurements might all contribute to the inconclusive results. However, such results undoubtedly sound the call 
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for a worldwide standardization of the air leak test.
A direct explanation of our data might be that ALT is not useful in the prevention of CAL and may thus be abandoned. We, probably together with all surgeons, certainly oppose such 
explanation because any colorectal surgeon would have seen a mechanically failed anasto-
mosis (e.g. anastomotic dehiscence) detected by ALT, in which the avoidance of a ALT would 
certainly cause catastrophic CAL. Rather than the superficial interpretation, our results have 
shown one clear cause of the inconclusive effect of ALT: the significantly higher CAL rate in 
ALT(+) patients demonstrates that ALT(+) patients are still under higher risk of developing CAL even though a repair procedure was performed in most cases. We recognize that it is 
certainly reasonable to assume that ALT(+) may have an even higher CAL rate without the 
repairing procedures. However, since ALT simply detects the mechanical insufficiency, our 
data at least demonstrates that the current repairing strategies in the ALT(+) cases, varying from additional sutures to performing a diverting stoma, have not effectively eliminated the 
mechanical risks of CAL in those positive cases. The high CAL rate in ALT(+) patients may 
extensively attenuate the preventive effect of ALT, resulting in the similar CAL rate between 
patients with and without ALT.
Though having been performed for decades, no standardized methodology or consensus 
has been reached, which is confirmed by our results. The fact that one inflated 60 mL of air during the test while another injected 400 mL of saline is disturbing and raises the question 
whether we are performing the same ALT. Unfortunately, the results from our study are not 
encouraging in this regard. Despite the lack of detailed methods, intraoperative ALT resulted 
in a positive rate varying from 1.5% to 24.7% among different studies(11, 19). Considering 
that intraoperative repair was applied in most ALT(+) patients, we should be aware that such a diverse range of positive rate strongly implies the possibility of overtreatment in 
many patients, particularly in centers with a high rate of ALT(+) cases. We intended to fur-
ther explore whether there is any difference among the intraoperative repairing methods in reducing postoperative CAL rate, while unfortunately such analysis was not possible with the current data since it requires much detailed information that are not reported in most inclusions.
From a biomechanical point of view, a standardized volume of the injected air or water is 
difficult to establish because of the variation in patients’ anatomy. Thereby, pressure should be considered as a means for standardization. It is important to note that an anastomosis (either handsewn or stapled) may not sustain intraluminal pressure as high as one may imagine. Although systematic evaluation of the burst pressure is not yet available, studies report that a newly constructed colorectal anastomosis bursts at the pressure around 70 
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to 184 mmHg(25). Compared to this pressure, injecting 400 mL of saline seems dangerous 
if not properly controlled. Therefore, a pressure indicator might be suggested during ALT. Actually measuring the intra-luminal pressure has been included as a very standard method in measuring the early-stage anastomotic strength in animal studies (26, 27). Although such technique is not presently available for human patients, we believe it is urgently needed. A 
barometer can be combined then with endoscopy or certain inflating devices to ensure a safety and ease of application.
Conclusion
In conclusion, currently available evidence regarding the value of ALT in prevention of CAL 
contains substantial risks of bias. Based on the evidence, performing ALT with the reported 
methodology has not effectively reduced the clinical CAL rate after surgery. This is partly 
because a positive result in ALT still predicts a higher risk of postoperative CAL, and addi-tional repairs with current methods do not decrease this risk. However, the evidence also 
suggests that performing ALT is necessary to identify patients with a higher risk of CAL. Being the quality control step of colorectal anastomosis, the air leak test is in dire need for worldwide standardization. Future studies with a higher level of evidence (e.g. double-blind 
RCT) should be initiated to verify the effectiveness of ALT.
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Abstract
PurposeColorectal anastomotic leakage (CAL) is one of the most severe complications after colorec-
tal surgery. This meta-analysis evaluates whether systemic or peritoneal inflammatory cy-tokines may contribute to early detection of CAL.
MethodsSystematic literature search was performed in the acknowledged medical databases accord-ing to the PRISMA guidelines to identify studies evaluating systemic and peritoneal levels 
of TNFα, IL1β, IL6 and IL10 for early detection of CAL. Means and standard deviations of 
systemic and peritoneal cytokine levels were extracted, respectively, for patients with and 
without CAL. The meta-analysis of the mean differences was carried out for each postoper-ative day using Review Manager.
Results
Seven articles were included. The meta-analysis was performed with 5 articles evaluating 
peritoneal cytokine levels. Peritoneal levels of IL6 were significantly higher in patients with 
CAL compared to patients without CAL on postoperative day 1, 2 and 3 (P < 0.05). Similar 
results were found for peritoneal levels of TNFα but on postoperative day 3, 4 and 5 (P < 
0.05). The articles regarding systemic cytokine levels did not report any significant differ-ence accordingly.
Conclusion
Increased postoperative levels of peritoneal IL6 and TNFα are significantly associated with CAL and may contribute to its early detection.
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Introduction
Despite the progress made in surgical techniques and perioperative management, morbid-
ity and mortality after colorectal surgery remain problematic. One of the major causes is colorectal anastomotic leakage (CAL), which contributes to one-third of all postoperative 
deaths after colorectal surgery(1). CAL occurs in 3% to 20% of patients after colorectal sur-gery(2-4). It is a defect of the colorectal wall at the anastomotic site leading to communica-
tion between the intra- and extra luminal compartments(5). Localized signs such as abdom-inal pain and postoperative ileus, though being considered as abdominal manifestations of CAL, are very common after colorectal surgery and therefore provide limited diagnostic value(6). Moreover, systemic manifestations or parameters such as fever, increase leukocyte count, or increased C-reactive Protein (CRP) levels are actually also frequently observed and therefore not sensitive in diagnosing CAL(7).
With the current postoperative regimes, CAL is usually confirmed by imaging studies such 
as endoscopy or CT-scan. The median day of diagnosis varies between postoperative day 8 
and 13(8-10). A recent review shows that more than 50% of CAL was at the highest severity 
when diagnosed, which requires re-laparotomy(11). This indicates that many early stages of CAL are not diagnosed until progressed to a severe state. So, the current regimes seem 
to be ineffective and insufficient in many cases based on the high rates of invasive re-in-
tervention(8, 9). To this end, methods for early detection of CAL require extensive further 
exploration.
Occurrence of CAL is a dynamic and progressive process. Before systemic symptoms includ-ing fever, leukocytosis, and other septic symptoms become manifest, localized infection at 
the site of the anastomosis first takes place(12), which involves varying immune cells and 
cytokines(13). Some cytokines such as TNFα, IL1β and IL6 are pro-inflammatory cytokines 
that mediate inflammatory response, whereas IL10 is considered as an anti-inflammatory 
cytokine modulating the inflammation(14, 15). Although the surgical trauma also influences levels of these cytokines, abnormal changes of the cytokines still indicate occurrence of the infectious complications including anastomotic leakage. Previous studies have suggested 
that monitoring cytokine levels in drain fluid or in blood samples may contribute to early 
detection of CAL, while firm evidence is not available yet. Therefore, this meta-analysis aims to evaluate the value of peritoneal and systemic cytokine levels for early detection of CAL.
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Methods
The methods of this meta-analysis followed the PRISMA (Preferred Reporting Items for Sys-tematic Reviews and Meta-analyses) statement(16).
Literature search
The literature search was performed in Medline, Embase, Cochrane, Web-of-science, and Google scholar libraries in August 2014 and updated in July 2015 by two authors. No restric-
tions regarding publication date or language were applied during the search strategy. The search was restricted to human studies.
Study selection
Titles and abstracts were screened for relevance by two authors (Z.W. and A.D.) inde-
pendently. All full text articles evaluating the predictive value of TNFΑ, IL1β, IL6 and IL10 in early detection of CAL after colorectal surgery were selected. Articles without a comparison 
between patients with and without CAL were excluded; reviews, letters to editor, and con-
gress abstracts were excluded as well.
Quality assessment
Two authors independently judged the quality of included articles using the QUADAS-2 
(Quality-Assessment in Diagnostic Accuracy Studies) method, which evaluates the risk of 
bias and the applicability according to four key domains including patient selection, index 
test, reference standard, and flow and timing(17). Level of evidence was estimated accord-ing to Levels of Evidence 2011 from the Centre for Evidence Based Medicine(18).
Data extraction
Two authors independently extracted means and standard deviations (SD) of cytokine lev-els of each postoperative day for patients with and without CAL respectively. Any discrep-
ancies were resolved by re-examination of data until consensus was reached. The mean and 
SD of cytokine levels per postoperative day were not provided in the articles of Matthiessen et al. (19) and Yamamoto et al. (20). Primary data of these articles were obtained from the 
authors themselves. The unit of levels of cytokines was not reported by Fouda et al. in their 
results(21), but was confirmed according to the methods and the instruction of their ELISA kit(22). All cytokine data were converted into the same unit ng/mL in the meta-analysis.
Statistical analysis
Quantitative statistical analysis for binary outcomes was carried out using mean differences 
with 95% confidence interval. The random-effects model was applied to obtain the 95% 
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confidence interval. Statistical heterogeneity was calculated with the I2 statistic, which rep-resents the percentage of variation in study estimates due to heterogeneity and tested by 
the Cochran Q test (modified χ2 test). All statistical analyses were performed using Review 
Manager version 5.3, the Nordic Cochrane Centre, Copenhagen, Denmark.
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Results
Results of study selection and evaluation
Seven articles met final inclusion criteria (Figure 1). All included studies evaluated perito-
neal or systemic cytokine levels after colorectal surgery for the diagnosis of CAL (Table 1). All included studies were found to be at high risk of bias while the applicability was con-
sidered to be positive (Table 2). The high risk of bias was related to poor patient selection. Furthermore, study designs of included studies led to a low level of evidence.
Figure 1. PRISMA flow chart representing selection of articles for review
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Table 2. Quality assessment of the included studies by judging risk of bias and applicability using 
Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) + = low risk of bias; - = high risk 
of bias; ? = not specified
Risk of Bias
Author Year Patient Selection Index Test Reference Standard Flow and timingBertram 2003 - + - -Fouda 2010 - + + -Herwig 2002 - + + -Matthiessen 2007 - + + -Yamamoto 2010 - + + -Ellebaek 2014 - + ? -Reisinger 2014 - + + -
Applicability
Author Year Patient Selection Index Test Reference Standard Flow and timingBertram 2003 + + - -Fouda 2010 + + + -Herwig 2002 + + + -Matthiessen 2007 + + + -Yamamoto 2010 + + + -Ellebaek 2014 + + ? -Reisinger 2014 + + + - Meta-analysis is a statistical method for pooling the results of several studies reporting sim-ilar outcomes in order to gain a better estimate of the effect size of an intervention. It is appropriate to perform a meta-analysis when outcomes are comparable and can be pooled meaningfully. Comparators should be at least similar enough to be combined. All the includ-
ed studies reported cytokine levels on a similar scale except for the studies of Ugras et al. 
(23) and Alonso et al. (24). The peritoneal cytokine level reported by Ugras et al. (23) are 
approximately 10 to 1000 times higher than the data from the other studies, while the data 
from Alonso et al. (24) are approximately 50 to 100 times lower than the other inclusions’. 
Despite both studies met final inclusion criteria, they were not included in the meta-analysis for peritoneal cytokines.
Definitions of CAL
The definitions of CAL were inconsistent between included studies (Table 3). The studies 
from Fouda et al. (21) and Bertram et al. (25) based the definition of CAL on clinical signs, 
mostly focusing on the aspect of drain fluid; the study from Yamamoto et al. (20) includ-ed additional imaging studies; the studies from Herwig et al. (26) and Reisinger et al. (27) 
defined CAL by the necessity of re-intervention. The definitions of CAL in the studies from Matthiessen et al. (19) and Ellebaek et al. (28) mainly focused on a demonstrated defect of the intestinal wall.
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Table 3. Definition of anastomotic leakage of included studies, CAL = colorectal anastomotic leakage
Author Year Complication DefinitionBertram 2003 CAL Patients were considered uneventful if recovery occurred without signs of anastomotic leakage within 14 days after operationFouda 2010 CAL AL was defined clinically as gas, pus, or fecal discharge from the drain, fecal discharge from the operative wound, pelvic abscess, peritonitis, 
and rectovaginal fistulaHerwig 2002 CAL Diagnosis of AL was confirmed by endoscopy, contrast enema, abdominal 
CT scan, microbiologic examination and finally by intraoperative 
findings during relaparotomyMatthiessen 2007 CAL Peritonitis caused by leakage, pelvic abscess, discharge of feces from 
the abdominal drain, or rectovaginal fistula, and leakage from all staple linesYamamoto 2010 Peritonitis The diagnosis of postoperative peritonitis was based on clinical findings 
along with imaginary data and the colour of abdominal exudatesEllebaek 2014 CAL Anastomotic leakage was defined as a demonstrated defect of the intestinal wall at the anastomotic site leading to a communication 
between the intra- and extra luminal compartment’sReisinger 2014 CAL Clinically relevant AL was defined as extra luminal presence of contrast 
fluid on contrast CT scans and/or leakage when relaparotomy was performed, requiring re-intervention
 
Enzyme-linked immunosorbent assay (ELISA)Although most studies used ELISA to determine the cytokine levels, different methods of 
measuring, handling and storing the samples were used in the included studies (Table 4).
 
Table 4. Specifying the methodology of cytokine level measurement of included studies NS = not 
specified ELISA = enzyme-linked immunosorbent assay
Author Year Cytokines Location Centrifugation Storage Cytokine 
measuring
ProducerBertram 2003 TNF, IL-6 Peritoneal 3000 rpm for 10 min at 4 °C - 80 °C ELISA Immulite, DPC Biermann GmbH, Bad Nauheim, GermanyFouda 2010 TNF, IL-6, IL-10 Peritoneal 3000 rpm for 10 min at 4 °C 20 °C ELISA NSHerwig 2002 TNF, IL-1β, IL-6 Peritoneal 2000 rpm for 10 min  -70 °C ELISA Coulter-Immunotech 
Diagnostics, Hamburg, GermanyMatthiessen 2007 TNF, IL-6, IL-10 Peritoneal NS NS ELISA DPC, Los Angeles, CA, USAYamamoto 2010 TNF, IL-1β, IL-6 Peritoneal 3000 rpm for 10 min - 80 °C ELISA R&D system, Minneapolis, 
MN, USAEllebaek 2014 TNF, IL-1β, IL-6, IL-10 Systemic 3600 rpm for 10 min at 4 °C - 80 °C ELISA Bio-Rad Laboratories, Hercules, CA, 
USAReisinger 2014 IL-6 Systemic 3500 rpm for 15 min - 80 °C ELISA NS
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Peritoneal cytokines
In total we included 5 studies in the meta-analysis for peritoneal levels of TNFΑ, IL6 and 
IL1β. The meta-analysis regarding peritoneal levels of cytokines included 228 patients who 
underwent colorectal surgery between 1996 and 2010. The mean level of cytokines on each postoperative day is reported in Figure 2 by calculating the weighted mean of each includ-ed study. As is shown in Figure 2 the peritoneal level of the cytokines varied after surgery. 
TNFΑ and IL6 levels substantially increased in patients with CAL while there was no or mild increase in patients without CAL.
Peritoneal levels of TNFΑ showed significant differences between patients with and without 
CAL at POD3 (P = 0.04), POD4 (P = 0.0002), and POD5 (P < 0.00001) (Figure 3). The me-
ta-analysis of POD3 included 4 studies while the meta-analyses of POD4 and POD5 only in-cluded 2 studies. Peritoneal levels of IL6 were different between patients with and without 
the CAL on POD1 (P = 0.05), POD2 (P = 0.03), and POD3 (P = 0.002) (Figure 4). All analyses 
for IL6 were based on 4 or 5 independent studies on the first three days. Nevertheless, peri-
toneal levels of IL1β and IL10 were only reported in one or two studies. Although we still 
the meta-analysis when possible, the results did not show significant differences between patients with and without CAL on each respective day (Figure S1).
Figure S1. Forest plot with 95% confidence interval (CI) of the mean difference of peritoneal levels 
of IL-1β (ng/mL) between colorectal anastomotic leakage (CAL) patients and non-CAL patients per 
postoperative day (POD) 1 (=A), 2 (=B) and 3 (=C).
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Systemic cytokines
Two studies were included for evaluation of systemic cytokine levels after colorectal surgery 
(27, 28). Moreover, the primary data was not available in the articles. Therefore, we did not perform a meta-analysis for the systemic levels of cytokines. However, neither of the studies 
showed any significant difference in the systemic cytokine levels (TNFΑ, IL1β, IL6 and IL10) between patients with and without CAL.
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Figure 2. Weighted means of peritoneal levels of TNF (2.A, ng/mL), IL-6 (2.B, ng/mL) and IL-1β (2.C, 
ng/mL) on each postoperative day (POD) comparing colorectal anastomotic leakage (CAL) patients 
with non-CAL patients; TNF (=A), IL-6 (=B), IL-1β (=C). The p values of differences are illustrated when relevant.
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Figure 3. Forest plot with 95% confidence interval (CI) of the mean difference of peritoneal levels 
of TNF (ng/mL) between colorectal anastomotic leakage (AL) patients and non-CAL patients per 
postoperative day (POD) 1 (=A), 2 (=B), 3 (=C), 4 (=D) and 5 (=E).
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Figure 4. Forest plot with 95% confidence interval (CI) of the mean difference of peritoneal levels of IL-6 (ng/mL) between colorectal anastomotic leakage (CAL) patients and non-CAL patients per 
postoperative day (POD) 1 (=A), 2 (=B), 3 (=C), 4 (=D) and 5 (=E).
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Discussion
CAL remains a dangerous complication after colorectal surgery. This meta-analysis summa-rizes previous literature of early detection for CAL by measuring peritoneal and systemic 
cytokine levels. Our data show that peritoneal levels of pro-inflammatory cytokines (i.e. IL6 
and TNFΑ) were higher in patients with CAL during early postoperative days, suggesting the diagnostic value of measuring the peritoneal cytokine level after surgery.
Among the candidate cytokines, TNFΑ and IL6 showed a statistically significant increase in 
CAL patients. These inflammatory cytokines are mainly secreted by macrophages and neu-
trophils, which infiltrate to the anastomotic area at the first days after construction of anas-
tomosis. Our previous animal studies have demonstrated that a significantly larger amount 
of iNOS+ (Inducible Nitric Oxide Synthase) producing cells (mainly macrophages subtype 1) 
infiltrate into the anastomotic area in the CAL cases than in those without CAL within the 
first postoperative days(29). In accordance with previous evidence, current data confirm the localized mechanism during the early stage of CAL, suggesting the importance of these two cytokines, especially IL6, in the early detection of CAL.
Nowadays the diagnosis of CAL still relies on clinical presentation and imaging studies. Early 
clinical presentation is often heterogeneous and nonspecific, resulting in delay of CAL diag-
nosis(9). In many cases, CAL does not turn clinically apparent until approximately the eighth postoperative day(30); in some cases, CAL may even become manifest until a median of the twelfth postoperative day when many patients have already been discharged(8). As shown 
in our results, increased peritoneal levels of pro-inflammatory cytokines were observed on postoperative day 1-5, which is much earlier than the current median day of CAL diagno-
sis(8). Especially IL6 was higher in CAL patients since the first postoperative day, indicating the possibility of early detection of CAL by monitoring of intra-peritoneal cytokines. Such 
possibility has been reported by the previous literature. The studies from Salgado et al. (31, 32) reported that the increase of peritoneal cytokine levels is prior to the clinical manifesta-tions of anastomotic leakage or increase of leukocytes in bariatric surgery. Similar investiga-
tions in the field of colorectal surgery are also warranted.
We also attempted to explore whether the systemic cytokine level could contribute to the early detection of CAL, since postoperative drainage is not often applied in colonic surgeries nowadays(33-35). Measurement of systemic cytokines might be of great assistance to early detection of CAL in patients without drainage if their early changes can be determined as 
well. Unfortunately, our data show that higher levels of cytokines were only observed in the 
peritoneal drainage but not in the blood sample. Despite the lack of high level-of-evidence 
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studies, our findings are in line with the previous study from Wiik et al. who reported a more 
extensive release of pro- and anti-inflammatory cytokines into the peritoneal cavity after 
abdominal surgery compared to the systemic response(12). This could be due to the fact that lymphocytes and monocytes at the site of CAL secrete these cytokines(36). In addition, other studies have demonstrated a poor diagnostic value of serum CRP or white blood cell 
count in the early detection of CAL(37). Accumulated evidence verified that the systematic 
changes of CAL are rather latent during the first postoperative days. Changes in systemic levels of cytokines seem to only occur when a critical condition emerges such as sepsis(38).
For the purpose of determining a reference level in colorectal surgery, we used exact values rather than the comparative risk ratios in statistical analysis, which was previously report-ed by Cini et al. (39). According to our data, it seems that although many included studies 
reported a significant risk of CAL with high cytokine levels, the repeatability of the cytokine 
levels among different studies still seems unsatisfactory. The variations in cytokine levels 
may be caused by several reasons. As mentioned above, the definition of CAL varies substan-
tially among the included studies (Table 3). The included articles used different definitions of CAL, which corresponds to different grades of CAL according to the International Study Group on Rectal Cancer, varying between subclinical CAL to the ones requiring surgical in-
tervention. This induced a mix of outcomes in this meta-analysis.
Due to the relatively low rate of infectious complications after colorectal surgery, studies 
with high level-of-evidence and a large number of patients on such topic are difficult to im-plement. It is understandable that in this early stage, most included studies yield very low level-of-evidence and high risks of bias. (Nested) case control studies are highly sensitive 
to bias, especially to the selection bias, which may influence reliability of the study results. Moreover, the included studies have to deal with a limited sample size, which also decreases 
the reliability. On the basis of these limitations the studies are sensitive to the type II error 
(i.e. false negative). However, this type II error has limited influence on the positive results 
of our analysis (for TNFΑ and IL6), supporting higher peritoneal cytokine levels in CAL pa-
tients compared to uncomplicated cases. Unfortunately, previous studies do not provide 
further data regarding the sensitivity and specificity of the peritoneal cytokine evaluation. Studies with high level-of-evidence and large amount of inclusions to determine the role of peritoneal cytokines in the early diagnosis of CAL are in the need, which is also one main focus of our on-going study.
ConclusionsIn this meta-analysis, we investigated both peritoneal and systemic cytokine levels after 
colorectal surgery. Our data demonstrate levels of the peritoneal pro-inflammatory cy-
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tokines (i.e. TNFΑ and IL6) substantially increase in CAL patients during the first postop-erative days, suggesting their potential diagnostic value, while the systemic cytokines have limited additional value in this regard. High level-of-evidence studies are warranted to de-termine the accuracy of peritoneal cytokines in the early diagnosis of CAL.
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Abstract
Aim
Anastomotic leakage (AL) is one of the most feared complications after rectal resection. This study aimed to assess a combination of biomarkers for early detection of AL after rectal cancer resection.
Method
This study was an international multicenter prospective cohort study. All patients received 
a pelvic drain after rectal cancer resection. On the first 3 postoperative days, drain fluid was 
collected daily and CRP was measured. MMP2, MMP9, glucose, lactate, IL1β, IL6, IL10, TNFα, 
Escherichia coli, Enterococcus faecalis, LBP and amylase were measured in drain fluid. Pre-diction models for AL were built for each postoperative day using multivariate penalized 
logistic regression. Model performance was estimated by c-index for discrimination. The model with best performance was visualized with a nomogram and calibration was plotted.
Results
In total, 292 patients were analyzed; 38(13.0%) patients suffered from AL, with a median 
interval to diagnosis of 6.0(IQR 4.0–14.8) days. AL occurred less often after partial than af-
ter total mesorectal excision (4.9% vs 15.2% p = 0.035). Of all patients with AL, 26(68.4%) patients required reoperation. AL was more often treated by reoperation in patients without 
a diverting ileostomy (18/20 vs 8/18 p = 0.03). The prediction model for postoperative day 
1 included MMP9, TNFα, diverting ileostomy and surgical technique (c-index = 0.71). The 
prediction model for postoperative day 2 only included CRP (c-index = 0.69). The prediction model for postoperative day 3 included CRP and MMP9 and obtained best model perfor-
mance (c-index = 0.78).
Conclusion
The combination of serum CRP and peritoneal MMP9 may be useful to predict AL earlier after rectal cancer resection. In clinical practice, this combination of biomarkers should be 
interpreted in clinical context as with any other diagnostic tool.
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Introduction
With the introduction of minimally-invasive techniques, the short-term outcomes of rectal 
surgery have improved over the last decades(1, 2). Despite these advances, the incidence of anastomotic leakage (AL) has not been reduced(3). Moreover, standardized recovery pro-grams have shortened hospital stay, yet with the downside of AL becoming clinically appar-
ent after discharge resulting in readmission and delayed management(4). Nowadays, 20% of AL is diagnosed after discharge with a mean time to diagnosis of 6 to 15 days(5, 6).
Current diagnostic strategy, consisting of on demand CT-scanning, fails to detect AL at an 
early stage as half of all leakages require reoperation(7, 8). Delayed reintervention after 
false-negative CT scanning is associated with increased mortality and prolonged hospital stay(9). In addition, delay in diagnosis of 2.5 days is associated with an increase in mortality 
from 24% to 39%(10). Hence, early detection is of paramount importance in order to mini-mize postoperative morbidity and mortality.
Previously, biomarkers in drain fluid have been proposed as an innovative strategy for early 
detection of AL. Elevated peritoneal levels of inflammatory cytokines and lactate as well as decreased pH seemed to be associated with AL and measurements of such parameters is thus of interest for early detection of AL(11). Furthermore, promising results were shown for lipopolysaccharide-binding protein (LBP) and Enterococcus faecalis in drain fluid(12, 13). However, implementation in clinical practice is lagging behind as previous studies were based on small sample sizes and were lacking estimation of predictive accuracy.
A systematic review concluded that combining biomarkers yielded improved predictive ac-
curacy compared to separate analysis of biomarkers(14). Therefore, we aimed to assess a combination of biomarkers for prediction of AL after rectal cancer resection and to deter-mine its predictive accuracy.
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Method
Patients
This study was designed as an international multicenter prospective cohort study. Ten hospitals in the Netherlands and Belgium participated in this study. Patients were includ-
ed between August 2015 and October 2017. The medical ethics committee of the Erasmus 
MC University Medical Center in The Netherlands and of the University Hospital Leuven in Belgium approved this study. Ethical approval was also obtained in the other participating 
hospitals. This study was registered at www.ISRCTN.org (Study ID: 84052649).
Patients aged 18 years and older who underwent partial mesorectal excision (PME) or total 
mesorectal excision (TME) with construction of a colorectal or coloanal anastomosis were eligible for inclusion. Pregnant women and patients who underwent an emergency proce-
dure were excluded. In addition, patients in whom no drain fluid was obtained or who un-
derwent surgery for another indication than adenocarcinoma were excluded. All patients 
gave written informed consent. The follow-up ended at the first outpatient clinic visit after hospital discharge.
Drain fluid collection and storage
All patients received a pelvic drain during surgery. Drain fluid was collected every morning 
on the first 3 postoperative days. Drain fluid was collected respecting rules of sterility with 
a syringe including a needle and deposited in a 10 mL EDTA tube. The drain fluid reservoir 
was replaced after collecting drain fluid. The EDTA tube was transported to the laboratory 
and the drain fluid samples were centrifuged (1955×g) for 10 minutes at 4°C. Subsequently 
the supernatant was removed. Drain fluid was aliquoted in five cryotubes of 2 mL and stored at -80°C until further analysis. C-reactive protein (CRP) was measured in peripheral blood 
samples at the hospitals’ clinical laboratory on the first 3 postoperative days.
Drain fluid analysis
Samples were thawed, vortexed and centrifuged for 1 minute at 10,000×g at 4°C before ana-lyzing. All biomarkers were measured in duplicate and the means were taken for further 
analysis. Matrix metalloproteinases (MMP2 and MMP9) and cytokines (IL1β, IL6, IL10 and 
TNFα) were measured using ProcartaPlex® Multiplex Immunoassay (ThermoFisher Sci-
entific) on a Luminex Magpix machine. For cytokine measurement, high sensitivity assays 
were used. Levels of α-amylase, glucose and lactate were measured using Roche/Hitachi 
cobas c systems from Roche Diagnostics, Indianapolis, USA. LBP was measured with en-
zyme linked immunosorbent assay (ELISA; R&D Systems, Minneapolis, USA) according to 
manufacturer’s instruction. Escherichia coli and Enterococcus faecalis were measured using 
193
Serum and peritoneal biomarkers predicting anastomotic leak
a semi-quantitative real time PCR strategy. Prior to DNA isolation, 500 μl of drain fluid was 
spiked with 5 μl Phocine Herpes Virus (PhHV) as an internal control from European Virus Archive (EVAg). Samples were spinned for 5 minutes at 8000g and the pellets resuspended 
in 180µl buffer (20 mM Tris, 2 mM EDTA, 1% Tween 80 and 50 mg/ml lysozyme). The sam-ples were incubated at 37°C, shaking at 600 rpm for 30 minutes after which 25 µl protein-
ase K was added followed by a 2-hour incubation at 56°C at 700 rpm. DNA extraction was 
performed using Macherey-Nagel NucleoSpin® Tissue kit (Bioké, Leiden, Nederland). Tem-
plate DNA was eluted in elution buffer in a total volume of 100 μl. Subsequently, primers for 
Escherichia coli and Enterococcus faecalis were added in accordance to the previously pub-
lished protocol(15). The StepOnePlus Real-Time PCR System (Applied Biosystems, Bleiswi-
jk, Nederland) was used for RT-PCR. Threshold cycles (Ct) were corrected for differences in 
extraction efficiency using the threshold cycle of the internal control PhHV.
Clinical data assessmentPatient characteristics (age, gender, BMI, medication use, bowel preparation, smoking, al-cohol abuse, ASA score, previous abdominal surgery, indication for surgery, preoperative radiotherapy, preoperative chemotherapy, location of lesion) and surgical characteristics 
(surgical procedure, surgical technique, conversion, construction of anastomosis, configu-
ration of anastomosis, diverting ileostomy) were prospectively registered. The creation of 
the anastomosis was registered as ‘stapler’ or ‘manual’. Manual anastomosis was performed using interrupted colo-anal sutures with a hand-sewn technique. If the anastomosis was constructed with a stapler and additional manual sutures were added this was registered 
as stapled. Transanal TME was defined as follows: part of a TME being performed with 
transanal assistance. This includes a semi-rigid platform with rigid instruments to perform 
a down-to-up TME.
AL was the primary outcome of interest being defined as a clinically manifest insufficiency of the anastomosis, leading to a clinical state requiring treatment (i.e. grade B/C)(7). AL 
was confirmed by either endoscopy, CT-scan and/or contrast enema or reoperation. Fistulae 
communicating with the anastomosis on CT-scan were classified as AL together with presa-
cral abscesses if extravasation of the colonic contrast was visible on radiological imaging. In addition, postoperative indicators (time to discharge, postoperative complications with their respective treatment strategies, readmission, reoperation and mortality) were pro-spectively registered. Elective stoma reversals were not registered as reoperation.
Statistical analysis
Continuous variables were described as median ± interquartile range (IQR) and com-
pared with the Mann-Whitney U test. Categorical variables were described as percentages 
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and compared with the Chi-square test or Fisher’s Exact test when needed. Comparisons 
of biomarkers were corrected for multiple testing using Holm’s method per postoperative day(16). Multiple imputation procedure was performed to impute missing data based on 10 completed datasets. For each postoperative day, multivariate penalized logistic regression models were constructed including clinically relevant baseline characteristics (age, gender, 
NSAIDS, corticosteroids, diverting Ileostomy, surgical procedure, approach) and all bio-markers. Prediction models for each postoperative day were built including covariates with 
a p-value < 0.1. Internal validation using the Bootstrap method was used to obtain correct-
ed estimates of model performance to avoid overfitting. Model performance was estimated 
by Harrell’s concordance index (c-index). The c-index measures how adequate the model discriminates between the outcome of interest and represents the probability that, in a ran-domly selected pair of patients, the model assigns a higher risk to the patient who is truly 
high risk compared with the patient who is truly low risk. C-index of 0.5 indicates no associ-ation between prediction and true outcome and a value of 1.0 indicates perfect association. 
C-indexes >0.75 are considered clinically useful(17). Calibration plot of the model with best 
c-index was built showing the relationship between observed probability of the outcome 
and predicted probability. The observed and expected rates are similar in a well calibrated 
model. The final model was visualized using a nomogram and captured in an online calcu-
lator (https://www.evidencio.com/models/show/1537). Two-sided p-values <0.05 were 
considered statistically significant. Analyses were performed using SPSS version 22 (IBM 
Corp., Armonk, NY, USA) and NLME, LATTICE, ARM, AOD and RMS package in R version 3.3.3 (http://www.r-project.org).
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Results
Study population
A total of 310 patients were included. Nine patients were excluded because no drain fluid 
was obtained, and 9 patients were excluded due to another surgery indication than rectal adenocarcinoma. In the end, 292 patients were eligible for analysis.
Table 1 represents baseline characteristics of the study population. The median time of fol-
low-up was 28.0 days (IQR 17.0 – 35.0). The median time to discharge was 7.0 days (IQR 
5.0 – 11.0). In total, 42 (14.4%) patients were readmitted to the hospital and 38 (13.0%) pa-
tients underwent reoperation. Infection at the drain insertion site was reported in 3 (1.0%) 
patients. No other complications of the pelvic drain were reported. Two (0.7%) patients 
died. One patient died of AL and the other patient died two days after hospital discharge of an unknown reason as no autopsy was performed.
Anastomotic leakage
In total, 38 (13.0%) patients suffered from AL. No differences in patient characteristics were 
observed for patients with and without AL. The incidence of AL was not different for pa-
tients with and without diverting ileostomy (11.4% vs 14.9% p= 0.371). AL occurred less 
often after PME than after TME (4.9% vs 15.2% p = 0.035) (Table 1).
AL was clinically manifest as a presacral abscess in 5 patients. Median time to diagnosis 
was 6.0 days (IQR 6.0 – 14.8). Patients with AL had a significantly longer hospital stay (16.0 
days vs 6.0 days p ≤ 0.001). Drain fluid production was not different for patients with and 
without AL (day 1 155 mL vs 180.0 mL p = 0.664, day 2 97.5 vs 100.0 p = 0.435, day 3 60.0 
vs 90.0 p= 0.141). 10
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In 30 (78.9%) patients AL was confirmed by a CT-scan, in 5 (13.2%) by proctoscopy and in 1 
(2.6%) patient by reoperation. Of all patients with AL, 26 (68.4%) patients required reoper-
ation whereas 12 (31.6%) patients were treated more conservatively (antibiotics, drainage or endosponge). AL was more often treated by reoperation in patients without a diverting 
ileostomy (18/20 vs 8/18 p = 0.03).
Biomarkers
Table 2 shows comparison of levels of biomarkers for patients with and without AL per 
postoperative day. Table 3 represents outcomes of multivariate penalized logistic regression analyses per postoperative day. Prediction models for each postoperative day were built 
including covariates with a p-value < 0.1 in the multivariate analysis. The prediction model 
for postoperative day 1 included MMP9, TNFα, diverting ileostomy and surgical technique. 
The prediction model for postoperative day 2 only included CRP. The prediction model for postoperative day 3 included both CRP and MMP9.
199
Serum and peritoneal biomarkers predicting anastomotic leak
Ta
bl
e 
2.
 Compa
rison o
f bioma
rker le
vels fo
r patie
nts wit
h and w
ithout 
anasto
motic l
eakage
 (AL).
Po
st
op
er
at
iv
e 
da
y 
1
Po
st
op
er
at
iv
e 
da
y 
2
Po
st
op
er
at
iv
e 
da
y 
3
A
L
N
*
M
ed
ia
n
Q
1†
Q
3‡
P 
va
lu
e
N
*
M
ed
ia
n
Q
1†
Q
3
P 
va
lu
e
N
*
M
ed
ia
n
Q
1†
Q
3‡
P 
va
lu
e
M
M
P2
×1
05
(p
g/
m
L)
Y
37
0.7
0.5
1.2
1.000
31
1.0
0.6
1.4
1.000
31
1.1
0.7
2.1
1.000
N
248
0.7
0.4
1.1
236
1.0
0.6
1.4
230
1.2
0.7
1.7
M
M
P9
×1
05
(p
g/
m
L)
Y
37
3.2
0.9
10.8
0.450
31
1.7
0.4
7.0
1.000
32
2.0
0.5
5.0
0.
01
1
N
247
2.0
0.9
4.1
235
1.0
0.5
2.0
231
0.6
0.3
1.5
Gl
uc
os
e
(m
m
ol
/L
)
Y
37
2.0
0.4
3.8
0.252
38
0.2
0.1
2.4
<0
.0
01
35
0.3
0.1
3.1
0.
01
1
N
247
3.4
1.5
4.6
241
2.4
0.1
4.7
238
2.9
0.1
5.0
La
ct
at
e
(m
m
ol
/L
)
Y
37
10.5
6.9
14.5
1.000
38
12.5
9.1
19.7
1.000
37
11.3
8.1
19.2
0.444
N
248
9.1
6.2
13.2
242
11.1
6.4
17.3
243
9.2
5.2
14.9
CR
P
(m
g/
m
L)
Y
36
69.5
35.0
105.8
0.459
36
152.5
83.5
215.5
<0
.0
01
37
170.0
113.8
290.5
<0
.0
01
N
241
50.0
30.9
80.0
213
86.0
47.1
135.9
215
78.0
41.0
125.0
IL
1
β
(p
g/
m
L)
Y
37
61.1
31.7
263.5
0.341
32
138.1
46.7
536.8
0.
01
1
31
190.0
28.6
3271.1
<0
.0
01
N
247
47.1
19.6
132.3
236
39.8
13.4
151.5
232
30.3
9.3
142.9
IL
6
(p
g/
m
L)
Y
36
69717.
71
9267.2
76184.
2 1
.000
32
73454
.52
3889.4
76334
.1
1.000
31
46178
.81
7483.5
76070.
8
0.301
N
246
51635.
323
484.4
76070.
8
236
41860
.71
7483.5
75786
.4
232
24738
.21
1239.9
68858
.8
IL
10
(p
g/
m
L)
Y
37
249.7
141.3
594.6
0.584
32
176.3
84.4
630.8
0.080
31
128.3
38.6
554.2
0.072
N
247
204.8
109.7
405.5
236
99.1
51.8
220.8
232
62.4
30.0
136.4
T
N
Fα
(p
g/
m
L)
Y
37
37.3
23.6
128.8
0.156
32
23.1
12.9
67.2
1.000
31
45.2
14.2
79.7
0.
03
6
N
246
30.1
16.4
59.1
237
21.5
12.0
39.8
231
17.7
9.9
34.0
E.
 C
ol
i
(C
t)
Y
37
34.2
32.4
35.8
1.000
33
34.8
31.4
37.5
1.000
30
34.3
26.7
36.4
1.000
N
247
34.6
32.4
37.0
231
34.6
32.4
36.7
227
34.7
32.9
36.6
E.
 F
ae
ca
li
s
(C
t)
Y
38
26.3
25.2
26.9
1.000
33
26.5
25.4
27.5
1.000
32
26.2
25.1
27.4
1.000
N
248
26.2
25.1
27.1
234
26.0
25.0
27.0
228
25.9
25.1
27.0
LB
P
(μ
g/
m
L)
Y
38
3.6
1.9
5.0
1.000
34
5.5
3.5
6.6
1.000
31
6.2
4.6
7.0
1.000
N
248
3.2
2.2
4.4
237
5.1
4.0
6.1
231
5.6
4.5
6.7
A
m
yl
as
e
(U
/L
)
Y
36
36.0
14.3
84.8
0.584
38
30.5
13.5
47.0
1.000
37
24.0
17.5
45.0
1.000
N
243
24.0
13.0
41.0
243
28.0
18.0
45.0
244
25.0
15.0
37.0
*N
, n
u
m
b
er
 o
f p
at
ie
n
ts
; †
 Q
1,
 f
ir
st
 q
u
ar
ti
le
; ‡
 Q
3
, t
h
ir
d 
qu
ar
ti
le 10
200
Chapter 10
The prediction model of postoperative day 1 had a c-index of 0.71 whereas the prediction 
model of postoperative day 2 had a c-index of 0.69. So, these prediction models were lacking 
discrimination and therefore, were not considered to be clinically useful. On the contrary, 
the prediction model of postoperative day 3, including CRP and MMP9, had a c-index of 0.78. 
This c-index indicated that in 78% of the time, the model assigned a higher probability to a patient with AL than a patient without AL. For the prediction model of postoperative day 3, a nomogram was constructed facilitating the calculation of the individual risk of AL after rectal cancer resection based on CRP and MMP9 on postoperative day 3 (Figure 1). An online calculator was built for this nomogram at https://www.evidencio.com/models/show/1537.
Figure 1. Nomogram of the prediction model of postoperative day 3 (c-index = 0.78). This nomogram can estimate the risk of anastomotic leakage (AL) after rectal resection on postoperative day 3 with serum CRP and peritoneal MMP9.
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Calibration was determined to estimate model performance with a calibration plot. In a cali-bration plot the predicted probability is plotted against the corresponding observed proba-
bility in the dataset. Ideally, this depicts a diagonal line and calibration is quantified by the mean absolute error. Figure 2 shows the calibration plot of the prediction model of postop-
erative day 3 (mean absolute error = 0.025).
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Figure 2. Calibration plot for nomogram predicting anastomotic leakage (AL) with serum CRP and 
peritoneal MMP9 on postoperative day 3. This plot represents the relationship between predicted 
probability from the nomogram and observed probability in the dataset. The bootstrap method was used to obtain corrected probabilities.
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Discussion and conclusions
This international multicenter prospective cohort study showed that the combination of serum CRP and peritoneal MMP9 may be useful to predict AL early after rectal cancer re-
section. The combination of these biomarkers can estimate the individual risk of AL after rectal cancer resection on the third postoperative day which was three days earlier than the median time to diagnosis (6 days).
As with any other biomarker in clinical practice, this tool only assesses the risk of AL re-
quiring confirmation through additional imaging. However, this tool might enable timely 
intervention and subsequently minimize morbidity and mortality. For example, if this tool shows that a patient has high risk of AL on the third postoperative day and AL is subse-
quently confirmed by additional imaging even before the leak becomes clinically apparent, early reintervention could minimize the consequences of AL. So, this tool facilitates decision making for surgeons even before clinical symptoms occur(18).
Serum CRP is already a useful negative predictor for AL after anterior resection(19, 20). 
Nevertheless, serum CRP monitoring lacks specificity and positive predictive value for AL, 
because CRP level also rises due to other inflammatory complications(21). Previous re-
search on biomarkers for AL showed that local biomarkers from peritoneal fluid were more 
specific than systemic biomarkers(22). The present study showed that peritoneal MMP9 was predictive for AL and therefore this biomarker has additional value in prediction of AL 
over serum CRP alone. Furthermore, the c-index of 0.78 of this combination showed ade-
quate discrimination which is important in a diagnostic setting where the classification of patients into different groups is of main interest.
MMP9 is a matrix metalloproteinase which plays a role in degradation of extracellular matrix 
proteins, especially of collagen, and is actively involved in inflammation reaction and wound 
healing process(23, 24). Previously, experimental studies have investigated the associa-tion between MMPs and colorectal AL. MMPs negatively affect anastomotic healing(25, 26) whereas MMP inhibitors provided enhanced breaking strength of colonic anastomoses(27). 
The most pronounced collagen loss provoked by MMP9 was seen in the suture-holding zone of a colonic anastomoses(28). In addition, anastomotic MMP9 activity was increased 3 days 
after operation in an experimental model of bacterial peritonitis(29). Translation to clinical research obtained similar results. Patients with elevated levels of MMP1, MMP2 and MMP9 in perioperative biopsies from the colon had more often AL(30). Actually, peritoneal MMP9 had already been evaluated as biomarker for AL. For colorectal resection, contradictory lit-
erature exists(31, 32). But for rectal resection, a pilot study showed that peritoneal MMP9 levels measured 4 hours after surgery were increased in patients who developed AL(33). 
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However, it remains unknown whether this association represents a causal relationship or resembles consequential effects of AL.
In rectal cancer surgery, diversion is commonly applied to protect the anastomosis from leaking(34). However, the incidence of AL was not different for patients with and without a 
diverting ileostomy (11.4% vs 14.9%). Nevertheless, in patients without a diverting ileos-tomy, AL was more often treated by reoperation than in patients with a diverting ileostomy 
(18/20 vs 8/18 p = 0.03). These results suggested that a diverting ileostomy allows less invasive treatment strategies. Accordingly, it was previously shown from population-based 
data of the Dutch ColoRectal Audit (DCRA) that a high tendency towards stoma construction in rectal cancer surgery did not reduce the incidence of AL(35).
The reported incidence of AL of 13.0% is high compared to several previous studies (3.0% 
- 11.1%)(36, 37). We hypothesize that the prospective design and inclusion of only rectal 
resections contribute to this relatively high incidence of AL. Another explanation is that the 
definition of AL varies and that some atypical presentations of leakages such as presacral 
abscesses or rectovaginal fistulas are not always included. In addition, The Dutch Snapshot 
study reported a comparable incidence of 13.4% within 30 days postoperatively(4).
Over the last decade, our research group has been involved in the search for a reliable bio-marker for AL after colorectal resection. In a clinical trial (APPEAL study), we demonstrated 
that PCR in drain fluid for Enterococcus faecalis could be predictive for AL after colorectal 
resection(13). However, the relatively low positive predictive value (PPV) of 30.2% on the 
third postoperative day indicated a substantial number of false positives. Therefore, the present study was conducted aiming to obtain a combination of biomarkers with increased predictive accuracy. In addition, the previous study showed that an increase of 1 standard deviation of the average level of LBP of postoperative day 1 is associated with an increased risk of leakage of 1.6(12). LBP is an acute phase protein that binds to lipopolysaccharide (LPS) to elicit an immune response to gram-negative bacteria(38). However, the present 
study did not confirm these results possibly due to different drain locations as the previous 
study obtained drain fluid from intra-abdominal drains whereas the present study used pel-
vic drains which were positioned extraperitoneal. Furthermore, the different microbiome 
of patients with colon and rectal cancer may be another explanation as the previous study 
also included colonic resections(39, 40). This previous study showed promising results for 
drain fluid analysis of the first 3 postoperative days. Therefore, we decided to limit drain 
fluid collection to this interval.
The GRECCAR 5 trial has shown that pelvic drainage after rectal excision for rectal cancer 
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does not reduce AL(41). On the other hand, pelvic drainage was not found to be detrimen-
tal(42). In this study, only 3 (1.0%) patients suffered from infection at the drain insertion site which could be managed without invasive treatment strategies. So, the opportunity to 
detect AL early after rectal resection with innovative drain fluid analysis might justify pelvic drainage after rectal resection.
MMP9 measurements can easily be implemented as Luminex is a commonly used method in clinical laboratories. It is a fast method and relatively cheap. However, there were some 
limitations. First of all, dislocation of the drain may have influenced drain fluid composi-
tion(43). Secondly, intraoperative spill could have affected drain fluid composition by elic-
iting an inflammatory response. In addition, the emerging transanal technique may impact 
pelvic contamination although no evidence exists.
Since prediction models tend to perform better on data on which the model was construct-
ed, external validation is essential before implementing prediction models in clinical prac-
tice(44). Furthermore, a phase II diagnostic study is required confirming that this tool truly predicts AL in a time changing direction which runs from the diagnostic test forward to diagnosis(45). In this manner, the effect on time to diagnosis can prospectively be assessed. In the end, the effect of early detection on morbidity and mortality requires phase III diag-nostic research.
This international multicenter prospective cohort study showed that the combination of serum CRP and peritoneal MMP9 may be useful to predict AL earlier after rectal cancer re-section. Nevertheless, it is important to mention that this tool should never replace clinical 
observations implying that the outcomes of this tool should be interpreted in clinical context as with any other diagnostic tool. 10
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Discussion
Anastomotic leakage (AL) remains the most feared complication after colorectal resection. 
The incidence varies from 4-33% and about one-third of the postoperative mortality af-
ter colorectal surgery is due to AL(1). Until today, the pathophysiology remains largely un-
known leaving the surgeon in the dark in designing specifically targeted strategies to over-come this severe postoperative complication.
Part I: Risk assessmentIn Part I risk assessment of AL after colorectal resection was investigated. Previously, many efforts have been devoted to identifying risk factors for AL after colorectal resection. How-
ever, as many surgeons may have experienced, it is not uncommon for patients without 
any apparent predisposition to develop AL. Therefore, it seems that selecting patients on 
risk factors may have limited value. Nevertheless, exploration of risk factors may increase 
knowledge on pathophysiology of AL. In addition, identification of adjustable risk factors may provide tools for optimization of prevention strategies.
Several previous studies suggested that early and late AL are different entities(2-8). How-
ever, there is no consensus in literature on the definition of late AL. Patients with early AL 
are more likely to undergo re-laparotomy as intervention(6, 8). On the other hand, the long-term stoma retention rate is higher in patients with late AL(7).
In Chapter 2 risk factors for early and late colorectal AL were identified in a nation-wide au-
dit (Dutch ColoRectal Audit)(9). Male sex and rectal cancer were associated with both early and late AL. Higher BMI, laparoscopy, emergency surgery and no diverting ileostomy were 
risk factors for early AL while Charlson Comorbidity Index ≥II, ASA ≥3, preoperative tumor 
complications, extensive additional resection because of tumor growth and preoperative ra-
diation were risk factors for late AL. These results supported the hypothesis that early AL might originate from a technically failed anastomosis resulting in immediate anastomotic dehiscence whereas late AL might be the result of delayed healing of a well-constructed anastomosis.
In Chapter 3 the same nation-wide audit (Dutch ColoRectal Audit) was used to explore whether the interval between preoperative short-course radiotherapy and surgery for rec-
tal cancer influenced the incidence of AL. Previously, the TME trial has shown that preoper-ative short-course radiotherapy reduces 10-year local recurrence rate compared to surgery 
alone, without any survival benefit in patients with resectable rectal cancer(10). Although no clear evidence is available, short-course radiotherapy with surgery within 1 week is com-
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mon practice. This study showed that elective surgery for rectal cancer <4 days after preop-erative short-course radiotherapy resulted in an increase of AL. A proper interval between radiotherapy and surgery should not only guarantee optimal surgical outcomes, but also optimal oncological outcomes as preoperative short-course radiotherapy is administrated 
to reduce local recurrence(10). Therefore, to establish an optimal interval regarding both surgical and oncological outcomes, prospective evaluation is required.
In Chapter 4 the effect of age on AL after colorectal cancer resection was explored. The incidence of colorectal cancer increases with age, with patients aged 60 years and older 
accounting for the majority of newly diagnosed cases in the Netherlands with 17% of newly diagnosed patients with colorectal cancer being 80 years and older(11). Several previous 
studies identified age as a risk factor for AL, however results were contradictive with some studies reporting a reduced incidence of AL in older patients, while others showed an in-creased incidence(12-17). In this study, data were derived from the same nation-wide audit 
(Dutch ColoRectal Audit). This population-based study showed that greater age was protec-tive for AL. However, this study demonstrated that in patients >80 years, mortality following 
AL was 27.0%. These results support preoperative informed decision making, especially in octogenarians.
In Chapter 5 short-course radiotherapy followed by surgery after a prolonged interval 
(SCRT-delay) for rectal cancer treatment in frail patients is evaluated. Locally advanced rectal cancer treatment consists of neoadjuvant chemoradiation followed by surgery according to 
Total Mesorectal Excision (TME) principles. Short-course radiotherapy followed by surgery 
after a prolonged interval (SCRT-delay) is recommended as an alternative to chemoradiation in frail patients with comorbidities or patients with a poor performance status because of the higher risk of surgical complications. Postoperative complications were evaluated after these two treatment strategies and it was shown that the incidence of AL was not different 
for neoadjuvant chemoradiation followed by surgery and SCRT-delay. The aging population, the rising incidence and the improved prognosis of rectal cancer will increase the need for 
surgery in the elderly population in the future. SCRT-delay might be a good alternative neo-adjuvant treatment option for frail LARC patients. However, standardized selection criteria based on geriatric assessment, information on treatment compliance, perioperative quality of life and patient preference is needed.
Part II: Surgical techniquesIn Part II the effect of surgical techniques on AL was discussed. With the introduction of min-imally invasive surgery, the outcomes of colorectal surgery have improved(18-20). However, these advancements have not reduced the incidence of AL after colorectal surgery.
11
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For rectal cancer resection, total mesorectal resection (TME) is the gold standard. This sur-gical technique, involving resection of the fatty envelope surrounding the rectum, has sub-stantially contributed to local control and survival of rectal cancer(21, 22). Lately, minimally 
invasive techniques have been introduced for rectal surgery(18-20). The COREAN trial and 
the COLORII trial have shown short-term and long-term benefits for laparoscopic TME com-
pared to open approach(23-25). Nevertheless, male sex and high Body Mass Index (BMI) are unfavorable patient characteristics for a laparoscopic approach(26). In addition, the limited view of the distal margin of the tumor and conversion rates to open surgery remain unsat-isfactory emphasizing the need for an innovative approach to overcome these limitations 
of laparoscopy(27-29). Transanal total mesorectal excision (TaTME) might be the solution. 
Since its introduction in 2010, TaTME has been proven to be a feasible and safe technique for 
rectal cancer resections and subsequently achieved widespread acceptance(30, 31). TaTME has been suggested to result in lower rates of AL due to the avoidance of cross stapling(32, 33). Nevertheless, evidence is scarce and is mainly obtained from observational studies with retrospective design(34-38).
In Chapter 6 postoperative morbidity after laparoscopic total mesorectal excision (LaTME) 
and transanal total mesorectal excision (TaTME) were compared. This study reported no 
difference in postoperative morbidity. More specifically, the incidence of AL was similar for 
LaTME and TaTME and the main advantage of TaTME seems to be the lower conversion rate 
to open surgery. This study is the first providing evidence from prospective observational data. However, oncological safety in terms of circumferential resection margin (CRM) in-
volvement and local recurrence should be obtained in a well-designed RCT(39).
In Chapter 7 the effect of the number of surgeons involved in the surgical procedure on postoperative morbidity after colorectal resection was investigated in a low-volume hospi-
tal. The hypothesis was that outcomes of elective colorectal surgery might improve when the surgical procedures were performed by two surgeons compared to one surgeon. Elective colorectal surgery in a low-volume hospital performed by two surgeons had no effect on the incidence of AL, however, it resulted in less reoperations.
Part III: PreventionIn Part III prevention of AL was addressed. Prevention of this postoperative complication remains the ultimate goal.
In Chapter 8 a systematic review and meta-analysis were described exploring whether 
the intraoperative air leak test (ALT) prevents colorectal AL. Although convincing evidence 
is scarce, ALT is the most commonly used method to identify mechanically failure of the 
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anastomosis(40). The positive ALT rate varied greatly among the included studies and this 
meta-analysis showed a higher incidence of AL in patients with a positive ALT compared to 
patients with a negative ALT. This finding indicated that current repair strategies of a failed 
anastomosis identified by the ALT may not be effective. Standardization of ALT and repair of a failed anastomosis seem necessary.
Part IV: Early detectionIn Part IV innovative techniques for early detection of AL were evaluated. Current diagnos-
tic strategy, consisting of on demand CT-scan, fails to detect AL in an early stage as 50% of all leakages are of the highest severity (i.e. Grade C) requiring reoperation(41-43). Hence, innovative strategies for early detection are under scrutiny and the search for reliable bio-markers is warranted(44).
In Chapter 9 available literature on systemic and peritoneal inflammatory cytokines meas-urement for early detection of colorectal AL was evaluated. Systemic measurement was 
not associated with AL while peritoneal IL6 and TNFα levels were associated with AL after 
colorectal resection. This systematic review and meta-analysis raised the question whether 
a combination of specific biomarkers, rather than one single marker, could provide a clini-
cally useful tool(45). To this end, high level-of-evident studies were warranted to determine 
the accuracy of peritoneal cytokines in the early diagnosis. Therefore, an international mul-
ticenter prospective cohort study was performed which is shown in the next chapter.
In Chapter 10 a multicenter prospective cohort study showed that the combination of serum CRP and peritoneal MMP9 on postoperative day 3 was predictive for AL while the median 
time to diagnosis was 6 days. Adequate model performance of this prediction model justifies further clinical evaluation. Nevertheless, it is important to mention that this tool should not replace clinical observation implying that the outcomes of this tool should be interpreted in 
clinical context as with any other diagnostic tool. This study showed that peritoneal MMP9 has additional value in predicting AL after rectal resection over serum CRP alone. MMP9 is a 
matrix metalloproteinase which plays a role in degradation of extracellular matrix proteins, 
especially of collagen, and is actively involved in the inflammation reaction and the process 
of wound healing(46, 47). Previously, experimental studies have already investigated the role of MMP in anastomotic healing. MMPs negatively affect anastomotic healing(48, 49) whereas MMP inhibitors provided enhanced breaking strength of colonic anastomoses(50). 
The most pronounced collagen loss provoked by MMP9 was seen in the suture-holding zone 
of a colonic anastomosis(51). Translation to clinical research obtained similar results. Pa-tients with elevated levels of MMP9 in perioperative obtained biopsies from the colon more often had AL(52). Actually, peritoneal MMP9 levels have already been evaluated as being 
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a biomarker for AL. A pilot study showed that peritoneal MMP9 levels, measured 4 hours after surgery, were increased in patients who had AL after rectal resection(53). However, it remains unknown whether this association represents a causal relationship or resembles consequential effects.
Future perspectives
To date, colorectal anastomotic leakage (AL) remains the most dreaded complication after colorectal resection resulting in high morbidity and mortality. In the future, because of the 
aging population, it can be expected that the incidence of colorectal cancer will increase and 
thereby the number of patients at risk for AL after colorectal resection(54). The etiology remains largely unknown as it remains unclear why some anastomoses leak while others do not, possibly because the process of anastomotic healing is not completely understood yet. Full understanding of the pathophysiology is key in determining innovative strategies for 
early detection and prevention of AL(55). Nevertheless, exploration of new clinical perspec-tives also contributes to our knowledge on the etiology of AL.
Early detection
Despite that absolute prevention of AL is ideal, early detection of AL is of paramount im-portance in order to minimize associated postoperative morbidity and mortality(56). Early diagnosis of AL allows timely remedial intervention and could therefore reduce morbidity 
and mortality(56). The difficulty is represented by the fact that AL presents in a variety of ways, ranging from rapid fulminant sepsis to a more insidious onset with failure to progress in the postoperative period. In addition, the challenge arises from the multifactorial etiology of AL(57). Future research should not only focus on development of innovative strategies for early detection, but once predictive accuracy is assured, clinical implementation should be 
strived for. Before clinical implementation, a phase II diagnostic study is required confirm-ing that this tool truly predicts AL in a time changing direction which runs from the diag-nostic test forward to diagnosis(58). In this manner, the effect on time to diagnosis can be assessed prospectively. In the end, the effect of early detection on morbidity and mortality requires phase III diagnostic research.
Drain fluid
Drain fluid analysis might contribute to early detection of AL after colorectal surgery. This thesis showed that the combination of serum CRP and peritoneal MMP9 on postoperative day 3 is predictive for AL after rectal resection. In addition, this thesis provides a clinical useful tool estimating the individual risk for AL from serum CRP and peritoneal MMP9 on 
postoperative day 3. Development in medical technology may bring a revolution in detection 
of AL after colorectal resection. The future may lie in biosensor technology with a biochip 
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with suitable biochemical recognition methods integrated in abdominal or pelvic drain sys-tems(59, 60). Moreover, this might enable continuous measurement of biomarkers provid-
ing inside in biomarkers profiles and facilitating early detection. Creation of such a sensor for biomarkers is a realistic aim(61).
By exploring drain fluid i.e. the surroundings of the anastomosis, we might gain insight in 
the pathophysiology of AL because the composition of drain fluid might not only resemble 
the effect of anastomotic dehiscence but per se it might also affect anastomotic healing. Ex-
ploring drain fluid might provide insight in the local inflammatory response to AL. Moreover, determining the effect of the local response on anastomotic healing could be of interest as 
local inflammation impairs wound healing by prolonging the inﬂammatory phase, and in-
ducing the expression of tissue proteases(62).
MicrobiomeFuture research could further focus on the association between the microbiome and AL after colorectal surgery as the intraluminal content might affect anastomotic healing(55). 
Evidence is available that AL can occur when the microbiome is depleted and specific path-ogenic bacterial strains predominate(63). In addition, intestinal microbes with the capacity to produce tissue proteases may break down collagen in the intestinal tissue contributing to anastomotic dehiscence. Enterococcus faecalis possesses this characteristic and it has been demonstrated that Enterococcus faecalis contributes to AL by activating MMP9, a matrix 
metalloproteinase which plays a role in degradation of extracellular matrix proteins, espe-cially collagen(47, 63).
Study design
In this era of evidence-based medicine, randomized controlled trials (RCTs) provide the 
highest level of evidence after meta-analysis and systematic reviews. However, RCTs inves-tigating AL after colorectal surgery as primary outcome measure are scarce as they would require large sample sizes due to, from a statistical point of view, the relatively low inci-
dence compromising power to detect a statistically significant difference. Nevertheless, pop-ulation-based observational studies offer the possibility to provide information about rare 
diseases. These population-based observational studies assure generalizability (external validation) as patients and providers are carefully selected in trials and therefore do not resemble the general population and current clinical practice(64). Results from these popu-
lation-based observational studies are thought to reflect clinical practice more accurately. In 
addition, observational data suffice for determination of risk factors. However, as allocation 
in these studies is not randomized, these studies are prone to confounding bias. The rapidly 
expanding field of big data analytics might play a pivotal role in the evolution of clinical 
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practice and research(65).
Finally, all future research efforts on colorectal AL, on a national and international basis, 
should be ever more coordinated by all scientific societies of colorectal surgery, medical 
industry and clinical centers, specifically dedicated to colorectal surgery, guaranteeing for better standardization, knowledge and inspiration.
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Summary
Anastomotic leakage (AL) remains the most dreaded complication after colorectal resection. 
This thesis aimed to explore new clinical perspectives of colorectal AL in order to minimize the incidence and the consequences of this postoperative complication.
Part I Risk assessmentIn Chapter 2, risk factors for early and late colorectal AL were identified in a nation-wide 
audit (Dutch ColoRectal Audit). A total of 36,929 patients who underwent colorectal can-
cer resection with the construction of primary anastomosis in The Netherlands between 
2011 and 2015 were analyzed. In total, 1,537 (4.1%) patients suffered from AL. Male sex and rectal cancer were associated with both early and late leakage. Higher Body Mass In-
dex (BMI), laparoscopy, emergency surgery and no diverting ileostomy were risk factors for 
early leakage while Charlson Comorbidity Index ≥ II, American Society of Anesthesiologists 
(ASA) score ≥ 3, preoperative tumor complications, extensive additional resection because 
of tumor growth and preoperative radiation were risk factors for late leakage. These results support the hypothesis that that early leakage might be related to technical failure of the 
anastomosis while late leakage seems be related to healing deficiencies.
In Chapter 3, the same nation-wide audit (Dutch ColoRectal Audit) was used to explore whether the interval between preoperative short-course radiotherapy and surgery for rec-
tal cancer influenced the incidence of AL. In total, 2,131 patients who underwent rectal can-cer resection with the construction of a primary anastomosis in the Netherlands between 
2011 and 2016 were analysed and 185 (8.7%) patients suffered from AL. Elective surgery 
for rectal cancer < 4 days after preoperative short-course radiotherapy resulted in an in-crease of AL.
In Chapter 4, the association between age and AL after colorectal resection was assessed. 
Data were derived from the same nation-wide audit (Dutch ColoRectal Audit). A total of 45,488 patients who underwent surgery for colorectal cancer in the Netherlands between 
2011 and 2016 were analysed. The incidence of AL was lowest in patients ≥ 80 years (6.4% 
in patients < 60 years, 5.5% in patients 60-69 years, 4.9% in patients ≥ 80 years). Multivar-
iate logistic regression showed that greater age was protective for AL. On the other hand, this population-based study showed that greater age was strongly associated with mortality 
after AL. In patients > 80 years old, mortality following AL was 27.0%.
In Chapter 5 postoperative complications were evaluated after neoadjuvant chemotherapy 
and surgery (CRT) for locally advanced rectal cancer and short-course radiotherapy fol-
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lowed by surgery after a prolonged interval (SCRT-delay). Data were derived from the same 
nation-wide audit (Dutch ColoRectal Audit). A total of 2,929 patients who underwent sur-
gery for locally advanced rectal cancer in the Netherlands between May 2014 and December 
2017 were analysed. After propensity score matching, the SCRT-delay group as well as the 
CRT group comprised 238 patients. In the SCRT-delay group, 63 patients (21.9%) received a 
primary anastomosis, compared to 1,253 patients (47.5%) in the CRT group. The frequency 
of re-interventions for anastomotic leakage was not different (4.8% vs. 7.6%, p = 0.583).
Part II Surgical techniquesIn Chapter 6, postoperative morbidity after laparoscopic total mesorectal excision (LaTME) 
and transanal total mesorectal excision (TaTME) was compared. This study was designed as a subgroup analysis of a prospective multicenter cohort study (Chapter 9). In total, 220 pa-
tients undergoing LaTME or TaTME were selected from the overall multicenter prospective cohort study. After propensity score matching, 48 patients for each group were compared. 
This study reported no difference in postoperative morbidity.
In Chapter 7, the effect of the number of surgeons involved in the surgical procedure on postoperative morbidity after colorectal resection was investigated in a low-volume hospi-tal. A total of 429 patients were included and 143 patients (33.3%) were operated by one 
surgeon whereas 286 patients (66.7%) were operated by two surgeons. Patients operated by two surgeons were younger, more often male, and had a higher BMI. A multivariate analy-sis with propensity scores revealed that surgery with two surgeons was associated with less reoperations. Colorectal anastomotic leakage and mortality were not associated with the number of surgeons involved in the surgical procedure.
Part III PreventionIn Chapter 8, a systematic review and meta-analysis was described exploring whether the 
intraoperative air leak test (ALT) prevents colorectal AL. This review stated that available 
evidence was prone to substantial risk of bias. The positive ALT rate varied from 1.5% to 
24.7% and a higher incidence of AL was found in patients with a positive ALT compared to 
patients with a negative ALT.
Part IV Early detectionIn Chapter 9, available literature about systemic and peritoneal inflammatory cytokines for 
early detection of colorectal AL was evaluated. This systematic review and meta-analysis 
included 7 studies that evaluated systemic and peritoneal levels of TNFα, IL1β, IL6 and IL10 after colorectal resection. Systemic cytokine levels were not associated with AL. Peritoneal 
levels of IL6 were significantly higher in patients with leakage on postoperative day 1,2 and 
12
228
Chapter 12
3 whereas peritoneal levels of TNFα were significantly higher in patients with leakage on postoperative day 3,4 and 5.
In Chapter 10, an international multicenter prospective cohort study was described which assessed a combination of biomarkers for early detection of AL after rectal resection. Sys-
temic CRP and peritoneal MMP2, MMP9, glucose, lactate, IL1β, IL6, IL10, TNFα, Escherichia coli, Enterococcus faecalis, LBP and amylase were analyzed. In total, 292 patients were ana-
lyzed and 38 (13.0%) patients suffered from AL. The prediction model, including CRP and MMP9 on postoperative day 3, obtained best model performance with adequate discrim-
ination (c-index = 0.78) and calibration (mean absolute error = 0.025). A nomogram was 
built in an online calculator. This study showed that that the combination of serum CRP and peritoneal MMP9 on postoperative day 3 was predictive for AL while the median time to diagnosis was 6 days.
In Chapter 11, the results of this thesis were discussed.
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Nederlandse samenvatting
Naadlekkage is thans de meest gevreesde complicatie na colorectale chirurgie. Dit proef-schrift richt zich op de verschillende klinische aspecten van colorectale naadlekkage om de incidentie in kaart te brengen en om de gevolgen van deze postoperatieve complicatie te verminderen.
Deel I RisicobeoordelingIn Hoofdstuk 2 werden risicofactoren voor vroege en late colorectale naadlekkage geïden-
tificeerd in een landelijke audit, namelijk in de Dutch ColoRectal Audit (DCRA). In dit onder-zoek werden 36.929 patiënten geanalyseerd, die in Nederland tussen 2011 en 2015 een re-sectie ondergingen vanwege een colorectaal carcinoom en bij wie een primaire naad oftewel 
anastomose werd aangelegd. In totaal ontwikkelden 1.537 (4,1%) patiënten postoperatief een naadlekkage. Het mannelijk geslacht en een rectumcarcinoom waren geassocieerd met het ontstaan van vroege en late naadlekkage. Hoge Body Mass Index (BMI), laparoscopie, spoedoperatie en geen ontlastend ileostoma waren risicofactoren voor vroege naadlekk-age. Charlson Comorbidity Index ≥ II, American Society of Anesthesiologists (ASA) score ≥ 3, preoperatieve tumorcomplicatie, uitgebreide resectie vanwege tumorgroei en neo-adjuvan-
te radiotherapie waren risicofactoren voor late naadlekkage. Deze resultaten bevestigen de hypothese dat een vroege naadlekkage gerelateerd is aan het technisch falen van de anasto-mose terwijl een late naadlekkage gerelateerd is aan een verminderde wondgenezing.
In Hoofdstuk 3 werd in dezelfde landelijke audit van de DCRA onderzocht of het interval tussen neo-adjuvante kortdurende radiotherapie en chirurgie voor een rectumcarcinoom invloed had op de incidentie van naadlekkage. In dit onderzoek werden 2.131 patiënten geanalyseerd, die in Nederland tussen 2011 en 2015 een operatie ondergingen vanwege een rectumcarcinoom en bij wie een primaire anastomose werd aangelegd. In totaal ont-
wikkelden 185 (8,7%) patiënten een naadlekkage. Uit dit onderzoek is gebleken dat een operatie binnen 4 dagen na kortdurende radiotherapie leidt tot een toename van het aantal naadlekkages.
In Hoofdstuk 4 werd onderzocht wat de invloed van de leeftijd is op het ontstaan van naad-
lekkage na een colorectale resectie. Data werden verkregen uit dezelfde landelijke audit van 
de DCRA. In dit onderzoek werden 45.488 patiënten geanalyseerd, die in Nederland tus-sen 2011 en 2016 een resectie ondergingen vanwege een colorectaal carcinoom en bij wie 
een primaire anastomose werd aangelegd. De incidentie van naadlekkage was het laagst bij 
patiënten ≥ 80 jaar (6,4% bij patiënten < 60 jaar; 5,5% bij patiënten 60-69 jaar; 4,9% bij 
patiënten ≥ 80 jaar). Multivariabele logistische regressie toonde aan dat een hogere leeftijd 
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beschermend was voor naadlekkage. Daartegenover toonde deze landelijke studie dat ho-gere leeftijd sterk geassocieerd was met mortaliteit na naadlekkage. Bij patiënten > 80 jaar 
was de mortaliteit na naadlekkage maar liefst 27,0%.
In Hoofdstuk 5 werden postoperatieve complicaties geëvalueerd na neo-adjuvante chemo-
therapie en chirurgie (CRT) voor een lokaal gevorderd rectumcarcinoom en kortdurende 
radiotherapie met chirurgie na een verlengd interval (SCRT-delay). Data werden verkregen 
uit dezelfde landelijke audit van de DCRA. In dit onderzoek werden 2.929 patiënten geana-lyseerd, die in Nederland tussen mei 2014 en december 2017 werden geopereerd voor een lokaal gevorderd rectumcarcinoom. Na het matchen op basis van de propensity score, zaten 
er 238 patiënten in beide groepen, In de SCRT-delay kregen 63 patiënten (21,9%) een pri-
maire anastomose, vergeleken met 1253 patiënten (47,5%) in de CRT-groep. De frequentie van re-interventies voor lekkage van anastomose was verschillend tussen de twee groepen 
(4,8% vs. 7,6%, p = 0,583).
Deel II Chirurgische techniekenIn Hoofdstuk 6 werd de postoperatieve morbiditeit na laparoscopische totale mesorectale 
excisie (LaTME) en transanale totale mesorectale excisie (TaTME) vergeleken. Deze studie was een subgroep analyse van een multicenter prospectieve cohortstudie (Hoofdstuk 9). In 
totaal werden er 220 patiënten die LaTME of TaTME ondergingen geselecteerd uit de co-hortstudie. Na matchen op basis van de propensity score, werden in totaal 48 patiënten in de 
LaTME groep en 48 in de TaTME groep vergeleken. In deze studie werden geen verschillen 
in naadlekkage incidentie gevonden. De postoperatieve morbiditeit was vergelijkbaar voor 
LaTME en TaTME.
In Hoofdstuk 7 werd onderzocht of het aantal chirurgen dat betrokken was bij een colo-rectale ingreep van invloed was op de postoperatieve uitkomsten in een klein ziekenhuis. 
In totaal werden 429 patiënten geïncludeerd, daarvan werden 143 patiënten (33,3%) door 
één chirurg geopereerd en 286 patiënten (66,7%) door twee chirurgen. Patiënten die door twee chirurgen werden geopereerd waren jonger, vaker van het mannelijk geslacht en had-den een hogere BMI. Een multivariabele logistische regressie met de propensity score liet zien dat het geopereerd worden door twee chirurgen geassocieerd was met minder her-operaties. Naadlekkage en mortaliteit waren niet geassocieerd met het aantal chirurgen dat betrokken was bij de chirurgische ingreep.
Deel III PreventieIn Hoofdstuk 8 werd een systematische review en meta-analyse uitgevoerd, waarin onder-
zocht werd of de fietsbandproef tijdens een colorectale resectie naadlekkage voorkomt. Er 
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werd geconcludeerd dat de beschikbare literatuur gevoelig was voor bias. De frequentie van 
een positieve fietsbandproef varieerde van 1,5% tot 24,7%. Er werd een hogere naadlekk-
age incidentie gevonden bij patiënten met een positieve fietsbandproef dan bij patiënten 
met een negatieve fietsbandproef.
Deel IV Vroegtijdige detectieIn Hoofdstuk 9 werd de beschikbare literatuur bestudeerd betreffende de waarde van 
systemische en peritoneale inflammatoire cytokines voor de vroege detectie van naadlekk-
age na een colorectale resectie. Dit systematische review omvatte 7 studies die TNFα, IL1β, IL6 en IL10 evalueerden. Systemische cytokines waren niet geassocieerd met naadlekk-
age. IL6 in drainvocht was significant hoger bij patiënten met naadlekkage op dag 1, 2 en 3 
postoperatief. TNFα in drainvocht was significant hoger bij patiënten met naadlekkage op dag 3, 4 en 5 postoperatief.
Hoofdstuk 10 betreft een internationale multicenter prospectieve cohortstudie waarin ge-zocht werd naar een combinatie van biomarkers die voorspellend was voor naadlekkage na resectie van een rectumcarcinoom. Serum CRP en MMP2, MMP9, glucose, lactaat, IL1ß, 
IL6, IL10, TNFa, Escherichia coli, Enterococcus faecalis, LBP en amylase werden geanaly-seerd in drainvocht op de eerste 3 dagen na de operatie. In totaal werden 292 patiënten 
geanalyseerd en 38 (13,0%) patiënten hadden naadlekkage. Het predictiemodel, inclusief 
CRP en MMP9 op postoperatieve dag 3, liet een adequate discriminatie (c-index = 0,78) en 
kalibratie (gemiddeld absoluut error = 0,025) zien. Deze studie toonde aan dat de combina-tie van serum CRP en MMP9 in drainvocht op postoperatieve dag 3 voorspellend was voor naadlekkage, terwijl de mediane tijd tot diagnose 6 dagen was.
In Hoofdstuk 11 werden de resultaten van dit proefschrift bediscussieerd.
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Dankwoord
Dit proefschrift was niet tot stand gekomen zonder de bijdrage van velen. Ik wil een aantal mensen in het bijzonder bedanken.
Mijn promotor, professor Lange, uiteraard wil ik u bedanken voor de kans die u mij 4 jaar ge-
leden heeft gegeven. U gaf mij toendertijd het vertrouwen om als jonge geneeskundestudent 
klinisch multicenter onderzoek te doen. Daar ben ik u enorm dankbaar voor. Hoe u als pro-fessor ons als onderzoekers in alle vrijheid stimuleert om met eigen onderzoeksvoorstellen te komen is uniek, en de betogen die hiermee gepaard gaan om u hiervan te overdagen zeer leerzaam!
Mijn andere promotor, professor D’Hoore, veel dank ben ik u verontschuldigd voor uw bij-
drage aan dit proefschrift. De APPEAL-II studie is mede door uw verdienste een succes in zowel Nederland als België geworden.
Mijn copromotor, professor Jeekel, uw passie voor het vak is ronduit aanstekelijk. Daarnaast is uw grenzeloze nieuwsgierigheid meer dan bewonderingswaardig. Als het onderzoek even 
niet vlekkeloos verliep, wist u mij met uw onuitputtelijke positiviteit te motiveren. Daar ben ik u dan ook zeer dankbaar voor.
Mijn andere copromotor, dr. Komen, beste Niels, dank dat ik van jou het stokje mocht over-nemen om de APPEAL-studie voort te zetten. Samen hebben we een mooi vervolg aan de eerste studie kunnen geven.
Professor Bemelman, Professor van Eijck, Professor Verhoef, geachte leden van de leescom-missie, dank voor de bereidheid om zitting te nemen in de leescommissie. Ik kijk uit naar de gedachtewisseling.
Professor Bouvy, Professor Kleinrensink en dr. Menon, geachte leden van de grote commis-sie, dank voor de bereidheid om zitting te nemen in de grote commissie. Het zal ongetwijfeld 
een interessante discussie worden. Professor Kleinrensink, het is zo ver, mijn proefschrift 
is af. De strijdbijl kan worden neergelegd en de kogelwerende vesten weer terug in de mot-
tenballen. Dank voor uw begeleiding, vrolijkheid en uw voorliefde voor Rotterdam. Anand, dank voor de begeleiding en gezelligheid!
Zhouqiao Wu, dear Ciao, it has already been 7 years ago that our friendship started over operating rats and it has resulted in several publications and a phenomenal trip to China 
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visiting your Gastric Cancer Congress and the Chinese Wall. Thank you for your support. I 
am looking forward to our next lunch at Jaffa!
Annelies, veel dank voor de ondersteuning bij het regelen van de formele zaken rondom mijn promotie!
Heelkunde-onderzoekers, de lunches, borrels en natuurlijk de skireizen waren een belang-
rijk onderdeel van het onderzoekersleven. Dank voor alle gezelligheid.
Mijn keldergenoten, Leo, Jeroen, Mike, Daan en Buttner, wat hebben we een mooie tijd ge-
had! Ondanks dat het daarbeneden af en toe net Diergaarde Blijdorp leek, had ik het voor 
geen goud willen missen. De kelder waar ‘R’ het wekelijks zwaar te verduren kreeg en zowel 
Bieber als Tino regelmatig op bezoek kwamen om ene keer per jaar vervangen te worden 
door die ene klassieke carnavalskraker. Gelukkig werd er niet alleen op Dumpert het ene na 
het andere succes behaald en kijk nu eens waar we allemaal staan! Dank voor jullie hulp en advies wanneer ik daarom verlegen zat. Lieve Yagmur, onze goede gesprekken bij een kop 
koffie of goed glas wijn zijn een feest! Lieve Gijs, Kristel en Pim, succes met de laatste loodjes.
Huize Kweenie, lieve kweenies, vanuit mijn ouderlijk huis werd hier mijn Rotterdamse op-voeding voortgezet. Het was heerlijk om in mijn laatste jaren in huis, waarin ik aan dit proef-schrift werkte, thuis te komen en dat hele onderzoek volledig achter me te laten en over te 
gaan op de orde van de dag… De afronding van dit proefschrift kan dan ook maar op één manier gevierd worden, en jullie het weten het, iets met keerweer en margherita, ik kijk er naar uit.
JC PIP, lieve pippers, ooit lelijk en dik, nu oud en bijna getrouwd. Ik koester de herinneringen aan onze mooie studententijd en ben enorm trots op waar we allemaal staan. Wij staan voor 
elkaar, één voor allen, allen voor één.
Lieve Nicole, ook jij hebt een grote bijdrage geleverd aan de totstandkoming van dit boekje! 
Dank voor jouw kritische blik. Gelukkig kom je bijna naar Rotterdam, dan kunnen we onze studie weer eens bespreken onder het genot van een lekkere rol koekjes...
Lieve Rozemarijn, onze vriendschap is simpelweg een feest. Waar we daar vroeger een hele 
beperkte definitie voor hadden, neemt dit tegenwoordig andere dimensies aan en wanen 
we ons online marketing experts of echte aquarel liefhebbers. Dank voor jouw creatieve bijdrage aan mijn proefschrift!
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Mijn paranimfen, Moshe en Roos, wie anders dan jullie hadden er op dit bijzondere moment naast mij kunnen staan. Al jarenlang, letterlijk door dik en dun, mijn beste vrienden. Lieve Mosh, sinds de eerste klas van het Erasmiaans hebben wij lief en leed met elkaar gedeeld. Ik bewonder jouw loyaliteit enorm, als je eenmaal in jouw hart zit, kom je er niet snel meer uit. 
Veel dank dat jij altijd voor mij en mijn naasten klaar staat! Lieve Roos, zo’n 12 jaar gelden is het begonnen toen wij op het hockeyveld de verdediging vormden. We gingen samen stude-ren, werden clubgenoten en natuurlijk stonden we samen achter de mooiste bar! Inmiddels 
is het tij gekeerd en hebben we al heel wat dromen waar mogen maken! De komende tijd zullen we helaas niet alles meer kunnen delen maar ik weet zeker dat onze hele slechte mu-zieksmaak een goede basis vormt voor de komende jaren.
Mijn oma, lieve oma miepiema, wat word ik toch altijd ontzettend verwend door jou! De we-kelijkse etentjes bij jou, met eten in overvloed en natuurlijk een moorkop toe, zijn een feest, vooral na een lange onderzoeksdag. Ik vind het jammer dat ik dat de komende tijd wat vaker zal missen! Hoe groos jij was toen ik mijn diploma van het Erasmiaans in ontvangst nam, is een enorme inspiratie geweest voor het schrijven van dit proefschrift. Eigenlijk verdien jij een hele pagina in dit proefschrift! Jij betekent heel veel voor mij!
Pap en mam, woorden schieten tekort als ik moet beschrijven hoe dankbaar ik jullie ben. 
Dankbaar voor de steun die ik altijd heb gehad bij de keuzes die ik de afgelopen jaren heb 
gemaakt. Dankbaar voor de veilige thuishaven die jullie mij gegeven hebben en dankbaar voor de Rotterdamse opvoeding waar ik van jongs af aan heb geleerd dat hard werken wordt beloond. Ik zou dit graag voor jullie terug doen. Bedankt voor alles.
Lieve Sjoerd, jouw vertrouwen, jouw geduld, jouw loyaliteit, jouw liefde en zelfs jouw sikke-neurigheid doen mij deugd. Wat hebben we het toch goed samen. 
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Cloë Lean Sparreboom was born on February 13th 1992. She grew up in Rotterdam and graduated from Erasmiaans Gymnasium in 
Rotterdam in 2010. After this, she moved to London, United King-dom to study English.
She returned and commenced medical school at the Erasmus Uni-
versity Rotterdam in 2011. During medical school, she undertook 
an internship in Suriname. In 2014 she acquired the bachelor’s degree in medicine and started the clinical research master at the Netherlands Institute for Health Sciences (NIHES) for which she attended a summer school 
at Johns Hopkins University School of Public Health in Baltimore, United States.
The first steps for her thesis were taken during the clinical research master program at the 
department of surgery, Erasmus MC University Medical Center under supervision of Prof. dr. 
J.F. Lange, Prof. dr. J. Jeekel and Prof. dr. G.J. Kleinrensink. In 2015 she got the opportunity to 
proceed with her research project as a PhD candidate. In 2017 she restarted medical school. 
Currently she is involved in clinical rotations and she expects to graduate in February 2020.
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